Peter Kolchinsky - Insider Trading Tracker

एक्यूमेन फार्मास्यूटिकल्स, इंक.

US ˙ NasdaqGS ˙ US00509G2093

परिचय

यह पृष्ठ Peter Kolchinsky के ज्ञात इनसाइडर व्यापार इतिहास का व्यापक विश्लेषण प्रदान करता है। इनसाइडर किसी कंपनी के अधिकारी, निदेशक या महत्वपूर्ण निवेशक होते हैं। इनसाइडर के लिए विशिष्ट, गैर-सार्वजनिक जानकारी के आधार पर अपनी कंपनियों में व्यापार करना गैरकानूनी है। इसका मतलब यह नहीं है कि उनके लिए अपनी कंपनियों में कोई भी व्यापार करना गैरकानूनी है। हालाँकि, उन्हें फॉर्म 4 के माध्यम से SEC को सभी ट्रेड्स की रिपोर्ट करनी होगी। इन प्रतिबंधों के बावजूद, अकादमिक शोध से पता चलता है कि इनसाइडर - सामान्य तौर पर - अपनी कंपनियों में बाजार से बेहतर प्रदर्शन करते हैं।

औसत व्यापार लाभप्रदता

औसत ट्रेड लाभप्रदता पिछले तीन वर्षों में इनसाइडर द्वारा की गई सभी खुले बाजार खरीद का औसत रिटर्न है। इसकी गणना करने के लिए, हम 10b5-1 ट्रेडिंग योजना के हिस्से के रूप में चिह्नित सभी ट्रेडों को छोड़कर, इनसाइडर द्वारा की गई प्रत्येक खुले बाजार, अनियोजित खरीदारी की जांच करते हैं। फिर हम 3, 6 और 12 महीनों में उन ट्रेडों के औसत प्रदर्शन की गणना करते हैं, प्रत्येक ट्रेड के लिए अंतिम प्रदर्शन मीट्रिक तैयार करने के लिए उनमें से प्रत्येक अवधि का औसत निकालते हैं। अंत में, हम इनसाइडर के लिए प्रदर्शन मीट्रिक की गणना करने के लिए सभी प्रदर्शन मीट्रिक का औसत निकालते हैं। इस सूची में केवल उन इनसाइडर को शामिल किया गया है जिन्होंने पिछले दो वर्षों में कम से कम तीन ट्रेड किए हैं।

यदि इस इनसाइडर ट्रेड की लाभप्रदता "N/A" है, तो इनसाइडर ने या तो पिछले तीन वर्षों में कोई खुले बाजार में खरीदारी नहीं की है, या उनके द्वारा किए गए व्यापार एक विश्वसनीय प्रदर्शन मीट्रिक की गणना करने के लिए बहुत हाल के हैं।

अपडेट फ्रीक्वेंसी: दैनिक

सर्वाधिक लाभदायक इनसाइडर व्यापारियों की सूची देखें।

उच्चतम रैंकिंग वाले इनसाइडर देखें

रिपोर्ट की गई इनसाइडर स्थिति वाली कंपनियाँ

SEC फाइलिंग से संकेत मिलता है कि Peter Kolchinsky ने निम्नलिखित कंपनियों में होल्डिंग्स या ट्रेड्स की सूचना दी है:

प्रतिभूति	टाइटल	नवीनतम रिपोर्ट की गई होल्डिंग्स
US:WVE / Wave Life Sciences Ltd.	Director, 10% Owner	28,815
US:CDTX / Cidara Therapeutics, Inc.	Director, 10% Owner	3,365,523
US:TYRA / Tyra Biosciences, Inc.	Director, 10% Owner	10,259,291
US:JANX / Janux Therapeutics, Inc.	Director, 10% Owner	6,250
US:ABOS / Acumen Pharmaceuticals, Inc.	Director, 10% Owner	12,800
US:HOWL / Werewolf Therapeutics, Inc.	Director, 10% Owner	6,237,482
	10% Owner	1,287,858
US:MLYS / Mineralys Therapeutics, Inc.	Director	4,280,051
	Director, 10% Owner	2,324,498
US:ETNB / 89bio, Inc.	Director, 10% Owner	19,554,319
US:VOR / Vor Biopharma Inc.	Director, 10% Owner	37,820,713
US:FDMT / 4D Molecular Therapeutics, Inc.	10% Owner	4,563,211
	Director, 10% Owner	1,471,943
US:FULC / Fulcrum Therapeutics, Inc.	10% Owner	10,229,099
	Director, 10% Owner	2,652,575
US: / AN2 THERAPEUTICS	10% Owner	300,853
	Director, 10% Owner	826,832
US:ELYM / Eliem Therapeutics, Inc.	Director, 10% Owner	2,866,375
US:ITOS / iTeos Therapeutics, Inc.		2,545,510
US:ACRV / Acrivon Therapeutics, Inc.	Director, 10% Owner	7,914,206
	10% Owner	295,844
US:NKTX / Nkarta, Inc.	Director, 10% Owner	10,050,818
US:SPRY / ARS Pharmaceuticals, Inc.	Director, 10% Owner	9,958,073
	Director, 10% Owner	694,755
US:ICVX / Icosavax, Inc.	Director, 10% Owner	0
US:PEPG / PepGen Inc.	Director, 10% Owner	9,179,273
US:SLDB / Solid Biosciences Inc.	Director, 10% Owner	4,192,216
US:DICE / DICE Therapeutics Inc		0
US:BDTX / Black Diamond Therapeutics, Inc.	Director	3,213,828
US:STSA / Satsuma Pharmaceuticals Inc		0
US:ELVN / Enliven Therapeutics, Inc.		2,122,465
US:FMTX / Forma Therapeutics Holdings Inc	10% Owner	0
US:KALA / KALA BIO, Inc.	10% Owner	7,039,613
US:CTKB / Cytek Biosciences, Inc.	Director, 10% Owner	13,381,054
US:RXST / RxSight, Inc.	10% Owner	2,838,938
	Chief Executive Officer, Director	1,098,318
US:SCPH / scPharmaceuticals Inc.	10% Owner	2,727,446
US:PHAT / Phathom Pharmaceuticals, Inc.	10% Owner	3,115,008
US:ORTX / Orchard Therapeutics plc - Depositary Receipt (Common Stock)	Director, 10% Owner	3,215,434
US:ITRM / Iterum Therapeutics plc	10% Owner	0
US:VRDN / Viridian Therapeutics, Inc.	10% Owner	410,686
US:RYTM / Rhythm Pharmaceuticals, Inc.		4,360,860
US:PCVX / Vaxcyte, Inc.	10% Owner	5,001,593
US:CRDF / Cardiff Oncology, Inc.	10% Owner	3,290,000
US:PMVP / PMV Pharmaceuticals, Inc.	10% Owner	0
	10% Owner	0
US:TGTX / TG Therapeutics, Inc.	10% Owner	12,629,868
US:INBX / Inhibrx Biosciences, Inc.	10% Owner	0
US:INZY / Inozyme Pharma, Inc.	10% Owner	0
	10% Owner	0
US:AKUS / Akouos Inc	10% Owner	0
US:VSTM / Verastem, Inc.	10% Owner	16,142,051
US:RARX / Ra Pharmaceuticals, Inc.	Director, 10% Owner	0
US:THOR / Synthorx Inc	Director, 10% Owner	0
US:DRNA / Dicerna Pharmaceuticals Inc	Director	0
US:EIGR / Eiger BioPharmaceuticals, Inc.	10% Owner	4,830,916
US:ARVN / Arvinas, Inc.		0
	10% Owner	0
US:KALV / KalVista Pharmaceuticals, Inc.	Director, 10% Owner	1,441,070
US:GTHX / G1 Therapeutics, Inc.		0
US:ACRS / Aclaris Therapeutics, Inc.	10% Owner	2,102,169
US:SGMO / Sangamo Therapeutics, Inc.		3,118,218
	10% Owner	7,760
US:DSCI / Derma Sciences, Inc.		1,694,876

चार्ट को कैसे समझे

निम्नलिखित चार्ट Peter Kolchinsky द्वारा किए गए प्रत्येक खुले-बाज़ार, गैर-योजनाबद्ध व्यापार के बाद प्रतिभूतियों के स्टॉक प्रदर्शन को दर्शाते हैं। गैर-योजनाबद्ध व्यापार वे व्यापार हैं जो 10b5-1 ट्रेडिंग योजना के हिस्से के रूप में नहीं किए गए थे। स्टॉक प्रदर्शन को शेयर मूल्य में संचयी प्रतिशत परिवर्तन के रूप में चार्ट किया गया है। उदाहरण के लिए, यदि कोई इनसाइडर व्यापार 1 जनवरी, 2019 को किया गया था, तो चार्ट आज तक प्रतिभूति में दैनिक प्रतिशत परिवर्तन दिखाएगा। यदि इस दौरान शेयर की कीमत $10 से $15 तक जाती है, तो शेयर की कीमत में संचयी प्रतिशत परिवर्तन 50% होगा। $10 से $20 तक की कीमत में परिवर्तन 100% होगा, और $10 से $5 की कीमत में परिवर्तन -50% होगा।

अंततः, हम यह निर्धारित करने का प्रयास कर रहे हैं कि इनसाइडर के व्यापार शेयर की कीमत में अतिरिक्त रिटर्न (सकारात्मक या नकारात्मक) से कितनी निकटता से संबंधित हैं, यह देखने के लिए कि क्या इनसाइडर, इनसाइडर जानकारी से लाभ के लिए अपने व्यापार का समय निर्धारित कर रहे हैं। उस स्थिति पर विचार करें जहां कोई इनसाइडर ऐसा कर रहा था। इस स्थिति में, हम या तो (a) खरीदारी के बाद सकारात्मक रिटर्न, या (a) बिक्री के बाद नकारात्मक रिटर्न की उम्मीद करेंगे। (a) के मामले में, खरीद चार्ट ऊपर की ओर झुके हुए वक्रों की एक श्रृंखला दिखाएगा, जो प्रत्येक खरीद लेनदेन के बाद सकारात्मक रिटर्न का संकेत देगा। (a) के मामले में, बिक्री चार्ट नीचे की ओर झुके हुए वक्रों की एक श्रृंखला दिखाएगा, जो प्रत्येक बिक्री लेनदेन के बाद नकारात्मक रिटर्न का संकेत देगा।

हालाँकि, केवल यह निष्कर्ष निकालने के लिए पर्याप्त नहीं है। यदि, उदाहरण के लिए, कंपनी का शेयर मूल्य कई वर्षों से गैर-चक्रीय चढ़ाई में था, तो हम उम्मीद करेंगे कि खरीद के बाद के सभी प्लॉट ऊपर की ओर झुके हुए होंगे। इसी तरह, कई वर्षों में गैर-चक्रीय गिरावट के परिणामस्वरूप व्यापार के बाद के प्लॉट नीचे की ओर झुकेंगे। इनमें से कोई भी चार्ट इनसाइडर व्यापार गतिविधि का सुझाव नहीं देगा।

सबसे मजबूत संकेतक वह स्थिति होगी जहां शेयर की कीमत बेहद चक्रीय थी, और खरीद चार्ट में सकारात्मक संकेत और बिक्री चार्ट पर नकारात्मक प्लॉट दोनों थे। यह स्थिति एक इनसाइडर के लिए अत्यधिक संकेत देने वाली होगी जो अपने वित्तीय लाभ के लिए ट्रेड्स का समय निर्धारित कर रहा था।

इनसाइडर खरीदारी ABOS / Acumen Pharmaceuticals, Inc. - अल्पकालिक लाभ विश्लेषण

इस अनुभाग में, हम ABOS / Acumen Pharmaceuticals, Inc. में की गई प्रत्येक अनियोजित, खुले बाज़ार की इनसाइडर खरीदारी की लाभप्रदता का विश्लेषण करते हैं। यह विश्लेषण यह समझने में मदद करता है कि क्या इनसाइडर लगातार असामान्य रिटर्न उत्पन्न करता है, और यह अनुसरण करने लायक है। यह विश्लेषण प्रत्येक व्यापार के बाद एक वर्ष के लिए है, और परिणाम सैद्धांतिक हैं।

निम्न तालिका सबसे हालिया खुले बाज़ार की खरीदारी को दर्शाती है जो स्वचालित ट्रेडिंग योजना का हिस्सा नहीं थी।

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन अधिकतम	मूल्य अधिकतम	अधिकतम लाभ ($)	अधिकतम रिटर्न (%)
2023-07-21	ABOS	RA CAPITAL MANAGEMENT, LLC	5,161,290	7.7500	5,161,290	7.7500	39,999,998	0	7.4000	-1,806,451	-4.52
2021-07-06	ABOS	RA CAPITAL MANAGEMENT, LLC	1,759,332	16.0000	1,759,332	16.0000	28,149,312
2021-07-06	ABOS	RA CAPITAL MANAGEMENT, LLC	115,668	16.0000	115,668	16.0000	1,850,688

समायोजित कीमत विभाजित-समायोजित कीमत है। समायोजित शेयर विभाजित-समायोजित शेयर हैं।

ABOS / Acumen Pharmaceuticals, Inc. Insider Trades

इनसाइडर बिक्री ABOS / Acumen Pharmaceuticals, Inc. - अल्पकालिक हानि विश्लेषण

इस अनुभाग में, हम ABOS / Acumen Pharmaceuticals, Inc. में की गई प्रत्येक अनियोजित, खुले बाज़ार की इनसाइडर बिक्री के अल्पकालिक नुकसान से बचने का विश्लेषण करते हैं। हानि से बचने का एक सुसंगत पैटर्न यह सुझाव दे सकता है कि भविष्य में बिक्री लेनदेन कीमत में गिरावट की भविष्यवाणी कर सकते हैं। यह विश्लेषण प्रत्येक व्यापार के बाद एक वर्ष के लिए है, और परिणाम सैद्धांतिक हैं।

निम्न तालिका सबसे हालिया खुले बाज़ार की बिक्री को दर्शाती है जो स्वचालित ट्रेडिंग योजना का हिस्सा नहीं थी।

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन न्यूनतम	मूल्य न्यूनतम	अधिकतम हानि बचाया ($)	अधिकतम हानि बचाया (%)
इस इनसाइडर और प्रतिभूति संयोजन के लिए कोई ज्ञात अनियोजित खुले बाज़ार व्यापार नहीं हैं

इनसाइडर खरीदारी ACRS / Aclaris Therapeutics, Inc. - अल्पकालिक लाभ विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन अधिकतम	मूल्य अधिकतम	अधिकतम लाभ ($)	अधिकतम रिटर्न (%)
2016-02-23	ACRS	RA CAPITAL MANAGEMENT, LLC	28,408	17.6187	28,408	17.6187	500,512	297	31.25	387,238	77.37
2016-02-22	ACRS	RA CAPITAL MANAGEMENT, LLC	11,318	15.9885	11,318	15.9885	180,958
2016-01-20	ACRS	RA CAPITAL MANAGEMENT, LLC	1,803	19.8830	1,803	19.8830	35,849
2016-01-19	ACRS	RA CAPITAL MANAGEMENT, LLC	4,200	19.8763	4,200	19.8763	83,480
2016-01-15	ACRS	RA CAPITAL MANAGEMENT, LLC	1,800	19.8572	1,800	19.8572	35,743
2016-01-13	ACRS	RA CAPITAL MANAGEMENT, LLC	5,543	19.9665	5,543	19.9665	110,674
2016-01-12	ACRS	RA CAPITAL MANAGEMENT, LLC	5,941	19.1188	5,941	19.1188	113,585
2016-01-11	ACRS	RA CAPITAL MANAGEMENT, LLC	4,153	17.9337	4,153	17.9337	74,479
2015-10-29	ACRS	RA CAPITAL MANAGEMENT, LLC	95,000	14.0000	95,000	14.0000	1,330,000
2015-10-28	ACRS	RA CAPITAL MANAGEMENT, LLC	149,200	14.0000	149,200	14.0000	2,088,800
2015-10-22	ACRS	RA CAPITAL MANAGEMENT, LLC	5,410	14.0264	5,410	14.0264	75,883
2015-10-21	ACRS	RA CAPITAL MANAGEMENT, LLC	3,100	14.8311	3,100	14.8311	45,976
2015-10-20	ACRS	RA CAPITAL MANAGEMENT, LLC	7,965	14.9491	7,965	14.9491	119,070
2015-10-19	ACRS	RA CAPITAL MANAGEMENT, LLC	23,934	14.8763	23,934	14.8763	356,049
2015-10-14	ACRS	RA CAPITAL MANAGEMENT, LLC	42,813	14.0563	42,813	14.0563	601,792
2015-10-08	ACRS	RA CAPITAL MANAGEMENT, LLC	21,691	10.9979	21,691	10.9979	238,555
2015-10-07	ACRS	RA CAPITAL MANAGEMENT, LLC	938,041	10.6605	938,041	10.6605	9,999,986
2015-10-07	ACRS	RA CAPITAL MANAGEMENT, LLC	1,250,000	11.0000	1,250,000	11.0000	13,750,000
2015-10-07	ACRS	RA CAPITAL MANAGEMENT, LLC	27,398	11.0000	27,398	11.0000	301,378

ACRS / Aclaris Therapeutics, Inc. Insider Trades

इनसाइडर बिक्री ACRS / Aclaris Therapeutics, Inc. - अल्पकालिक हानि विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन न्यूनतम	मूल्य न्यूनतम	अधिकतम हानि बचाया ($)	अधिकतम हानि बचाया (%)
2016-09-16	ACRS	RA CAPITAL MANAGEMENT, LLC	150,000	24.5000	150,000	24.5000	3,675,000	53	20.5300	-595,500	-16.20
2016-09-16	ACRS	RA CAPITAL MANAGEMENT, LLC	23,600	24.5429	23,600	24.5429	579,212
2016-09-15	ACRS	RA CAPITAL MANAGEMENT, LLC	20,000	24.0350	20,000	24.0350	480,700
2016-09-15	ACRS	RA CAPITAL MANAGEMENT, LLC	273,000	24.0000	273,000	24.0000	6,552,000
2016-09-15	ACRS	RA CAPITAL MANAGEMENT, LLC	58,950	24.2000	58,950	24.2000	1,426,590

इनसाइडर खरीदारी ACRV / Acrivon Therapeutics, Inc. - अल्पकालिक लाभ विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन अधिकतम	मूल्य अधिकतम	अधिकतम लाभ ($)	अधिकतम रिटर्न (%)
2022-11-17	ACRV	RA CAPITAL MANAGEMENT, LLC	3,389,500	12.5000	3,389,500	12.5000	42,368,750	89	23.2000	36,267,650	85.60

ACRV / Acrivon Therapeutics, Inc. Insider Trades

इनसाइडर बिक्री ACRV / Acrivon Therapeutics, Inc. - अल्पकालिक हानि विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन न्यूनतम	मूल्य न्यूनतम	अधिकतम हानि बचाया ($)	अधिकतम हानि बचाया (%)
इस इनसाइडर और प्रतिभूति संयोजन के लिए कोई ज्ञात अनियोजित खुले बाज़ार व्यापार नहीं हैं

इनसाइडर खरीदारी ARVN / Arvinas, Inc. - अल्पकालिक लाभ विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन अधिकतम	मूल्य अधिकतम	अधिकतम लाभ ($)	अधिकतम रिटर्न (%)
2018-10-01	ARVN	RA CAPITAL MANAGEMENT, LLC	1,000,000	16.0000	1,000,000	16.0000	16,000,000	298	27.61	11,610,000	72.56

इनसाइडर बिक्री ARVN / Arvinas, Inc. - अल्पकालिक हानि विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन न्यूनतम	मूल्य न्यूनतम	अधिकतम हानि बचाया ($)	अधिकतम हानि बचाया (%)
इस इनसाइडर और प्रतिभूति संयोजन के लिए कोई ज्ञात अनियोजित खुले बाज़ार व्यापार नहीं हैं

इनसाइडर खरीदारी BDTX / Black Diamond Therapeutics, Inc. - अल्पकालिक लाभ विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन अधिकतम	मूल्य अधिकतम	अधिकतम लाभ ($)	अधिकतम रिटर्न (%)
2023-07-05	BDTX	RA CAPITAL MANAGEMENT, LLC	935,850	5.0000	935,850	5.0000	4,679,250	306	7.3900	2,236,682	47.80

BDTX / Black Diamond Therapeutics, Inc. Insider Trades

इनसाइडर बिक्री BDTX / Black Diamond Therapeutics, Inc. - अल्पकालिक हानि विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन न्यूनतम	मूल्य न्यूनतम	अधिकतम हानि बचाया ($)	अधिकतम हानि बचाया (%)
इस इनसाइडर और प्रतिभूति संयोजन के लिए कोई ज्ञात अनियोजित खुले बाज़ार व्यापार नहीं हैं

इनसाइडर खरीदारी CDTX / Cidara Therapeutics, Inc. - अल्पकालिक लाभ विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन अधिकतम	मूल्य अधिकतम	अधिकतम लाभ ($)	अधिकतम रिटर्न (%)
2025-06-26	CDTX	RA CAPITAL MANAGEMENT, LLC	2,272,727	44.0000	2,272,727	44.0000	99,999,988	56	67.4900	53,386,357	53.39

CDTX / Cidara Therapeutics, Inc. Insider Trades

इनसाइडर बिक्री CDTX / Cidara Therapeutics, Inc. - अल्पकालिक हानि विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन न्यूनतम	मूल्य न्यूनतम	अधिकतम हानि बचाया ($)	अधिकतम हानि बचाया (%)
इस इनसाइडर और प्रतिभूति संयोजन के लिए कोई ज्ञात अनियोजित खुले बाज़ार व्यापार नहीं हैं

इनसाइडर खरीदारी CLYM / Climb Bio, Inc. - अल्पकालिक लाभ विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन अधिकतम	मूल्य अधिकतम	अधिकतम लाभ ($)	अधिकतम रिटर्न (%)
2024-06-27	ELYM	RA CAPITAL MANAGEMENT, LLC	11,949,171	3.8400	11,949,171	3.8400	45,884,817	26	8.9300	60,821,281	132.55
2024-06-27	ELYM	RA CAPITAL MANAGEMENT, LLC	1,059,375	3.8400	1,059,375	3.8400	4,068,000
2021-08-12	ELYM	RA CAPITAL MANAGEMENT, LLC	3,004,782	12.5000	3,004,782	12.5000	37,559,775
2021-08-12	ELYM	RA CAPITAL MANAGEMENT, LLC	195,218	12.5000	195,218	12.5000	2,440,225

इनसाइडर बिक्री CLYM / Climb Bio, Inc. - अल्पकालिक हानि विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन न्यूनतम	मूल्य न्यूनतम	अधिकतम हानि बचाया ($)	अधिकतम हानि बचाया (%)
इस इनसाइडर और प्रतिभूति संयोजन के लिए कोई ज्ञात अनियोजित खुले बाज़ार व्यापार नहीं हैं

इनसाइडर खरीदारी CRDF / Cardiff Oncology, Inc. - अल्पकालिक लाभ विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन अधिकतम	मूल्य अधिकतम	अधिकतम लाभ ($)	अधिकतम रिटर्न (%)
इस इनसाइडर और प्रतिभूति संयोजन के लिए कोई ज्ञात अनियोजित खुले बाज़ार व्यापार नहीं हैं

CRDF / Cardiff Oncology, Inc. Insider Trades

इनसाइडर बिक्री CRDF / Cardiff Oncology, Inc. - अल्पकालिक हानि विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन न्यूनतम	मूल्य न्यूनतम	अधिकतम हानि बचाया ($)	अधिकतम हानि बचाया (%)
इस इनसाइडर और प्रतिभूति संयोजन के लिए कोई ज्ञात अनियोजित खुले बाज़ार व्यापार नहीं हैं

इनसाइडर खरीदारी CTKB / Cytek Biosciences, Inc. - अल्पकालिक लाभ विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन अधिकतम	मूल्य अधिकतम	अधिकतम लाभ ($)	अधिकतम रिटर्न (%)
2021-07-27	CTKB	RA CAPITAL MANAGEMENT, LLC	2,762,786	17.0000	2,762,786	17.0000	46,967,362	50	27.93	30,197,251	64.29
2021-07-27	CTKB	RA CAPITAL MANAGEMENT, LLC	187,214	17.0000	187,214	17.0000	3,182,638

CTKB / Cytek Biosciences, Inc. Insider Trades

इनसाइडर बिक्री CTKB / Cytek Biosciences, Inc. - अल्पकालिक हानि विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन न्यूनतम	मूल्य न्यूनतम	अधिकतम हानि बचाया ($)	अधिकतम हानि बचाया (%)
इस इनसाइडर और प्रतिभूति संयोजन के लिए कोई ज्ञात अनियोजित खुले बाज़ार व्यापार नहीं हैं

इनसाइडर खरीदारी ETNB / 89bio, Inc. - अल्पकालिक लाभ विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन अधिकतम	मूल्य अधिकतम	अधिकतम लाभ ($)	अधिकतम रिटर्न (%)
2025-01-30	ETNB	RA CAPITAL MANAGEMENT, LLC	5,714,285	8.7500	5,714,285	8.7500	49,999,994	6	11.6600	16,628,570	33.26
2024-03-04	ETNB	RA CAPITAL MANAGEMENT, LLC	1,350,000	15.3500	1,350,000	15.3500	20,722,500
2023-03-24	ETNB	RA CAPITAL MANAGEMENT, LLC	2,461,538	16.2500	2,461,538	16.2500	39,999,992
2022-10-18	ETNB	RA CAPITAL MANAGEMENT, LLC	1,172,741	7.6500	1,172,741	7.6500	8,971,469
2022-07-01	ETNB	RA CAPITAL MANAGEMENT, LLC	2,816,900	3.5500	2,816,900	3.5500	9,999,995
2021-06-02	ETNB	RA CAPITAL MANAGEMENT, LLC	22,138	18.7700	22,138	18.7700	415,530
2021-05-28	ETNB	RA CAPITAL MANAGEMENT, LLC	123,505	18.7700	123,505	18.7700	2,318,189
2021-05-27	ETNB	RA CAPITAL MANAGEMENT, LLC	35,535	18.7600	35,535	18.7600	666,637
2021-05-26	ETNB	RA CAPITAL MANAGEMENT, LLC	48,377	18.0300	48,377	18.0300	872,237
2020-09-17	ETNB	RA CAPITAL MANAGEMENT, LLC	1,300,000	28.0000	1,300,000	28.0000	36,400,000
2020-07-08	ETNB	RA CAPITAL MANAGEMENT, LLC	275,000	27.5000	275,000	27.5000	7,562,500
2019-11-11	ETNB	RA CAPITAL MANAGEMENT, LLC	1,500,000	16.0000	1,500,000	16.0000	24,000,000

इनसाइडर बिक्री ETNB / 89bio, Inc. - अल्पकालिक हानि विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन न्यूनतम	मूल्य न्यूनतम	अधिकतम हानि बचाया ($)	अधिकतम हानि बचाया (%)
इस इनसाइडर और प्रतिभूति संयोजन के लिए कोई ज्ञात अनियोजित खुले बाज़ार व्यापार नहीं हैं

इनसाइडर खरीदारी FDMT / 4D Molecular Therapeutics, Inc. - अल्पकालिक लाभ विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन अधिकतम	मूल्य अधिकतम	अधिकतम लाभ ($)	अधिकतम रिटर्न (%)
इस इनसाइडर और प्रतिभूति संयोजन के लिए कोई ज्ञात अनियोजित खुले बाज़ार व्यापार नहीं हैं

FDMT / 4D Molecular Therapeutics, Inc. Insider Trades

इनसाइडर बिक्री FDMT / 4D Molecular Therapeutics, Inc. - अल्पकालिक हानि विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन न्यूनतम	मूल्य न्यूनतम	अधिकतम हानि बचाया ($)	अधिकतम हानि बचाया (%)
इस इनसाइडर और प्रतिभूति संयोजन के लिए कोई ज्ञात अनियोजित खुले बाज़ार व्यापार नहीं हैं

इनसाइडर खरीदारी FULC / Fulcrum Therapeutics, Inc. - अल्पकालिक लाभ विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन अधिकतम	मूल्य अधिकतम	अधिकतम लाभ ($)	अधिकतम रिटर्न (%)
2023-01-20	FULC	RA CAPITAL MANAGEMENT, LLC	1,923,076	13.0000	1,923,076	13.0000	24,999,988	26	12.9500	-96,154	-0.38
2023-01-04	FULC	RA CAPITAL MANAGEMENT, LLC	122,334	7.0276	122,334	7.0276	859,714
2023-01-04	FULC	RA CAPITAL MANAGEMENT, LLC	58,369	7.7968	58,369	7.7968	455,091
2022-12-27	FULC	RA CAPITAL MANAGEMENT, LLC	4,089	5.9941	4,089	5.9941	24,510
2022-12-19	FULC	RA CAPITAL MANAGEMENT, LLC	98,787	5.8997	98,787	5.8997	582,814
2022-12-16	FULC	RA CAPITAL MANAGEMENT, LLC	1,341,420	5.4195	1,341,420	5.4195	7,269,826
2022-12-15	FULC	RA CAPITAL MANAGEMENT, LLC	237,029	5.4950	237,029	5.4950	1,302,474
2022-12-14	FULC	RA CAPITAL MANAGEMENT, LLC	824,600	5.4591	824,600	5.4591	4,501,574

FULC / Fulcrum Therapeutics, Inc. Insider Trades

इनसाइडर बिक्री FULC / Fulcrum Therapeutics, Inc. - अल्पकालिक हानि विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन न्यूनतम	मूल्य न्यूनतम	अधिकतम हानि बचाया ($)	अधिकतम हानि बचाया (%)
इस इनसाइडर और प्रतिभूति संयोजन के लिए कोई ज्ञात अनियोजित खुले बाज़ार व्यापार नहीं हैं

इनसाइडर खरीदारी HOWL / Werewolf Therapeutics, Inc. - अल्पकालिक लाभ विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन अधिकतम	मूल्य अधिकतम	अधिकतम लाभ ($)	अधिकतम रिटर्न (%)
2025-05-14	HOWL	RA CAPITAL MANAGEMENT, LLC	162,539	0.9800	162,539	0.9800	159,288	23	1.4200	71,517	44.90
2025-05-13	HOWL	RA CAPITAL MANAGEMENT, LLC	52,974	0.9800	52,974	0.9800	51,915
2025-05-12	HOWL	RA CAPITAL MANAGEMENT, LLC	320,913	0.8600	320,913	0.8600	275,985
2023-01-06	HOWL	RA CAPITAL MANAGEMENT, LLC	1,853,000	2.2100	1,853,000	2.2100	4,095,130
2021-06-16	HOWL	RA CAPITAL MANAGEMENT, LLC	9,285	13.3700	9,285	13.3700	124,140
2021-06-15	HOWL	RA CAPITAL MANAGEMENT, LLC	7,958	12.9500	7,958	12.9500	103,056
2021-06-14	HOWL	RA CAPITAL MANAGEMENT, LLC	306,055	12.7500	306,055	12.7500	3,902,201
2021-05-04	HOWL	RA CAPITAL MANAGEMENT, LLC	1,609,212	16.0000	1,609,212	16.0000	25,747,392
2021-05-04	HOWL	RA CAPITAL MANAGEMENT, LLC	105,788	16.0000	105,788	16.0000	1,692,608

HOWL / Werewolf Therapeutics, Inc. Insider Trades

इनसाइडर बिक्री HOWL / Werewolf Therapeutics, Inc. - अल्पकालिक हानि विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन न्यूनतम	मूल्य न्यूनतम	अधिकतम हानि बचाया ($)	अधिकतम हानि बचाया (%)
इस इनसाइडर और प्रतिभूति संयोजन के लिए कोई ज्ञात अनियोजित खुले बाज़ार व्यापार नहीं हैं

इनसाइडर खरीदारी IMRA / Bitwise Funds Trust - Bitwise MARA Option Income Strategy ETF - अल्पकालिक लाभ विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन अधिकतम	मूल्य अधिकतम	अधिकतम लाभ ($)	अधिकतम रिटर्न (%)
2023-01-03	IMRA	RA CAPITAL MANAGEMENT, LLC	629,297	3.9982	157,324	15.9928	2,516,055	51	6.3200	-1,521,767	-60.48
2022-12-09	IMRA	RA CAPITAL MANAGEMENT, LLC	19,299	3.9300	4,825	15.7200	75,845
2022-12-08	IMRA	RA CAPITAL MANAGEMENT, LLC	10,600	3.7500	2,650	15.0000	39,750
2022-10-24	IMRA	RA CAPITAL MANAGEMENT, LLC	26,460	3.9100	6,615	15.6400	103,459
2022-10-21	IMRA	RA CAPITAL MANAGEMENT, LLC	48,100	3.9200	12,025	15.6800	188,552
2022-10-20	IMRA	RA CAPITAL MANAGEMENT, LLC	11,342	3.9500	2,836	15.8000	44,801
2022-10-19	IMRA	RA CAPITAL MANAGEMENT, LLC	125,726	3.8867	31,432	15.5468	488,659
2022-10-18	IMRA	RA CAPITAL MANAGEMENT, LLC	234,799	3.7600	58,700	15.0400	882,844
2022-10-17	IMRA	RA CAPITAL MANAGEMENT, LLC	145,672	3.3600	36,418	13.4400	489,458
2020-03-16	IMRA	RA CAPITAL MANAGEMENT, LLC	625,000	16.0000	156,250	64.0000	10,000,000

IMRA / Bitwise Funds Trust - Bitwise MARA Option Income Strategy ETF Insider Trades

इनसाइडर बिक्री IMRA / Bitwise Funds Trust - Bitwise MARA Option Income Strategy ETF - अल्पकालिक हानि विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन न्यूनतम	मूल्य न्यूनतम	अधिकतम हानि बचाया ($)	अधिकतम हानि बचाया (%)
इस इनसाइडर और प्रतिभूति संयोजन के लिए कोई ज्ञात अनियोजित खुले बाज़ार व्यापार नहीं हैं

इनसाइडर खरीदारी INBX / Inhibrx Biosciences, Inc. - अल्पकालिक लाभ विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन अधिकतम	मूल्य अधिकतम	अधिकतम लाभ ($)	अधिकतम रिटर्न (%)
इस इनसाइडर और प्रतिभूति संयोजन के लिए कोई ज्ञात अनियोजित खुले बाज़ार व्यापार नहीं हैं

INBX / Inhibrx Biosciences, Inc. Insider Trades

इनसाइडर बिक्री INBX / Inhibrx Biosciences, Inc. - अल्पकालिक हानि विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन न्यूनतम	मूल्य न्यूनतम	अधिकतम हानि बचाया ($)	अधिकतम हानि बचाया (%)
इस इनसाइडर और प्रतिभूति संयोजन के लिए कोई ज्ञात अनियोजित खुले बाज़ार व्यापार नहीं हैं

इनसाइडर खरीदारी JANX / Janux Therapeutics, Inc. - अल्पकालिक लाभ विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन अधिकतम	मूल्य अधिकतम	अधिकतम लाभ ($)	अधिकतम रिटर्न (%)
2025-03-07	JANX	RA CAPITAL MANAGEMENT, LLC	110,206	31.0200	110,206	31.0200	3,418,590	54	33.2000	240,249	7.03
2025-03-06	JANX	RA CAPITAL MANAGEMENT, LLC	372,093	30.7800	372,093	30.7800	11,453,023
2025-03-05	JANX	RA CAPITAL MANAGEMENT, LLC	304,287	30.5600	304,287	30.5600	9,299,011
2025-03-05	JANX	RA CAPITAL MANAGEMENT, LLC	37,455	31.3000	37,455	31.3000	1,172,342
2024-10-18	JANX	RA CAPITAL MANAGEMENT, LLC	1,200,000	44.7500	1,200,000	44.7500	53,700,000
2023-07-19	JANX	RA CAPITAL MANAGEMENT, LLC	495,008	12.4600	495,008	12.4600	6,167,800
2021-06-15	JANX	RA CAPITAL MANAGEMENT, LLC	2,752,190	17.0000	2,752,190	17.0000	46,787,230
2021-06-15	JANX	RA CAPITAL MANAGEMENT, LLC	188,986	17.0000	188,986	17.0000	3,212,762

JANX / Janux Therapeutics, Inc. Insider Trades

इनसाइडर बिक्री JANX / Janux Therapeutics, Inc. - अल्पकालिक हानि विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन न्यूनतम	मूल्य न्यूनतम	अधिकतम हानि बचाया ($)	अधिकतम हानि बचाया (%)
इस इनसाइडर और प्रतिभूति संयोजन के लिए कोई ज्ञात अनियोजित खुले बाज़ार व्यापार नहीं हैं

इनसाइडर खरीदारी KALA / KALA BIO, Inc. - अल्पकालिक लाभ विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन अधिकतम	मूल्य अधिकतम	अधिकतम लाभ ($)	अधिकतम रिटर्न (%)
2020-03-13	KALA	RA CAPITAL MANAGEMENT, LLC	6,337,135	7.8900	126,743	394.5000	49,999,995	81	689.5	37,388,614	74.78
2018-10-03	KALA	RA CAPITAL MANAGEMENT, LLC	2,424,242	8.2500	48,485	412.5000	19,999,996
2017-07-25	KALA	RA CAPITAL MANAGEMENT, LLC	533,333	15.0000	10,667	750.0000	7,999,995

इनसाइडर बिक्री KALA / KALA BIO, Inc. - अल्पकालिक हानि विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन न्यूनतम	मूल्य न्यूनतम	अधिकतम हानि बचाया ($)	अधिकतम हानि बचाया (%)
2022-05-26	KALA	RA CAPITAL MANAGEMENT, LLC	1,005,686	0.3636	20,114	18.1800	365,667	210	3.6700	-291,852	-79.81
2022-05-25	KALA	RA CAPITAL MANAGEMENT, LLC	1,434,509	0.4200	28,690	21.0000	602,494
2022-05-24	KALA	RA CAPITAL MANAGEMENT, LLC	144,805	0.5100	2,896	25.5000	73,851
2022-05-23	KALA	RA CAPITAL MANAGEMENT, LLC	1,250,000	0.6500	25,000	32.5000	812,500

इनसाइडर खरीदारी KALV / KalVista Pharmaceuticals, Inc. - अल्पकालिक लाभ विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन अधिकतम	मूल्य अधिकतम	अधिकतम लाभ ($)	अधिकतम रिटर्न (%)
2017-10-12	KALV	RA CAPITAL MANAGEMENT, LLC	850,000	8.5000	850,000	8.5000	7,225,000	356	22.6500	12,027,500	166.47

KALV / KalVista Pharmaceuticals, Inc. Insider Trades

इनसाइडर बिक्री KALV / KalVista Pharmaceuticals, Inc. - अल्पकालिक हानि विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन न्यूनतम	मूल्य न्यूनतम	अधिकतम हानि बचाया ($)	अधिकतम हानि बचाया (%)
इस इनसाइडर और प्रतिभूति संयोजन के लिए कोई ज्ञात अनियोजित खुले बाज़ार व्यापार नहीं हैं

इनसाइडर खरीदारी MLYS / Mineralys Therapeutics, Inc. - अल्पकालिक लाभ विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन अधिकतम	मूल्य अधिकतम	अधिकतम लाभ ($)	अधिकतम रिटर्न (%)
2025-03-13	MLYS	RA CAPITAL MANAGEMENT, LLC	1,296,296	13.5000	1,296,296	13.5000	17,499,996	176	34.8000	27,611,105	157.78
2023-02-14	MLYS	RA CAPITAL MANAGEMENT, LLC	131,600	16.0000	131,600	16.0000	2,105,600
2023-02-14	MLYS	RA CAPITAL MANAGEMENT, LLC	1,118,400	16.0000	1,118,400	16.0000	17,894,400

MLYS / Mineralys Therapeutics, Inc. Insider Trades

इनसाइडर बिक्री MLYS / Mineralys Therapeutics, Inc. - अल्पकालिक हानि विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन न्यूनतम	मूल्य न्यूनतम	अधिकतम हानि बचाया ($)	अधिकतम हानि बचाया (%)
इस इनसाइडर और प्रतिभूति संयोजन के लिए कोई ज्ञात अनियोजित खुले बाज़ार व्यापार नहीं हैं

इनसाइडर खरीदारी NKTX / Nkarta, Inc. - अल्पकालिक लाभ विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन अधिकतम	मूल्य अधिकतम	अधिकतम लाभ ($)	अधिकतम रिटर्न (%)
2024-03-27	NKTX	RA CAPITAL MANAGEMENT, LLC	3,000,000	10.0000	3,000,000	10.0000	30,000,000	0	11.0850	3,255,000	10.85
2022-04-26	NKTX	RA CAPITAL MANAGEMENT, LLC	2,200,000	15.0000	2,200,000	15.0000	33,000,000
2020-07-14	NKTX	RA CAPITAL MANAGEMENT, LLC	3,333,333	18.0000	3,333,333	18.0000	59,999,994

इनसाइडर बिक्री NKTX / Nkarta, Inc. - अल्पकालिक हानि विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन न्यूनतम	मूल्य न्यूनतम	अधिकतम हानि बचाया ($)	अधिकतम हानि बचाया (%)
इस इनसाइडर और प्रतिभूति संयोजन के लिए कोई ज्ञात अनियोजित खुले बाज़ार व्यापार नहीं हैं

इनसाइडर खरीदारी PCVX / Vaxcyte, Inc. - अल्पकालिक लाभ विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन अधिकतम	मूल्य अधिकतम	अधिकतम लाभ ($)	अधिकतम रिटर्न (%)
इस इनसाइडर और प्रतिभूति संयोजन के लिए कोई ज्ञात अनियोजित खुले बाज़ार व्यापार नहीं हैं

इनसाइडर बिक्री PCVX / Vaxcyte, Inc. - अल्पकालिक हानि विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन न्यूनतम	मूल्य न्यूनतम	अधिकतम हानि बचाया ($)	अधिकतम हानि बचाया (%)
2020-10-08	PCVX	RA CAPITAL MANAGEMENT, LLC	167,661	50.6860	167,661	50.6860	8,498,065	214	16.45	-5,740,042	-67.55
2020-10-07	PCVX	RA CAPITAL MANAGEMENT, LLC	98,597	50.9501	98,597	50.9501	5,023,527
2020-10-01	PCVX	RA CAPITAL MANAGEMENT, LLC	15,967	48.6444	15,967	48.6444	776,705
2020-09-30	PCVX	RA CAPITAL MANAGEMENT, LLC	124,656	50.2653	124,656	50.2653	6,265,871
2020-09-29	PCVX	RA CAPITAL MANAGEMENT, LLC	80,707	52.0771	80,707	52.0771	4,202,987

इनसाइडर खरीदारी PEPG / PepGen Inc. - अल्पकालिक लाभ विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन अधिकतम	मूल्य अधिकतम	अधिकतम लाभ ($)	अधिकतम रिटर्न (%)
2024-02-09	PEPG	RA CAPITAL MANAGEMENT, LLC	2,557,593	10.6400	2,557,593	10.6400	27,212,790	168	18.5500	20,230,561	74.34
2022-05-10	PEPG	RA CAPITAL MANAGEMENT, LLC	2,979,451	12.0000	2,979,451	12.0000	35,753,412
2022-05-10	PEPG	RA CAPITAL MANAGEMENT, LLC	249,749	12.0000	249,749	12.0000	2,996,988

इनसाइडर बिक्री PEPG / PepGen Inc. - अल्पकालिक हानि विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन न्यूनतम	मूल्य न्यूनतम	अधिकतम हानि बचाया ($)	अधिकतम हानि बचाया (%)
इस इनसाइडर और प्रतिभूति संयोजन के लिए कोई ज्ञात अनियोजित खुले बाज़ार व्यापार नहीं हैं

इनसाइडर खरीदारी PHAT / Phathom Pharmaceuticals, Inc. - अल्पकालिक लाभ विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन अधिकतम	मूल्य अधिकतम	अधिकतम लाभ ($)	अधिकतम रिटर्न (%)
2020-04-01	PHAT	RA CAPITAL MANAGEMENT, LLC	117,600	24.8609	117,600	24.8609	2,923,642	68	54.6	3,497,319	119.62
2020-03-31	PHAT	RA CAPITAL MANAGEMENT, LLC	30,600	24.5511	30,600	24.5511	751,264
2020-03-27	PHAT	RA CAPITAL MANAGEMENT, LLC	30,000	24.6000	30,000	24.6000	738,000

PHAT / Phathom Pharmaceuticals, Inc. Insider Trades

इनसाइडर बिक्री PHAT / Phathom Pharmaceuticals, Inc. - अल्पकालिक हानि विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन न्यूनतम	मूल्य न्यूनतम	अधिकतम हानि बचाया ($)	अधिकतम हानि बचाया (%)
2021-03-11	PHAT	RA CAPITAL MANAGEMENT, LLC	710,000	43.7500	710,000	43.7500	31,062,500	365	13.6600	-21,363,900	-68.78

इनसाइडर खरीदारी PMVP / PMV Pharmaceuticals, Inc. - अल्पकालिक लाभ विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन अधिकतम	मूल्य अधिकतम	अधिकतम लाभ ($)	अधिकतम रिटर्न (%)
2020-09-29	PMVP	RA CAPITAL MANAGEMENT, LLC	950,000	18.0000	950,000	18.0000	17,100,000	93	61.51	41,334,500	241.72

PMVP / PMV Pharmaceuticals, Inc. Insider Trades

इनसाइडर बिक्री PMVP / PMV Pharmaceuticals, Inc. - अल्पकालिक हानि विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन न्यूनतम	मूल्य न्यूनतम	अधिकतम हानि बचाया ($)	अधिकतम हानि बचाया (%)
इस इनसाइडर और प्रतिभूति संयोजन के लिए कोई ज्ञात अनियोजित खुले बाज़ार व्यापार नहीं हैं

इनसाइडर खरीदारी RXST / RxSight, Inc. - अल्पकालिक लाभ विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन अधिकतम	मूल्य अधिकतम	अधिकतम लाभ ($)	अधिकतम रिटर्न (%)
इस इनसाइडर और प्रतिभूति संयोजन के लिए कोई ज्ञात अनियोजित खुले बाज़ार व्यापार नहीं हैं

इनसाइडर बिक्री RXST / RxSight, Inc. - अल्पकालिक हानि विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन न्यूनतम	मूल्य न्यूनतम	अधिकतम हानि बचाया ($)	अधिकतम हानि बचाया (%)
इस इनसाइडर और प्रतिभूति संयोजन के लिए कोई ज्ञात अनियोजित खुले बाज़ार व्यापार नहीं हैं

इनसाइडर खरीदारी RYTM / Rhythm Pharmaceuticals, Inc. - अल्पकालिक लाभ विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन अधिकतम	मूल्य अधिकतम	अधिकतम लाभ ($)	अधिकतम रिटर्न (%)
इस इनसाइडर और प्रतिभूति संयोजन के लिए कोई ज्ञात अनियोजित खुले बाज़ार व्यापार नहीं हैं

RYTM / Rhythm Pharmaceuticals, Inc. Insider Trades

इनसाइडर बिक्री RYTM / Rhythm Pharmaceuticals, Inc. - अल्पकालिक हानि विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन न्यूनतम	मूल्य न्यूनतम	अधिकतम हानि बचाया ($)	अधिकतम हानि बचाया (%)
2020-12-03	RYTM	RA CAPITAL MANAGEMENT, LLC	10,582	31.2300	10,582	31.2300	330,476	363	8.62	-239,258	-72.40
2020-12-03	RYTM	RA CAPITAL MANAGEMENT, LLC	12,976	29.1100	12,976	29.1100	377,731
2020-12-03	RYTM	RA CAPITAL MANAGEMENT, LLC	139,308	28.9500	139,308	28.9500	4,032,967
2020-12-03	RYTM	RA CAPITAL MANAGEMENT, LLC	44,738	28.7500	44,738	28.7500	1,286,218
2020-12-02	RYTM	RA CAPITAL MANAGEMENT, LLC	18,879	32.5000	18,879	32.5000	613,568
2020-12-02	RYTM	RA CAPITAL MANAGEMENT, LLC	12,060	32.2300	12,060	32.2300	388,694
2020-07-02	RYTM	RA CAPITAL MANAGEMENT, LLC	44,153	22.0363	44,153	22.0363	972,969
2020-07-01	RYTM	RA CAPITAL MANAGEMENT, LLC	25,527	21.8714	25,527	21.8714	558,311
2020-06-30	RYTM	RA CAPITAL MANAGEMENT, LLC	61,901	22.1521	61,901	22.1521	1,371,237
2020-06-29	RYTM	RA CAPITAL MANAGEMENT, LLC	52,049	22.1906	52,049	22.1906	1,154,999
2020-06-26	RYTM	RA CAPITAL MANAGEMENT, LLC	86,706	23.3069	86,706	23.3069	2,020,848
2020-06-25	RYTM	RA CAPITAL MANAGEMENT, LLC	11,568	25.0491	11,568	25.0491	289,768

इनसाइडर खरीदारी SCPH / scPharmaceuticals Inc. - अल्पकालिक लाभ विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन अधिकतम	मूल्य अधिकतम	अधिकतम लाभ ($)	अधिकतम रिटर्न (%)
2020-02-14	SCPH	RA CAPITAL MANAGEMENT, LLC	271,993	8.2000	271,993	8.2000	2,230,343	87	10.96	750,701	33.66

SCPH / scPharmaceuticals Inc. Insider Trades

इनसाइडर बिक्री SCPH / scPharmaceuticals Inc. - अल्पकालिक हानि विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन न्यूनतम	मूल्य न्यूनतम	अधिकतम हानि बचाया ($)	अधिकतम हानि बचाया (%)
2021-03-15	SCPH	RA CAPITAL MANAGEMENT, LLC	110,588	7.0332	110,588	7.0332	777,788	263	3.88	-348,706	-44.83
2021-03-12	SCPH	RA CAPITAL MANAGEMENT, LLC	39,469	7.2162	39,469	7.2162	284,816

इनसाइडर खरीदारी SGMO / Sangamo Therapeutics, Inc. - अल्पकालिक लाभ विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन अधिकतम	मूल्य अधिकतम	अधिकतम लाभ ($)	अधिकतम रिटर्न (%)
2014-07-17	SGMO	RA CAPITAL MANAGEMENT, LLC	37,215	12.2588	37,215	12.2588	456,211	245	18.5400	233,755	51.24
2014-05-07	SGMO	RA CAPITAL MANAGEMENT, LLC	6,998	11.7100	6,998	11.7100	81,947
2014-05-07	SGMO	RA CAPITAL MANAGEMENT, LLC	40,566	11.7350	40,566	11.7350	476,042
2014-05-07	SGMO	RA CAPITAL MANAGEMENT, LLC	35,736	12.0850	35,736	12.0850	431,870
2014-04-30	SGMO	RA CAPITAL MANAGEMENT, LLC	51,211	13.2850	51,211	13.2850	680,338
2014-04-30	SGMO	RA CAPITAL MANAGEMENT, LLC	73,289	13.5674	73,289	13.5674	994,341
2014-04-28	SGMO	RA CAPITAL MANAGEMENT, LLC	74,844	13.2945	74,844	13.2945	995,014
2014-04-25	SGMO	RA CAPITAL MANAGEMENT, LLC	166,000	13.6312	166,000	13.6312	2,262,779
2014-04-17	SGMO	RA CAPITAL MANAGEMENT, LLC	41,500	14.0231	41,500	14.0231	581,959
2014-04-15	SGMO	RA CAPITAL MANAGEMENT, LLC	1,079	13.1008	1,079	13.1008	14,136
2014-04-15	SGMO	RA CAPITAL MANAGEMENT, LLC	20,750	13.1600	20,750	13.1600	273,070
2014-04-11	SGMO	RA CAPITAL MANAGEMENT, LLC	83,000	14.4800	83,000	14.4800	1,201,840
2014-04-11	SGMO	RA CAPITAL MANAGEMENT, LLC	33,992	14.4875	33,992	14.4875	492,459
2014-04-10	SGMO	RA CAPITAL MANAGEMENT, LLC	83,000	14.9077	83,000	14.9077	1,237,339
2014-04-08	SGMO	RA CAPITAL MANAGEMENT, LLC	121,876	15.4934	121,876	15.4934	1,888,274
2014-04-07	SGMO	RA CAPITAL MANAGEMENT, LLC	33,667	15.4249	33,667	15.4249	519,310
2014-04-04	SGMO	RA CAPITAL MANAGEMENT, LLC	179,031	15.3812	179,031	15.3812	2,753,712
2014-04-03	SGMO	RA CAPITAL MANAGEMENT, LLC	195,126	16.6149	195,126	16.6149	3,241,999
2014-03-28	SGMO	RA CAPITAL MANAGEMENT, LLC	21,840	17.0700	21,840	17.0700	372,809
2014-03-28	SGMO	RA CAPITAL MANAGEMENT, LLC	62,160	17.1050	62,160	17.1050	1,063,247
2014-03-27	SGMO	RA CAPITAL MANAGEMENT, LLC	4,200	17.3500	4,200	17.3500	72,870
2014-03-27	SGMO	RA CAPITAL MANAGEMENT, LLC	251,987	17.6576	251,987	17.6576	4,449,486
2014-03-26	SGMO	RA CAPITAL MANAGEMENT, LLC	19,320	17.8750	19,320	17.8750	345,345
2014-03-26	SGMO	RA CAPITAL MANAGEMENT, LLC	190,693	18.1620	190,693	18.1620	3,463,366
2014-03-25	SGMO	RA CAPITAL MANAGEMENT, LLC	21,000	19.3300	21,000	19.3300	405,930
2014-03-25	SGMO	RA CAPITAL MANAGEMENT, LLC	42,000	19.4418	42,000	19.4418	816,556
2014-03-25	SGMO	RA CAPITAL MANAGEMENT, LLC	21,000	19.4550	21,000	19.4550	408,555
2014-03-21	SGMO	RA CAPITAL MANAGEMENT, LLC	101,808	21.2163	101,808	21.2163	2,159,989
2014-03-17	SGMO	RA CAPITAL MANAGEMENT, LLC	52,161	23.0217	52,161	23.0217	1,200,835
2014-03-13	SGMO	RA CAPITAL MANAGEMENT, LLC	71,319	22.7619	71,319	22.7619	1,623,356
2014-03-10	SGMO	RA CAPITAL MANAGEMENT, LLC	12,522	22.2952	12,522	22.2952	279,180
2014-03-07	SGMO	RA CAPITAL MANAGEMENT, LLC	258,377	22.2487	258,377	22.2487	5,748,552
2014-03-06	SGMO	RA CAPITAL MANAGEMENT, LLC	42,001	22.4450	42,001	22.4450	942,712
2014-03-06	SGMO	RA CAPITAL MANAGEMENT, LLC	42,000	22.5603	42,000	22.5603	947,533
2014-02-28	SGMO	RA CAPITAL MANAGEMENT, LLC	42,000	18.0987	42,000	18.0987	760,145
2014-02-26	SGMO	RA CAPITAL MANAGEMENT, LLC	32,194	19.1501	32,194	19.1501	616,518
2014-02-26	SGMO	RA CAPITAL MANAGEMENT, LLC	42,000	19.8982	42,000	19.8982	835,724
2014-02-12	SGMO	RA CAPITAL MANAGEMENT, LLC	42,000	18.0386	42,000	18.0386	757,621
2014-02-11	SGMO	RA CAPITAL MANAGEMENT, LLC	42,000	19.6494	42,000	19.6494	825,275
2014-02-05	SGMO	RA CAPITAL MANAGEMENT, LLC	13,694	18.1650	13,694	18.1650	248,752
2014-02-05	SGMO	RA CAPITAL MANAGEMENT, LLC	17,640	18.2100	17,640	18.2100	321,224
2014-02-05	SGMO	RA CAPITAL MANAGEMENT, LLC	10,666	18.3623	10,666	18.3623	195,852
2013-12-13	SGMO	RA CAPITAL MANAGEMENT, LLC	5,040	12.0875	5,040	12.0875	60,921
2013-12-12	SGMO	RA CAPITAL MANAGEMENT, LLC	9,600	12.0907	9,600	12.0907	116,071
2013-07-17	SGMO	RA CAPITAL MANAGEMENT, LLC	19,200	9.7862	19,200	9.7862	187,895

SGMO / Sangamo Therapeutics, Inc. Insider Trades

इनसाइडर बिक्री SGMO / Sangamo Therapeutics, Inc. - अल्पकालिक हानि विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन न्यूनतम	मूल्य न्यूनतम	अधिकतम हानि बचाया ($)	अधिकतम हानि बचाया (%)
2014-08-01	SGMO	RA CAPITAL MANAGEMENT, LLC	27,770	12.8232	27,770	12.8232	356,100	363	8.8	-111,724	-31.37
2014-07-30	SGMO	RA CAPITAL MANAGEMENT, LLC	20,592	12.3500	20,592	12.3500	254,311
2014-07-30	SGMO	RA CAPITAL MANAGEMENT, LLC	57,890	12.3600	57,890	12.3600	715,520
2014-07-30	SGMO	RA CAPITAL MANAGEMENT, LLC	31,108	12.5940	31,108	12.5940	391,774
2014-07-29	SGMO	RA CAPITAL MANAGEMENT, LLC	1,407	12.4122	1,407	12.4122	17,464
2014-07-28	SGMO	RA CAPITAL MANAGEMENT, LLC	24,810	12.1000	24,810	12.1000	300,201
2014-07-28	SGMO	RA CAPITAL MANAGEMENT, LLC	35,271	12.1140	35,271	12.1140	427,273
2014-07-25	SGMO	RA CAPITAL MANAGEMENT, LLC	47,429	12.3121	47,429	12.3121	583,951
2014-07-24	SGMO	RA CAPITAL MANAGEMENT, LLC	124,050	12.2792	124,050	12.2792	1,523,235
2014-07-01	SGMO	RA CAPITAL MANAGEMENT, LLC	33,080	15.9550	33,080	15.9550	527,791
2014-07-01	SGMO	RA CAPITAL MANAGEMENT, LLC	49,620	16.0461	49,620	16.0461	796,207
2014-06-16	SGMO	RA CAPITAL MANAGEMENT, LLC	1,838	16.3541	1,838	16.3541	30,059
2014-06-16	SGMO	RA CAPITAL MANAGEMENT, LLC	3,695	16.5231	3,695	16.5231	61,053
2014-06-16	SGMO	RA CAPITAL MANAGEMENT, LLC	137,171	16.5235	137,171	16.5235	2,266,545
2014-06-16	SGMO	RA CAPITAL MANAGEMENT, LLC	107,796	16.5950	107,796	16.5950	1,788,875
2014-06-09	SGMO	RA CAPITAL MANAGEMENT, LLC	60,955	15.4985	60,955	15.4985	944,711
2014-06-09	SGMO	RA CAPITAL MANAGEMENT, LLC	22,545	15.5000	22,545	15.5000	349,448
2014-06-06	SGMO	RA CAPITAL MANAGEMENT, LLC	9,852	14.0718	9,852	14.0718	138,635
2014-06-06	SGMO	RA CAPITAL MANAGEMENT, LLC	41,749	14.1300	41,749	14.1300	589,913
2014-06-06	SGMO	RA CAPITAL MANAGEMENT, LLC	83,500	14.4000	83,500	14.4000	1,202,400
2014-06-05	SGMO	RA CAPITAL MANAGEMENT, LLC	918,499	13.0000	918,499	13.0000	11,940,487
2014-06-05	SGMO	RA CAPITAL MANAGEMENT, LLC	586	13.1071	586	13.1071	7,681
2014-06-05	SGMO	RA CAPITAL MANAGEMENT, LLC	18,377	13.9771	18,377	13.9771	256,857
2014-06-05	SGMO	RA CAPITAL MANAGEMENT, LLC	32,899	14.1300	32,899	14.1300	464,863
2014-06-05	SGMO	RA CAPITAL MANAGEMENT, LLC	66,253	14.1305	66,253	14.1305	936,188
2014-06-05	SGMO	RA CAPITAL MANAGEMENT, LLC	48,849	14.1350	48,849	14.1350	690,481
2014-06-04	SGMO	RA CAPITAL MANAGEMENT, LLC	20,659	13.0803	20,659	13.0803	270,226
2014-06-04	SGMO	RA CAPITAL MANAGEMENT, LLC	20,826	13.1050	20,826	13.1050	272,925
2014-06-04	SGMO	RA CAPITAL MANAGEMENT, LLC	29,155	13.1050	29,155	13.1050	382,076
2014-06-03	SGMO	RA CAPITAL MANAGEMENT, LLC	76,833	12.8600	76,833	12.8600	988,072
2014-05-30	SGMO	RA CAPITAL MANAGEMENT, LLC	41,651	13.3800	41,651	13.3800	557,290
2014-05-30	SGMO	RA CAPITAL MANAGEMENT, LLC	24,233	13.4468	24,233	13.4468	325,856
2014-05-29	SGMO	RA CAPITAL MANAGEMENT, LLC	9,390	13.5127	9,390	13.5127	126,884
2014-05-29	SGMO	RA CAPITAL MANAGEMENT, LLC	146,285	13.5330	146,285	13.5330	1,979,675
2014-05-28	SGMO	RA CAPITAL MANAGEMENT, LLC	124,387	13.4218	124,387	13.4218	1,669,497
2014-05-28	SGMO	RA CAPITAL MANAGEMENT, LLC	24,302	13.4744	24,302	13.4744	327,455
2014-05-27	SGMO	RA CAPITAL MANAGEMENT, LLC	154,574	13.5502	154,574	13.5502	2,094,509
2014-05-27	SGMO	RA CAPITAL MANAGEMENT, LLC	108,863	13.5580	108,863	13.5580	1,475,965
2014-05-23	SGMO	RA CAPITAL MANAGEMENT, LLC	51,597	13.2704	51,597	13.2704	684,713
2014-05-22	SGMO	RA CAPITAL MANAGEMENT, LLC	15,578	13.5083	15,578	13.5083	210,432
2014-05-22	SGMO	RA CAPITAL MANAGEMENT, LLC	40,818	13.5750	40,818	13.5750	554,104
2014-05-13	SGMO	RA CAPITAL MANAGEMENT, LLC	56,060	13.1164	56,060	13.1164	735,305
2014-05-12	SGMO	RA CAPITAL MANAGEMENT, LLC	19,389	13.0090	19,389	13.0090	252,232
2014-05-12	SGMO	RA CAPITAL MANAGEMENT, LLC	10,270	13.0573	10,270	13.0573	134,098
2014-05-08	SGMO	RA CAPITAL MANAGEMENT, LLC	20,825	12.3900	20,825	12.3900	258,022
2014-05-08	SGMO	RA CAPITAL MANAGEMENT, LLC	62,475	12.3980	62,475	12.3980	774,565
2014-04-22	SGMO	RA CAPITAL MANAGEMENT, LLC	39,591	14.7031	39,591	14.7031	582,110
2014-04-22	SGMO	RA CAPITAL MANAGEMENT, LLC	43,409	14.8623	43,409	14.8623	645,158
2014-04-22	SGMO	RA CAPITAL MANAGEMENT, LLC	166,000	14.8623	166,000	14.8623	2,467,142
2014-04-22	SGMO	RA CAPITAL MANAGEMENT, LLC	62,250	14.8750	62,250	14.8750	925,969
2014-04-22	SGMO	RA CAPITAL MANAGEMENT, LLC	41,500	15.0159	41,500	15.0159	623,160
2014-04-16	SGMO	RA CAPITAL MANAGEMENT, LLC	21,829	14.0940	21,829	14.0940	307,658
2014-04-14	SGMO	RA CAPITAL MANAGEMENT, LLC	3,055	14.7841	3,055	14.7841	45,165
2014-04-10	SGMO	RA CAPITAL MANAGEMENT, LLC	3,403	15.6702	3,403	15.6702	53,326
2014-04-09	SGMO	RA CAPITAL MANAGEMENT, LLC	69,856	16.2681	69,856	16.2681	1,136,424
2014-04-01	SGMO	RA CAPITAL MANAGEMENT, LLC	48,500	17.8751	48,500	17.8751	866,942
2014-04-01	SGMO	RA CAPITAL MANAGEMENT, LLC	24,900	17.8850	24,900	17.8850	445,336
2014-04-01	SGMO	RA CAPITAL MANAGEMENT, LLC	50,000	17.9450	50,000	17.9450	897,250
2014-04-01	SGMO	RA CAPITAL MANAGEMENT, LLC	51,500	18.0760	51,500	18.0760	930,914
2014-04-01	SGMO	RA CAPITAL MANAGEMENT, LLC	75,100	18.1350	75,100	18.1350	1,361,938
2014-03-19	SGMO	RA CAPITAL MANAGEMENT, LLC	17,808	24.2830	17,808	24.2830	432,432
2014-03-18	SGMO	RA CAPITAL MANAGEMENT, LLC	34,440	23.7448	34,440	23.7448	817,771
2014-03-18	SGMO	RA CAPITAL MANAGEMENT, LLC	49,560	23.7450	49,560	23.7450	1,176,802
2014-03-12	SGMO	RA CAPITAL MANAGEMENT, LLC	123,480	23.4000	123,480	23.4000	2,889,432
2014-03-06	SGMO	RA CAPITAL MANAGEMENT, LLC	31,531	23.1786	31,531	23.1786	730,844
2014-03-06	SGMO	RA CAPITAL MANAGEMENT, LLC	241,471	23.2350	241,471	23.2350	5,610,579
2014-03-06	SGMO	RA CAPITAL MANAGEMENT, LLC	20,415	24.0014	20,415	24.0014	489,989
2014-03-06	SGMO	RA CAPITAL MANAGEMENT, LLC	40,482	24.0950	40,482	24.0950	975,414
2014-03-06	SGMO	RA CAPITAL MANAGEMENT, LLC	21,001	24.1000	21,001	24.1000	506,124
2014-03-03	SGMO	RA CAPITAL MANAGEMENT, LLC	67,200	18.2100	67,200	18.2100	1,223,712
2014-03-03	SGMO	RA CAPITAL MANAGEMENT, LLC	16,800	18.2256	16,800	18.2256	306,190
2014-02-27	SGMO	RA CAPITAL MANAGEMENT, LLC	14,953	19.2600	14,953	19.2600	287,995
2014-02-27	SGMO	RA CAPITAL MANAGEMENT, LLC	17,243	19.4574	17,243	19.4574	335,504
2014-02-20	SGMO	RA CAPITAL MANAGEMENT, LLC	39	18.3900	39	18.3900	717
2014-02-20	SGMO	RA CAPITAL MANAGEMENT, LLC	35,280	18.4000	35,280	18.4000	649,152
2014-02-19	SGMO	RA CAPITAL MANAGEMENT, LLC	6,720	18.5149	6,720	18.5149	124,420
2014-02-18	SGMO	RA CAPITAL MANAGEMENT, LLC	11,172	18.1058	11,172	18.1058	202,278
2014-02-14	SGMO	RA CAPITAL MANAGEMENT, LLC	15,380	18.6064	15,380	18.6064	286,166
2014-02-13	SGMO	RA CAPITAL MANAGEMENT, LLC	15,409	18.4592	15,409	18.4592	284,438
2014-02-07	SGMO	RA CAPITAL MANAGEMENT, LLC	34,688	18.5203	34,688	18.5203	642,432
2014-02-06	SGMO	RA CAPITAL MANAGEMENT, LLC	7,312	18.4194	7,312	18.4194	134,683
2014-01-09	SGMO	RA CAPITAL MANAGEMENT, LLC	27,483	18.4678	27,483	18.4678	507,551
2014-01-09	SGMO	RA CAPITAL MANAGEMENT, LLC	44,957	18.2800	44,957	18.2800	821,814
2013-07-25	SGMO	RA CAPITAL MANAGEMENT, LLC	4,071	9.5135	4,071	9.5135	38,729
2013-07-25	SGMO	RA CAPITAL MANAGEMENT, LLC	191,999	9.4950	191,999	9.4950	1,823,031
2013-07-25	SGMO	RA CAPITAL MANAGEMENT, LLC	19,200	10.0000	19,200	10.0000	192,000
2013-07-25	SGMO	RA CAPITAL MANAGEMENT, LLC	76,800	9.9100	76,800	9.9100	761,088
2013-07-25	SGMO	RA CAPITAL MANAGEMENT, LLC	76,800	10.0000	76,800	10.0000	768,000
2013-07-23	SGMO	RA CAPITAL MANAGEMENT, LLC	5,012	9.3652	5,012	9.3652	46,938
2013-07-22	SGMO	RA CAPITAL MANAGEMENT, LLC	76,801	9.5600	76,801	9.5600	734,218
2013-07-22	SGMO	RA CAPITAL MANAGEMENT, LLC	11,520	9.5650	11,520	9.5650	110,189
2013-07-22	SGMO	RA CAPITAL MANAGEMENT, LLC	23,042	9.6000	23,042	9.6000	221,203
2013-07-19	SGMO	RA CAPITAL MANAGEMENT, LLC	23,040	9.7744	23,040	9.7744	225,202
2013-07-19	SGMO	RA CAPITAL MANAGEMENT, LLC	76,800	9.8500	76,800	9.8500	756,480
2013-07-19	SGMO	RA CAPITAL MANAGEMENT, LLC	4,532	9.8500	4,532	9.8500	44,640
2013-07-19	SGMO	RA CAPITAL MANAGEMENT, LLC	105,522	9.8500	105,522	9.8500	1,039,392
2013-07-18	SGMO	RA CAPITAL MANAGEMENT, LLC	74,035	10.0155	74,035	10.0155	741,498
2013-07-17	SGMO	RA CAPITAL MANAGEMENT, LLC	19,200	10.2350	19,200	10.2350	196,512
2013-07-17	SGMO	RA CAPITAL MANAGEMENT, LLC	29,070	10.2129	29,070	10.2129	296,889

इनसाइडर खरीदारी SLDB / Solid Biosciences Inc. - अल्पकालिक लाभ विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन अधिकतम	मूल्य अधिकतम	अधिकतम लाभ ($)	अधिकतम रिटर्न (%)
2024-01-11	SLDB	RA CAPITAL MANAGEMENT, LLC	904,160	5.5300	904,160	5.5300	5,000,005	68	14.7500	8,336,356	166.73
2021-03-19	SLDB	RA CAPITAL MANAGEMENT, LLC	2,206,685	5.7500	147,112	86.2500	12,688,439

SLDB / Solid Biosciences Inc. Insider Trades

इनसाइडर बिक्री SLDB / Solid Biosciences Inc. - अल्पकालिक हानि विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन न्यूनतम	मूल्य न्यूनतम	अधिकतम हानि बचाया ($)	अधिकतम हानि बचाया (%)
इस इनसाइडर और प्रतिभूति संयोजन के लिए कोई ज्ञात अनियोजित खुले बाज़ार व्यापार नहीं हैं

इनसाइडर खरीदारी SPRY / ARS Pharmaceuticals, Inc. - अल्पकालिक लाभ विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन अधिकतम	मूल्य अधिकतम	अधिकतम लाभ ($)	अधिकतम रिटर्न (%)
2024-03-27	SPRY	RA CAPITAL MANAGEMENT, LLC	505,954	9.7900	505,954	9.7900	4,953,290	229	17.4900	3,895,846	78.65
2024-03-26	SPRY	RA CAPITAL MANAGEMENT, LLC	457,745	9.5500	457,745	9.5500	4,371,465
2024-03-25	SPRY	RA CAPITAL MANAGEMENT, LLC	437,600	9.0600	437,600	9.0600	3,964,656
2023-09-21	SPRY	RA CAPITAL MANAGEMENT, LLC	2,508,691	2.9700	2,508,691	2.9700	7,450,812
2023-09-21	SPRY	RA CAPITAL MANAGEMENT, LLC	191,309	3.8300	191,309	3.8300	732,713
2023-08-29	SPRY	RA CAPITAL MANAGEMENT, LLC	3,750,000	6.2000	3,750,000	6.2000	23,250,000

SPRY / ARS Pharmaceuticals, Inc. Insider Trades

इनसाइडर बिक्री SPRY / ARS Pharmaceuticals, Inc. - अल्पकालिक हानि विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन न्यूनतम	मूल्य न्यूनतम	अधिकतम हानि बचाया ($)	अधिकतम हानि बचाया (%)
इस इनसाइडर और प्रतिभूति संयोजन के लिए कोई ज्ञात अनियोजित खुले बाज़ार व्यापार नहीं हैं

इनसाइडर खरीदारी TGTX / TG Therapeutics, Inc. - अल्पकालिक लाभ विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन अधिकतम	मूल्य अधिकतम	अधिकतम लाभ ($)	अधिकतम रिटर्न (%)
इस इनसाइडर और प्रतिभूति संयोजन के लिए कोई ज्ञात अनियोजित खुले बाज़ार व्यापार नहीं हैं

TGTX / TG Therapeutics, Inc. Insider Trades

इनसाइडर बिक्री TGTX / TG Therapeutics, Inc. - अल्पकालिक हानि विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन न्यूनतम	मूल्य न्यूनतम	अधिकतम हानि बचाया ($)	अधिकतम हानि बचाया (%)
2020-09-09	TGTX	RA CAPITAL MANAGEMENT, LLC	158,589	25.8072	158,589	25.8072	4,092,738	344	21.78	-638,670	-15.60

इनसाइडर खरीदारी TYRA / Tyra Biosciences, Inc. - अल्पकालिक लाभ विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन अधिकतम	मूल्य अधिकतम	अधिकतम लाभ ($)	अधिकतम रिटर्न (%)
2025-06-16	TYRA	RA CAPITAL MANAGEMENT, LLC	11,813	10.1300	11,813	10.1300	119,666	72	12.8800	32,486	27.15
2025-06-13	TYRA	RA CAPITAL MANAGEMENT, LLC	120,167	10.2000	120,167	10.2000	1,225,703
2025-06-12	TYRA	RA CAPITAL MANAGEMENT, LLC	31,307	10.2000	31,307	10.2000	319,331
2025-06-09	TYRA	RA CAPITAL MANAGEMENT, LLC	186,850	10.1900	186,850	10.1900	1,904,002
2025-06-05	TYRA	RA CAPITAL MANAGEMENT, LLC	213,334	10.0400	213,334	10.0400	2,141,873
2025-06-04	TYRA	RA CAPITAL MANAGEMENT, LLC	997,864	9.6300	997,864	9.6300	9,609,430
2024-11-08	TYRA	RA CAPITAL MANAGEMENT, LLC	1,220,681	16.2500	1,220,681	16.2500	19,836,066
2021-09-17	TYRA	RA CAPITAL MANAGEMENT, LLC	1,250,000	16.0000	1,250,000	16.0000	20,000,000

TYRA / Tyra Biosciences, Inc. Insider Trades

इनसाइडर बिक्री TYRA / Tyra Biosciences, Inc. - अल्पकालिक हानि विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन न्यूनतम	मूल्य न्यूनतम	अधिकतम हानि बचाया ($)	अधिकतम हानि बचाया (%)
इस इनसाइडर और प्रतिभूति संयोजन के लिए कोई ज्ञात अनियोजित खुले बाज़ार व्यापार नहीं हैं

इनसाइडर खरीदारी VOR / Vor Biopharma Inc. - अल्पकालिक लाभ विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन अधिकतम	मूल्य अधिकतम	अधिकतम लाभ ($)	अधिकतम रिटर्न (%)
2021-02-09	VOR	RA CAPITAL MANAGEMENT, LLC	2,848,596	18.0000	2,848,596	18.0000	51,274,728	16	54.0800	102,777,344	200.44
2021-02-09	VOR	RA CAPITAL MANAGEMENT, LLC	130,970	18.0000	130,970	18.0000	2,357,460

इनसाइडर बिक्री VOR / Vor Biopharma Inc. - अल्पकालिक हानि विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन न्यूनतम	मूल्य न्यूनतम	अधिकतम हानि बचाया ($)	अधिकतम हानि बचाया (%)
इस इनसाइडर और प्रतिभूति संयोजन के लिए कोई ज्ञात अनियोजित खुले बाज़ार व्यापार नहीं हैं

इनसाइडर खरीदारी VRDN / Viridian Therapeutics, Inc. - अल्पकालिक लाभ विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन अधिकतम	मूल्य अधिकतम	अधिकतम लाभ ($)	अधिकतम रिटर्न (%)
इस इनसाइडर और प्रतिभूति संयोजन के लिए कोई ज्ञात अनियोजित खुले बाज़ार व्यापार नहीं हैं

VRDN / Viridian Therapeutics, Inc. Insider Trades

इनसाइडर बिक्री VRDN / Viridian Therapeutics, Inc. - अल्पकालिक हानि विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन न्यूनतम	मूल्य न्यूनतम	अधिकतम हानि बचाया ($)	अधिकतम हानि बचाया (%)
इस इनसाइडर और प्रतिभूति संयोजन के लिए कोई ज्ञात अनियोजित खुले बाज़ार व्यापार नहीं हैं

इनसाइडर खरीदारी VSTM / Verastem, Inc. - अल्पकालिक लाभ विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन अधिकतम	मूल्य अधिकतम	अधिकतम लाभ ($)	अधिकतम रिटर्न (%)
इस इनसाइडर और प्रतिभूति संयोजन के लिए कोई ज्ञात अनियोजित खुले बाज़ार व्यापार नहीं हैं

इनसाइडर बिक्री VSTM / Verastem, Inc. - अल्पकालिक हानि विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन न्यूनतम	मूल्य न्यूनतम	अधिकतम हानि बचाया ($)	अधिकतम हानि बचाया (%)
2020-06-25	VSTM	RA CAPITAL MANAGEMENT, LLC	1,161,300	1.9116	96,775	22.9392	2,219,941	340	3.87	-1,845,422	-83.13
2020-04-27	VSTM	RA CAPITAL MANAGEMENT, LLC	1,301,300	2.3070	108,442	27.6840	3,002,099

इनसाइडर खरीदारी WVE / Wave Life Sciences Ltd. - अल्पकालिक लाभ विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन अधिकतम	मूल्य अधिकतम	अधिकतम लाभ ($)	अधिकतम रिटर्न (%)
2023-12-11	WVE	RA CAPITAL MANAGEMENT, LLC	1,000,000	5.0000	1,000,000	5.0000	5,000,000	333	16.4400	11,440,000	228.80
2023-12-11	WVE	RA CAPITAL MANAGEMENT, LLC	1,000,000	5.0000	1,000,000	5.0000	5,000,000
2022-06-16	WVE	RA CAPITAL MANAGEMENT, LLC	9,480,052	2.1500	9,480,052	2.1500	20,382,112
2019-01-24	WVE	RA CAPITAL MANAGEMENT, LLC	263,158	38.0000	263,158	38.0000	10,000,004
2017-11-14	WVE	RA CAPITAL MANAGEMENT, LLC	23,398	23.9999	23,398	23.9999	561,550
2017-11-13	WVE	RA CAPITAL MANAGEMENT, LLC	400,000	23.3000	400,000	23.3000	9,320,000
2015-11-16	WVE	RA CAPITAL MANAGEMENT, LLC	1,875,000	16.0000	1,875,000	16.0000	30,000,000

WVE / Wave Life Sciences Ltd. Insider Trades

इनसाइडर बिक्री WVE / Wave Life Sciences Ltd. - अल्पकालिक हानि विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन न्यूनतम	मूल्य न्यूनतम	अधिकतम हानि बचाया ($)	अधिकतम हानि बचाया (%)
इस इनसाइडर और प्रतिभूति संयोजन के लिए कोई ज्ञात अनियोजित खुले बाज़ार व्यापार नहीं हैं

इनसाइडर व्यापार इतिहास

यह तालिका सिक्योरिटीज एक्सचेंज कमीशन (SEC) को बताए अनुसार Peter Kolchinsky द्वारा किए गए इनसाइडर व्यापारों की पूरी सूची दिखाती है।

फ़ाइल तिथि	ट्रांजेक्शन तिथि	फॉर्म	टिकर	प्रतिभूति	कोड	10b5-1	शेयर	शेष शेयर	प्रतिशत परिवर्तन	शेयर कीमत	ट्रांजेक्शन वैल्यू	शेष मूल्य
2025-08-13	2025-08-11	4	WVE	Wave Life Sciences Ltd. Ordinary Shares	A - Award		12,700	28,815	78.81
2025-06-30	2025-06-26	4	CDTX	Cidara Therapeutics, Inc. Common Stock	P - Purchase		2,272,727	3,365,523	207.97	44.00	99,999,988	148,083,012
2025-06-16	2025-06-16	4	TYRA	Tyra Biosciences, Inc. Common Stock	P - Purchase		11,813	10,259,291	0.12	10.13	119,666	103,926,618
2025-06-16	2025-06-13	4	TYRA	Tyra Biosciences, Inc. Common Stock	P - Purchase		120,167	10,247,478	1.19	10.20	1,225,703	104,524,276
2025-06-16	2025-06-12	4	TYRA	Tyra Biosciences, Inc. Common Stock	P - Purchase		31,307	10,127,311	0.31	10.20	319,331	103,298,572
2025-06-13	2025-06-11	4	JANX	Janux Therapeutics, Inc. Common Stock	A - Award		3,750	6,250	150.00
2025-06-11	2025-06-09	4	TYRA	Tyra Biosciences, Inc. Common Stock	P - Purchase		186,850	10,096,004	1.89	10.19	1,904,002	102,878,281
2025-06-06	2025-06-05	4	TYRA	Tyra Biosciences, Inc. Common Stock	P - Purchase		213,334	9,909,154	2.20	10.04	2,141,873	99,487,906
2025-06-06	2025-06-04	4	TYRA	Tyra Biosciences, Inc. Common Stock	P - Purchase		997,864	9,695,820	11.47	9.63	9,609,430	93,370,747
2025-06-05	2025-06-04	4	ABOS	Acumen Pharmaceuticals, Inc. Common Stock	A - Award		12,800	12,800
2025-05-14	2025-05-14	4	HOWL	Werewolf Therapeutics, Inc. Common Stock	P - Purchase		162,539	6,237,482	2.68	0.98	159,288	6,112,732
2025-05-14	2025-05-13	4	HOWL	Werewolf Therapeutics, Inc. Common Stock	P - Purchase		52,974	6,074,943	0.88	0.98	51,915	5,953,444
2025-05-14	2025-05-12	4	HOWL	Werewolf Therapeutics, Inc. Common Stock	P - Purchase		320,913	6,021,969	5.63	0.86	275,985	5,178,893
2025-04-30	2025-04-28	4	JBIO	Jade Biosciences, Inc. Common Stock	J - Other		1,062,326	1,287,858	471.03
2025-03-17	2025-03-13	4	MLYS	Mineralys Therapeutics, Inc. Common Stock	P - Purchase		1,296,296	4,280,051	43.45	13.50	17,499,996	57,780,688
2025-03-07	2025-03-07	4	JANX	Janux Therapeutics, Inc. Common Stock	P - Purchase		110,206	10,141,287	1.10	31.02	3,418,590	314,582,723
2025-03-07	2025-03-06	4	JANX	Janux Therapeutics, Inc. Common Stock	P - Purchase		372,093	10,031,081	3.85	30.78	11,453,023	308,756,673
2025-03-07	2025-03-05	4	JANX	Janux Therapeutics, Inc. Common Stock	P - Purchase		37,455	9,658,988	0.39	31.30	1,172,342	302,326,324
2025-03-07	2025-03-05	4	JANX	Janux Therapeutics, Inc. Common Stock	P - Purchase		304,287	9,621,533	3.27	30.56	9,299,011	294,034,048
2025-02-10	2025-02-10	4	SION	Sionna Therapeutics, Inc. Common Stock	P - Purchase		102,414	2,324,498	4.61	18.00	1,843,452	41,840,964
2025-02-10	2025-02-10	4	SION	Sionna Therapeutics, Inc. Common Stock	P - Purchase		1,022,586	6,923,365	17.33	18.00	18,406,548	124,620,570
2025-02-10	2025-02-10	4	SION	Sionna Therapeutics, Inc. Common Stock	C - Conversion		179,975	327,808	121.74
2025-02-10	2025-02-10	4	SION	Sionna Therapeutics, Inc. Common Stock	C - Conversion		2,222,084	2,222,084
2025-02-10	2025-02-10	4	SION	Sionna Therapeutics, Inc. Common Stock	C - Conversion		527,444	869,651	154.13
2025-02-10	2025-02-10	4	SION	Sionna Therapeutics, Inc. Common Stock	C - Conversion		5,021,990	5,900,779	571.47
2025-02-06		3	SION	Sionna Therapeutics, Inc. Common Stock				878,789
2025-02-06		3	SION	Sionna Therapeutics, Inc. Common Stock				342,207
2025-02-06		3	SION	Sionna Therapeutics, Inc. Common Stock				147,833
2025-02-03	2025-01-30	4	ETNB	89bio, Inc. Common Stock	P - Purchase		5,714,285	19,554,319	41.29	8.75	49,999,994	171,100,291
2024-12-30	2024-12-30	4	VOR	Vor Biopharma Inc. Common Stock	A - Award		16,897,159	37,820,713	80.76
2024-12-10	2024-12-09	4	FDMT	4D Molecular Therapeutics, Inc. Common Stock	J - Other		-535,000	4,563,211	-10.49
2024-11-29	2024-11-26	4	CDTX	Cidara Therapeutics, Inc. Common Stock	A - Award		389,716	1,092,796	55.43	14.91	5,811,445	16,295,774
2024-11-25		3	FDMT	4D Molecular Therapeutics, Inc. Common Stock				5,098,211
2024-11-13	2024-11-08	4	TYRA	Tyra Biosciences, Inc. Common Stock	P - Purchase		1,220,681	8,697,956	16.33	16.25	19,836,066	141,341,785
2024-10-30	2024-10-28	4	SEPN	Septerna, Inc. Common Stock	P - Purchase		341,600	1,471,943	30.22	18.00	6,148,800	26,494,974
2024-10-30	2024-10-28	4	SEPN	Septerna, Inc. Common Stock	P - Purchase		3,828,400	5,523,915	225.80	18.00	68,911,200	99,430,470
2024-10-30	2024-10-28	4	SEPN	Septerna, Inc. Common Stock	C - Conversion		1,130,343	1,130,343
2024-10-30	2024-10-28	4	SEPN	Septerna, Inc. Common Stock	C - Conversion		1,695,515	1,695,515
2024-10-22	2024-10-18	4	JANX	Janux Therapeutics, Inc. Common Stock	P - Purchase		1,200,000	9,317,246	14.78	44.75	53,700,000	416,946,758
2024-10-22	2024-10-18	4	TYRA	Tyra Biosciences, Inc. Common Stock	J - Other		-1,000,000	7,477,275	-11.80
2024-09-23		3	FULC	Fulcrum Therapeutics, Inc. Common Stock				10,229,099
2024-09-18	2024-09-16	4	BCAX	Bicara Therapeutics Inc. Common Stock	P - Purchase		152,480	2,652,575	6.10	18.00	2,744,640	47,746,350
2024-09-18	2024-09-16	4	BCAX	Bicara Therapeutics Inc. Common Stock	P - Purchase		1,680,520	4,303,418	64.07	18.00	30,249,360	77,461,524
2024-09-18	2024-09-16	4	BCAX	Bicara Therapeutics Inc. Common Stock	C - Conversion		2,500,095	2,500,095
2024-09-18	2024-09-16	4	BCAX	Bicara Therapeutics Inc. Common Stock	C - Conversion		2,622,898	2,622,898
2024-08-23	2024-08-21	4	FULC	Fulcrum Therapeutics, Inc. Common Stock	J - Other		-8,500,000	3,109,704	-73.21
2024-08-14	2024-08-12	4	WVE	Wave Life Sciences Ltd. Ordinary Shares	A - Award		16,115	16,115
2024-08-13	2024-08-09	4	ANTX	AN2 Therapeutics, Inc. Common Stock	S - Sale		-114,759	300,853	-27.61	1.08	-123,940	324,921
2024-08-13	2024-08-09	4	ANTX	AN2 Therapeutics, Inc. Common Stock	S - Sale		-3,410,335	1,725,348	-66.40	1.08	-3,683,162	1,863,376
2024-07-24	2024-07-22	4	ARTV	Artiva Biotherapeutics, Inc. Common Stock	P - Purchase		688,326	826,832	496.96	12.00	8,259,912	9,921,984
2024-07-24	2024-07-22	4	ARTV	Artiva Biotherapeutics, Inc. Common Stock	P - Purchase		7,645,007	8,693,579	729.09	12.00	91,740,084	104,322,948
2024-07-24	2024-07-22	4	ARTV	Artiva Biotherapeutics, Inc. Common Stock	J - Other		138,506	138,506		10.20	1,412,761	1,412,761
2024-07-24	2024-07-22	4	ARTV	Artiva Biotherapeutics, Inc. Common Stock	J - Other		323,181	1,048,572	44.55	10.20	3,296,446	10,695,434
2024-07-24	2024-07-22	4	ARTV	Artiva Biotherapeutics, Inc. Common Stock	C - Conversion		68,320	68,320
2024-07-24	2024-07-22	4	ARTV	Artiva Biotherapeutics, Inc. Common Stock	C - Conversion		264,571	264,571
2024-07-24	2024-07-22	4	ARTV	Artiva Biotherapeutics, Inc. Common Stock	C - Conversion		725,391	725,391
2024-07-22	2024-07-19	4	CDTX	Cidara Therapeutics, Inc. Common Stock	C - Conversion		703,080	703,080
2024-07-01	2024-06-27	4	ELYM	Eliem Therapeutics, Inc. Common Stock	P - Purchase		1,059,375	2,866,375	58.63	3.84	4,068,000	11,006,880
2024-07-01	2024-06-27	4	ELYM	Eliem Therapeutics, Inc. Common Stock	P - Purchase		11,949,171	23,521,757	103.25	3.84	45,884,817	90,323,547
2024-07-01	2024-06-27	4	ELYM	Eliem Therapeutics, Inc. Common Stock	A - Award		1,807,000	1,807,000
2024-07-01	2024-06-27	4	ELYM	Eliem Therapeutics, Inc. Common Stock	A - Award		2,479,872	2,479,872
2024-07-01	2024-06-27	4	ELYM	Eliem Therapeutics, Inc. Common Stock	A - Award		973,000	11,572,586	9.18
2024-06-28	2024-06-26	4	JANX	Janux Therapeutics, Inc. Common Stock	A - Award		2,500	2,500
2024-06-20	2024-06-17	4	AVTE	Aerovate Therapeutics, Inc. Common Stock	P - Purchase		928,110	7,893,678	13.32	1.67	1,549,944	13,182,442
2024-05-14	2024-05-12	4	ITOS	iTeos Therapeutics, Inc. Common Stock	J - Other		-900,000	2,545,510	-26.12
2024-04-15	2024-04-11	4	ETNB	89bio, Inc. Common Stock	X - Other		1,408,450	13,840,034	11.33	5.32	7,499,996	73,698,181
2024-04-15	2024-04-11	4	ACRV	Acrivon Therapeutics, Inc. Common Stock	A - Award		3,530,000	7,914,206	80.52	8.50	30,005,000	67,270,751
2024-04-04	2024-04-02	4	BOLD	Boundless Bio, Inc. Common Stock	P - Purchase		15,625	295,844	5.58	16.00	250,000	4,733,504
2024-04-04	2024-04-02	4	BOLD	Boundless Bio, Inc. Common Stock	C - Conversion		280,219	280,219
2024-04-04	2024-04-02	4	BOLD	Boundless Bio, Inc. Common Stock	P - Purchase		296,875	1,884,787	18.70	16.00	4,750,000	30,156,592
2024-04-04	2024-04-02	4	BOLD	Boundless Bio, Inc. Common Stock	C - Conversion		1,587,912	1,587,912
2024-03-29	2024-03-27	4	NKTX	Nkarta, Inc. Common Stock	P - Purchase		3,000,000	10,050,818	42.55	10.00	30,000,000	100,508,180
2024-03-27	2024-03-27	4	SPRY	ARS Pharmaceuticals, Inc. Common Stock	P - Purchase		505,954	9,958,073	5.35	9.79	4,953,290	97,489,535
2024-03-27	2024-03-26	4	SPRY	ARS Pharmaceuticals, Inc. Common Stock	P - Purchase		457,745	9,452,119	5.09	9.55	4,371,465	90,267,736
2024-03-27	2024-03-25	4	SPRY	ARS Pharmaceuticals, Inc. Common Stock	P - Purchase		437,600	8,994,374	5.11	9.06	3,964,656	81,489,028
2024-03-25	2024-03-21	4	LENZ	LENZ Therapeutics, Inc. Common Stockj	P - Purchase		64,971	694,755	10.32	15.03	976,514	10,442,168
2024-03-25	2024-03-21	4	LENZ	LENZ Therapeutics, Inc. Common Stock	P - Purchase		933,038	3,319,339	39.10	15.03	14,023,561	49,889,665
2024-03-25	2024-03-21	4	LENZ	LENZ Therapeutics, Inc. Common Stock	A - Award		164,729	164,729
2024-03-25	2024-03-21	4	LENZ	LENZ Therapeutics, Inc. Common Stock	A - Award		694,755	694,755
2024-03-25	2024-03-21	4	LENZ	LENZ Therapeutics, Inc. Common Stock	A - Award		2,386,301	2,386,301
2024-03-06	2024-03-04	4	ETNB	89bio, Inc. Common Stock	P - Purchase		1,350,000	12,431,584	12.18	15.35	20,722,500	190,824,814
2024-02-20	2024-02-19	4	ICVX	Icosavax, Inc. Common Stock	U - Other		-638,668	0	-100.00
2024-02-20	2024-02-19	4	ICVX	Icosavax, Inc. Common Stock	U - Other		-5,324,897	0	-100.00
2024-02-20	2024-02-19	4	ICVX	Icosavax, Inc. Common Stock	U - Other		-5,543	0	-100.00
2024-02-14	2024-02-12	4	MLYS	Mineralys Therapeutics, Inc. Common Stock	A - Award		1,672,508	2,983,755	127.55	13.50	22,578,858	40,280,692
2024-02-13	2024-02-09	4	PEPG	PepGen Inc. Common Stock	P - Purchase		2,557,593	9,179,273	38.62	10.64	27,212,790	97,667,465
2024-02-08	2024-02-06	4	TYRA	Tyra Biosciences, Inc. Common Stock	A - Award		3,180,155	8,477,275	60.04	13.01	41,373,817	110,289,348
2024-01-17	2023-12-11	4/A	WVE	Wave Life Sciences Ltd. Common Stock	P - Purchase		1,000,000	18,202,009	5.81	5.00	5,000,000	91,010,045
2024-01-12	2024-01-11	4	SLDB	Solid Biosciences Inc. Common Stock	P - Purchase		904,160	4,192,216	27.50	5.53	5,000,005	23,182,954
2023-12-13	2023-12-11	4	WVE	Wave Life Sciences Ltd. Common Stock	P - Purchase		1,000,000	19,202,009	5.49	5.00	5,000,000	96,010,045
2023-09-25	2023-09-21	4	SPRY	ARS Pharmaceuticals, Inc. Common Stock	P - Purchase		191,309	8,556,774	2.29	3.83	732,713	32,772,444
2023-09-25	2023-09-21	4	SPRY	ARS Pharmaceuticals, Inc. Common Stock	P - Purchase		2,508,691	8,365,465	42.83	2.97	7,450,812	24,845,431
2023-08-31	2023-08-29	4	SPRY	ARS Pharmaceuticals, Inc. Common Stock	P - Purchase		3,750,000	5,856,774	178.00	6.20	23,250,000	36,311,999
2023-08-22	2023-08-18	4	ANTX	AN2 Therapeutics, Inc. Common Stock	P - Purchase		1,777,778	5,135,683	52.94	9.00	16,000,002	46,221,147
2023-08-09	2023-08-09	4	DICE	DICE Therapeutics, Inc. Common Stock	U - Other		-786,407	0	-100.00
2023-08-09	2023-08-09	4	DICE	DICE Therapeutics, Inc. Common Stock	U - Other		-7,070,205	0	-100.00
2023-07-25	2023-07-21	4	ABOS	Acumen Pharmaceuticals, Inc. Common Stock	P - Purchase		5,161,290	13,043,179	65.48	7.75	39,999,998	101,084,637
2023-07-21	2023-07-19	4	JANX	Janux Therapeutics, Inc. Common Stock	P - Purchase		495,008	8,117,246	6.49	12.46	6,167,800	101,140,885
2023-07-07	2023-07-05	4	BDTX	Black Diamond Therapeutics, Inc. Common Stock	P - Purchase		935,850	3,213,828	41.08	5.00	4,679,250	16,069,140
2023-06-12	2023-06-08	4	STSA	Satsuma Pharmaceuticals, Inc. Common Stock	U - Other		-5,914,252	0	-100.00
2023-03-30	2023-03-24	4	ETNB	89bio, Inc. Common Stock	P - Purchase		2,461,538	11,081,584	28.56	16.25	39,999,992	180,075,740
2023-03-30	2023-03-30	4	DICE	DICE Therapeutics, Inc. Common Stock	P - Purchase		195,997	7,070,205	2.85	28.74	5,632,954	203,197,692
2023-03-30	2023-03-29	4	DICE	DICE Therapeutics, Inc. Common Stock	P - Purchase		66,369	6,874,208	0.97	29.38	1,949,921	201,964,231
2023-03-30	2023-03-28	4	DICE	DICE Therapeutics, Inc. Common Stock	P - Purchase		246,779	6,807,839	3.76	29.24	7,215,818	199,061,212
2023-03-27	2023-03-27	4	DICE	DICE Therapeutics, Inc. Common Stock	P - Purchase		151,132	6,561,060	2.36	27.48	4,153,107	180,297,929
2023-03-27	2023-03-24	4	DICE	DICE Therapeutics, Inc. Common Stock	P - Purchase		192,335	6,409,928	3.09	26.87	5,168,041	172,234,765
2023-03-27	2023-03-23	4	DICE	DICE Therapeutics, Inc. Common Stock	P - Purchase		155,089	6,217,593	2.56	26.67	4,136,224	165,823,205
2023-02-27	2023-02-23	4	ELVN	Enliven Therapeutics, Inc. Common Stock	A - Award		1,152,460	2,122,465	118.81
2023-02-16	2023-02-14	4	MLYS	Mineralys Therapeutics, Inc. Common Stock	P - Purchase		1,118,400	1,311,247	579.94	16.00	17,894,400	20,979,952
2023-02-16	2023-02-14	4	MLYS	Mineralys Therapeutics, Inc. Common Stock	C - Conversion		192,847	192,847
2023-02-16	2023-02-14	4	MLYS	Mineralys Therapeutics, Inc. Common Stock	P - Purchase		131,600	1,867,229	7.58	16.00	2,105,600	29,875,664
2023-02-16	2023-02-14	4	MLYS	Mineralys Therapeutics, Inc. Common Stock	C - Conversion		1,735,629	1,735,629
2023-01-24	2023-01-20	4	FULC	Fulcrum Therapeutics, Inc. Common Stock	P - Purchase		1,923,076	11,609,704	19.85	13.00	24,999,988	150,926,152
2023-01-10	2023-01-06	4	HOWL	Werewolf Therapeutics, Inc. Common Stock	P - Purchase		1,853,000	5,701,056	48.15	2.21	4,095,130	12,599,334
2023-01-06	2023-01-04	4	FULC	Fulcrum Therapeutics, Inc. Common Stock	P - Purchase		58,369	9,686,628	0.61	7.80	455,091	75,524,701
2023-01-06	2023-01-04	4	FULC	Fulcrum Therapeutics, Inc. Common Stock	P - Purchase		122,334	9,628,259	1.29	7.03	859,714	67,663,553
2023-01-05	2023-01-03	4	IMRA	IMARA Inc. Common Stock	P - Purchase		629,297	3,880,021	19.36	4.00	2,516,055	15,513,100
2022-12-29	2022-12-27	4	FULC	Fulcrum Therapeutics, Inc. Common Stock	P - Purchase		4,089	9,505,925	0.04	5.99	24,510	56,979,465
2022-12-21	2022-12-19	4	FULC	Fulcrum Therapeutics, Inc. Common Stock	P - Purchase		98,787	9,501,836	1.05	5.90	582,814	56,057,982
2022-12-16	2022-12-16	4	FULC	Fulcrum Therapeutics, Inc. Common Stock	P - Purchase		1,341,420	9,403,049	16.64	5.42	7,269,826	50,959,824
2022-12-16	2022-12-15	4	FULC	Fulcrum Therapeutics, Inc. Common Stock	P - Purchase		237,029	8,061,629	3.03	5.50	1,302,474	44,298,651
2022-12-16	2022-12-14	4	FULC	Fulcrum Therapeutics, Inc. Common Stock	P - Purchase		824,600	7,824,600	11.78	5.46	4,501,574	42,715,274
2022-12-12	2022-12-09	4	IMRA	IMARA Inc. Common Stock	P - Purchase		19,299	3,250,724	0.60	3.93	75,845	12,775,345
2022-12-12	2022-12-08	4	IMRA	IMARA Inc. Common Stock	P - Purchase		10,600	3,231,425	0.33	3.75	39,750	12,117,844
2022-12-09	2022-12-09	4	VOR	Vor Biopharma Inc. Common Stock	A - Award		11,627,907	20,923,554	125.09	4.30	50,000,000	89,971,282
2022-12-05	2022-12-02	4	SLDB	Solid Biosciences Inc. Common Stock	A - Award		109,661	109,661
2022-12-05	2022-12-02	4	SLDB	Solid Biosciences Inc. Common Stock	A - Award		300,412	3,288,056	10.06
2022-12-05	2022-12-02	4	SLDB	Solid Biosciences Inc. Common Stock	A - Award		2,163,120	2,987,644	262.35	7.05	15,249,996	21,062,890
2022-11-21	2022-11-17	4	ACRV	Acrivon Therapeutics, Inc. Common Stock	C - Conversion		426,302	426,302
2022-11-21	2022-11-17	4	ACRV	Acrivon Therapeutics, Inc. Common Stock	P - Purchase		3,389,500	4,384,206	340.75	12.50	42,368,750	54,802,575
2022-11-21	2022-11-17	4	ACRV	Acrivon Therapeutics, Inc. Common Stock	C - Conversion		994,706	994,706
2022-11-10	2022-11-08	4	SPRY	ARS Pharmaceuticals, Inc. Common Stock	A - Award		902,904	902,904
2022-11-10	2022-11-08	4	SPRY	ARS Pharmaceuticals, Inc. Common Stock	A - Award		2,106,774	2,106,774
2022-10-24	2022-10-24	4	IMRA	IMARA Inc. Common Stock	P - Purchase		26,460	3,220,825	0.83	3.91	103,459	12,593,426
2022-10-24	2022-10-21	4	IMRA	IMARA Inc. Common Stock	P - Purchase		48,100	3,194,365	1.53	3.92	188,552	12,521,911
2022-10-24	2022-10-20	4	IMRA	IMARA Inc. Common Stock	P - Purchase		11,342	3,146,265	0.36	3.95	44,801	12,427,747
2022-10-20	2022-10-18	4	ETNB	89bio, Inc. Common Stock	P - Purchase		1,172,741	8,955,410	15.07	7.65	8,971,469	68,508,886
2022-10-19		3	IMRA	IMARA Inc. Common Stock				2,628,726
2022-10-19	2022-10-17	4	DICE	DICE Therapeutics, Inc. Common Stock	P - Purchase		1,640,000	6,848,911	31.48	36.50	59,860,000	249,985,252
2022-10-19	2022-10-19	4	IMRA	IMARA Inc. Common Stock	P - Purchase		125,726	3,134,923	4.18	3.89	488,659	12,184,505
2022-10-19	2022-10-18	4	IMRA	IMARA Inc. Common Stock	P - Purchase		234,799	3,009,197	8.46	3.76	882,844	11,314,581
2022-10-19	2022-10-17	4	IMRA	IMARA Inc. Common Stock	P - Purchase		145,672	2,774,398	5.54	3.36	489,458	9,321,977
2022-10-14	2022-10-14	4	FMTX	Forma Therapeutics Holdings, Inc. Common Stock	U - Other		-1,511,425	0	-100.00
2022-10-14	2022-10-14	4	FMTX	Forma Therapeutics Holdings, Inc. Common Stock	U - Other		-7,500,226	0	-100.00
2022-10-14	2022-10-14	4	FMTX	Forma Therapeutics Holdings, Inc. Common Stock	U - Other		-7,250	0	-100.00
2022-08-26		3	FULC	Fulcrum Therapeutics, Inc. Common Stock				7,000,000
2022-08-05	2022-08-04	4	ANTX	AN2 Therapeutics, Inc. Common Stock	P - Purchase		100	3,773,517	0.00	7.99	799	30,150,401
2022-08-05	2022-08-03	4	ANTX	AN2 Therapeutics, Inc. Common Stock	P - Purchase		1,809	3,773,417	0.05	7.48	13,531	28,225,159
2022-07-28	2022-07-27	4	ANTX	AN2 Therapeutics, Inc. Common Stock	P - Purchase		8,281	3,771,608	0.22	7.91	65,503	29,833,419
2022-07-28	2022-07-26	4	ANTX	AN2 Therapeutics, Inc. Common Stock	P - Purchase		14,938	3,763,327	0.40	7.71	115,172	29,015,251
2022-07-06	2022-07-01	4	ETNB	89bio, Inc. Common Stock	P - Purchase		2,816,900	7,782,669	56.73	3.55	9,999,995	27,628,475
2022-06-23	2022-06-21	4	ANTX	AN2 Therapeutics, Inc. Common Stock	P - Purchase		302	3,748,389	0.01	7.99	2,413	29,949,628
2022-06-21	2022-06-16	4	WVE	Wave Life Sciences Ltd. Ordinary Shares	P - Purchase		9,480,052	17,202,009	122.77	2.15	20,382,112	36,984,319
2022-06-15	2022-06-14	4	ANTX	AN2 Therapeutics, Inc. Common Stock	P - Purchase		61,424	3,748,087	1.67	7.97	489,402	29,863,258
2022-06-15	2022-06-13	4	ANTX	AN2 Therapeutics, Inc. Common Stock	P - Purchase		20,000	3,686,663	0.55	7.90	158,000	29,124,638
2022-06-14	2022-06-10	4	ICVX	Icosavax, Inc. Common Stock	A - Award		5,543	5,543
2022-06-09	2022-06-08	4	FTMX	Forma Therapeutics Holdings, Inc. Common Stock	A - Award		4,500	7,250	163.64
2022-05-26	2022-05-26	4	KALA	Kala Pharmaceuticals, Inc. Common Stock	S - Sale		-1,005,686	7,039,613	-12.50	0.36	-365,667	2,559,603
2022-05-25	2022-05-25	4	KALA	Kala Pharmaceuticals, Inc. Common Stock	S - Sale		-1,434,509	8,045,299	-15.13	0.42	-602,494	3,379,026
2022-05-25	2022-05-24	4	KALA	Kala Pharmaceuticals, Inc. Common Stock	S - Sale		-144,805	9,479,808	-1.50	0.51	-73,851	4,834,702
2022-05-25	2022-05-23	4	KALA	Kala Pharmaceuticals, Inc. Common Stock	S - Sale		-1,250,000	9,624,613	-11.49	0.65	-812,500	6,255,998
2022-05-12	2022-05-10	4	PEPG	PepGen Inc. Series B Preferred Stock	C - Conversion		-646,306	0	-100.00
2022-05-12	2022-05-10	4	PEPG	PepGen Inc. Series B Preferred Stock	C - Conversion		-1,508,048	0	-100.00
2022-05-12	2022-05-10	4	PEPG	PepGen Inc. Series A-2 Preferred Stock	C - Conversion		-211,410	0	-100.00
2022-05-12	2022-05-10	4	PEPG	PepGen Inc. Series A-2 Preferred Stock	C - Conversion		-425,497	0	-100.00
2022-05-12	2022-05-10	4	PEPG	PepGen Inc. Series A-2 Preferred Stock	C - Conversion		-2,199,741	0	-100.00
2022-05-12	2022-05-10	4	PEPG	PepGen Inc. Common Stock	C - Conversion		207,672	207,672
2022-05-12	2022-05-10	4	PEPG	PepGen Inc. Common Stock	P - Purchase		249,749	1,302,600	23.72	12.00	2,996,988	15,631,200
2022-05-12	2022-05-10	4	PEPG	PepGen Inc. Common Stock	C - Conversion		1,052,851	1,052,851
2022-05-12	2022-05-10	4	PEPG	PepGen Inc. Common Stock	P - Purchase		2,979,451	6,621,680	81.80	12.00	35,753,412	79,460,160
2022-05-12	2022-05-10	4	PEPG	PepGen Inc. Common Stock	C - Conversion		3,642,229	3,642,229
2022-05-10	2022-05-06	4	PEPG	PepGen Inc. Stock Option (Right to Buy)	A - Award		11,667	11,667
2022-04-28	2022-04-26	4	NKTX	Nkarta, Inc. Common Stock	P - Purchase		2,200,000	7,805,129	39.25	15.00	33,000,000	117,076,935
2022-03-31	2022-03-29	4	ANTX	AN2 Therapeutics, Inc. Series B Preferred Stock	C - Conversion		-299,999	0	-100.00
2022-03-31	2022-03-29	4	ANTX	AN2 Therapeutics, Inc. Series B Preferred Stock	C - Conversion		-1,699,998	0	-100.00
2022-03-31	2022-03-29	4	ANTX	AN2 Therapeutics, Inc. Common Stock	P - Purchase		115,613	415,612	38.54	15.00	1,734,195	6,234,180
2022-03-31	2022-03-29	4	ANTX	AN2 Therapeutics, Inc. Common Stock	C - Conversion		299,999	299,999
2022-03-31	2022-03-29	4	ANTX	AN2 Therapeutics, Inc. Common Stock	P - Purchase		1,551,053	3,251,051	91.24	15.00	23,265,795	48,765,765
2022-03-31	2022-03-29	4	ANTX	AN2 Therapeutics, Inc. Common Stock	C - Conversion		1,699,998	1,699,998
2022-03-30	2022-03-29	4	ICVX	Icosavax, Inc. Common Stock	P - Purchase		8,900	5,963,565	0.15	4.75	42,271	28,324,548
2022-03-30	2022-03-28	4	ICVX	Icosavax, Inc. Common Stock	P - Purchase		175,318	5,953,665	3.03	4.53	794,611	26,984,391
2022-03-16	2022-03-15	4	CTKB	Cytek Biosciences, Inc. Common Stock	P - Purchase	X	241,727	13,381,054	1.84	12.27	2,964,999	164,130,670
2022-03-16	2022-03-14	4	CTKB	Cytek Biosciences, Inc. Common Stock	P - Purchase	X	342,143	13,139,327	2.67	12.35	4,223,926	162,211,561
2022-03-11	2022-03-11	4	CTKB	Cytek Biosciences, Inc. Common Stock	P - Purchase	X	337,492	12,797,184	2.71	12.77	4,309,334	163,403,403
2022-03-11	2022-03-10	4	CTKB	Cytek Biosciences, Inc. Common Stock	P - Purchase	X	256,992	12,459,692	2.11	12.95	3,327,584	161,330,584
2022-03-11	2022-03-09	4	CTKB	Cytek Biosciences, Inc. Common Stock	P - Purchase	X	40,154	12,202,700	0.33	12.99	521,753	158,559,443
2022-03-08	2022-03-08	4	CTKB	Cytek Biosciences, Inc. Common Stock	P - Purchase	X	245,701	12,162,546	2.06	12.86	3,160,059	156,427,369
2022-03-08	2022-03-07	4	CTKB	Cytek Biosciences, Inc. Common Stock	P - Purchase	X	337,901	11,916,845	2.92	12.61	4,260,965	150,272,607
2022-03-08	2022-03-04	4	CTKB	Cytek Biosciences, Inc. Common Stock	P - Purchase	X	63,662	11,578,944	0.55	12.99	827,230	150,457,956
2022-03-02	2022-03-02	4	CTKB	Cytek Biosciences, Inc. Common Stock	P - Purchase	X	138,255	11,515,282	1.22	12.89	1,782,218	148,441,197
2022-03-02	2022-03-01	4	CTKB	Cytek Biosciences, Inc. Common Stock	P - Purchase	X	294,864	11,377,027	2.66	12.98	3,826,303	147,633,991
2022-03-02	2022-02-28	4	CTKB	Cytek Biosciences, Inc. Common Stock	P - Purchase	X	8,746	11,082,163	0.08	12.97	113,430	143,729,005
2022-02-25	2022-02-25	4	CTKB	Cytek Biosciences, Inc. Common Stock	P - Purchase	X	18,991	11,073,417	0.17	12.99	246,699	143,847,009
2022-02-25	2022-02-24	4	CTKB	Cytek Biosciences, Inc. Common Stock	P - Purchase	X	186,467	11,054,426	1.72	13.03	2,429,851	144,050,225
2022-02-25	2022-02-23	4	CTKB	Cytek Biosciences, Inc. Common Stock	P - Purchase	X	214,922	10,867,959	2.02	13.41	2,883,114	145,790,410
2022-02-22	2022-02-22	4	CTKB	Cytek Biosciences, Inc. Common Stock	P - Purchase	X	214,922	10,653,037	2.06	13.46	2,892,055	143,350,462
2022-02-22	2022-02-18	4	CTKB	Cytek Biosciences, Inc. Common Stock	P - Purchase	X	166,229	10,438,115	1.62	14.12	2,346,389	147,338,168
2022-02-22	2022-02-17	4	CTKB	Cytek Biosciences, Inc. Common Stock	P - Purchase	X	166,229	10,271,886	1.64	14.78	2,457,264	151,843,128
2022-02-16	2022-02-16	4	CTKB	Cytek Biosciences, Inc. Common Stock	P - Purchase	X	166,200	10,105,657	1.67	14.98	2,489,377	151,364,552
2022-02-16	2022-02-15	4	CTKB	Cytek Biosciences, Inc. Common Stock	P - Purchase	X	166,200	9,939,457	1.70	14.99	2,490,524	148,943,757
2022-02-16	2022-02-14	4	CTKB	Cytek Biosciences, Inc. Common Stock	P - Purchase	X	166,229	9,773,257	1.73	14.72	2,446,924	143,864,298
2021-09-20	2021-09-17	4	DICE	DICE Therapeutics, Inc. Series C-1 Preferred Stock	C - Conversion		-274,986	0	-100.00
2021-09-20	2021-09-17	4	DICE	DICE Therapeutics, Inc. Series C-1 Preferred Stock	C - Conversion		-641,635	0	-100.00
2021-09-20	2021-09-17	4	DICE	DICE Therapeutics, Inc. Series C Preferred Stock	C - Conversion		-433,843	0	-100.00
2021-09-20	2021-09-17	4	DICE	DICE Therapeutics, Inc. Series C Preferred Stock	C - Conversion		-2,458,447	0	-100.00
2021-09-20	2021-09-17	4	DICE	DICE Therapeutics, Inc. Common Stock	P - Purchase		77,578	786,407	10.94	17.00	1,318,826	13,368,919
2021-09-20	2021-09-17	4	DICE	DICE Therapeutics, Inc. Common Stock	C - Conversion		708,829	708,829
2021-09-20	2021-09-17	4	DICE	DICE Therapeutics, Inc. Common Stock	P - Purchase		1,322,422	4,422,504	42.66	17.00	22,481,174	75,182,568
2021-09-20	2021-09-17	4	DICE	DICE Therapeutics, Inc. Common Stock	C - Conversion		3,100,082	3,100,082
2021-09-17	2021-09-17	4	TYRA	Tyra Biosciences, Inc. Series B Preferred Stock	C - Conversion		-182,257	0	-100.00
2021-09-17	2021-09-17	4	TYRA	Tyra Biosciences, Inc. Series B Preferred Stock	C - Conversion		-546,773	0	-100.00
2021-09-17	2021-09-17	4	TYRA	Tyra Biosciences, Inc. Series A Preferred Stock	C - Conversion		-170,448	0	-100.00
2021-09-17	2021-09-17	4	TYRA	Tyra Biosciences, Inc. Series A Preferred Stock	C - Conversion		-393,940	0	-100.00
2021-09-17	2021-09-17	4	TYRA	Tyra Biosciences, Inc. Series A Preferred Stock	C - Conversion		-1,011,370	0	-100.00
2021-09-17	2021-09-17	4	TYRA	Tyra Biosciences, Inc. Common Stock	C - Conversion		442,721	442,721
2021-09-17	2021-09-17	4	TYRA	Tyra Biosciences, Inc. Common Stock	C - Conversion		1,496,613	1,496,613
2021-09-17	2021-09-17	4	TYRA	Tyra Biosciences, Inc. Common Stock	P - Purchase		1,250,000	5,297,120	30.89	16.00	20,000,000	84,753,920
2021-09-17	2021-09-17	4	TYRA	Tyra Biosciences, Inc. Common Stock	C - Conversion		4,047,120	4,047,120
2021-08-18	2021-08-16	4	WVE	Wave Life Sciences Ltd. Share Option (right to buy)	A - Award		42,000	42,000
2021-08-16	2021-08-12	4	ELYM	Eliem Therapeutics, Inc. Series A-1 Preferred Stock	C - Conversion		-139,481	0	-100.00
2021-08-16	2021-08-12	4	ELYM	Eliem Therapeutics, Inc. Series A Preferred Stock	C - Conversion		-485,493	0	-100.00
2021-08-16	2021-08-12	4	ELYM	Eliem Therapeutics, Inc. Series B Preferred Stock	C - Conversion		-288,461	0	-100.00
2021-08-16	2021-08-12	4	ELYM	Eliem Therapeutics, Inc. Series A-1 Preferred Stock	C - Conversion		-518,164	0	-100.00
2021-08-16	2021-08-12	4	ELYM	Eliem Therapeutics, Inc. Series A Preferred Stock	C - Conversion		-708,333	0	-100.00
2021-08-16	2021-08-12	4	ELYM	Eliem Therapeutics, Inc. Series B Preferred Stock	C - Conversion		-673,076	0	-100.00
2021-08-16	2021-08-12	4	ELYM	Eliem Therapeutics, Inc. Series A-1 Preferred Stock	C - Conversion		-1,415,002	0	-100.00
2021-08-16	2021-08-12	4	ELYM	Eliem Therapeutics, Inc. Series A Preferred Stock	C - Conversion		-2,639,507	0	-100.00
2021-08-16	2021-08-12	4	ELYM	Eliem Therapeutics, Inc. Common Stock	C - Conversion		624,974	841,087	289.19
2021-08-16	2021-08-12	4	ELYM	Eliem Therapeutics, Inc. Common Stock	P - Purchase		195,218	483,679	67.68	12.50	2,440,225	6,045,988
2021-08-16	2021-08-12	4	ELYM	Eliem Therapeutics, Inc. Common Stock	C - Conversion		288,461	288,461
2021-08-16	2021-08-12	4	ELYM	Eliem Therapeutics, Inc. Common Stock	C - Conversion		1,226,497	1,226,497
2021-08-16	2021-08-12	4	ELYM	Eliem Therapeutics, Inc. Common Stock	P - Purchase		3,004,782	10,599,586	39.56	12.50	37,559,775	132,494,825
2021-08-16	2021-08-12	4	ELYM	Eliem Therapeutics, Inc. Common Stock	C - Conversion		4,727,585	7,594,804	164.88
2021-08-13		3	RXST	RxSight, Inc. Common Stock				2,838,938
2021-08-13		3	RXST	RxSight, Inc. Common Stock				213,858
2021-08-11	2021-08-09	4	ELYM	Eliem Therapeutics, Inc. Stock Option (Right to Buy)	A - Award		20,000	20,000
2021-08-09		3	ELYM	Eliem Therapeutics, Inc. Common Stock				2,867,219
2021-08-09		3	ELYM	Eliem Therapeutics, Inc. Common Stock				216,113
2021-08-04	2021-08-02	4	ICVX	Icosavax, Inc. Series B-1 Preferred Stock	C - Conversion		-1,940,306	0	-100.00
2021-08-04	2021-08-02	4	ICVX	Icosavax, Inc. Series B-1 Preferred Stock	C - Conversion		-10,995,066	0	-100.00
2021-08-04	2021-08-02	4	ICVX	Icosavax, Inc. Common Stock	P - Purchase		171,766	638,668	36.79	15.00	2,576,490	9,580,020
2021-08-04	2021-08-02	4	ICVX	Icosavax, Inc. Common Stock	C - Conversion		466,902	466,902
2021-08-04	2021-08-02	4	ICVX	Icosavax, Inc. Common Stock	P - Purchase		2,494,900	5,140,679	94.30	15.00	37,423,500	77,110,185
2021-08-04	2021-08-02	4	ICVX	Icosavax, Inc. Common Stock	C - Conversion		2,645,779	2,645,779
2021-07-29	2021-07-27	4	CTKB	Cytek Biosciences, Inc. Series D Preferred Stock	C - Conversion		-507,724	0	-100.00
2021-07-29	2021-07-27	4	CTKB	Cytek Biosciences, Inc. Series D Preferred Stock	C - Conversion		-998,553	0	-100.00
2021-07-29	2021-07-27	4	CTKB	Cytek Biosciences, Inc. Series D Preferred Stock	C - Conversion		-5,150,751	0	-100.00
2021-07-29	2021-07-27	4	CTKB	Cytek Biosciences, Inc. Common Stock	C - Conversion		507,724	507,724
2021-07-29	2021-07-27	4	CTKB	Cytek Biosciences, Inc. Common Stock	P - Purchase		187,214	1,185,767	18.75	17.00	3,182,638	20,158,039
2021-07-29	2021-07-27	4	CTKB	Cytek Biosciences, Inc. Common Stock	C - Conversion		998,553	998,553
2021-07-29	2021-07-27	4	CTKB	Cytek Biosciences, Inc. Common Stock	P - Purchase		2,762,786	7,913,537	53.64	17.00	46,967,362	134,530,129
2021-07-29	2021-07-27	4	CTKB	Cytek Biosciences, Inc. Common Stock	C - Conversion		5,150,751	5,150,751
2021-07-08	2021-07-06	4	ABOS	Acumen Pharmaceuticals, Inc. Series B Preferred Stock	C - Conversion		-588,850	0	-100.00
2021-07-08	2021-07-06	4	ABOS	Acumen Pharmaceuticals, Inc. Series B Preferred Stock	C - Conversion		-1,184,366	0	-100.00
2021-07-08	2021-07-06	4	ABOS	Acumen Pharmaceuticals, Inc. Series B Preferred Stock	C - Conversion		-6,122,557	0	-100.00
2021-07-08	2021-07-06	4	ABOS	Acumen Pharmaceuticals, Inc. Common Stock	C - Conversion		588,850	588,850
2021-07-08	2021-07-06	4	ABOS	Acumen Pharmaceuticals, Inc. Common Stock	P - Purchase		115,668	1,300,034	9.77	16.00	1,850,688	20,800,544
2021-07-08	2021-07-06	4	ABOS	Acumen Pharmaceuticals, Inc. Common Stock	C - Conversion		1,184,366	1,184,336	-3,947,886.67
2021-07-08	2021-07-06	4	ABOS	Acumen Pharmaceuticals, Inc. Common Stock	P - Purchase		1,759,332	7,881,889	28.74	16.00	28,149,312	126,110,224
2021-07-08	2021-07-06	4	ABOS	Acumen Pharmaceuticals, Inc. Common Stock	C - Conversion		6,122,557	6,122,557
2021-07-06	2021-07-02	4	AVTE	Aerovate Therapeutics, Inc. Series A Preferred Stock	C - Conversion		-966,506	0	-100.00
2021-07-06	2021-07-02	4	AVTE	Aerovate Therapeutics, Inc. Series A Preferred Stock	C - Conversion		-3,066,397	0	-100.00
2021-07-06	2021-07-02	4	AVTE	Aerovate Therapeutics, Inc. Series A Preferred Stock	C - Conversion		-8,232,679	0	-100.00
2021-07-06	2021-07-02	4	AVTE	Aerovate Therapeutics, Inc. Series Seed Preferred Stock	C - Conversion		-4,000,000	0	-100.00
2021-07-06	2021-07-02	4	AVTE	Aerovate Therapeutics, Inc. Common Stock	C - Conversion		311,170	311,170
2021-07-06	2021-07-02	4	AVTE	Aerovate Therapeutics, Inc. Common Stock	C - Conversion		987,244	987,244
2021-07-06	2021-07-02	4	AVTE	Aerovate Therapeutics, Inc. Common Stock	P - Purchase		2,785,714	6,965,568	66.65	14.00	38,999,996	97,517,952
2021-07-06	2021-07-02	4	AVTE	Aerovate Therapeutics, Inc. Common Stock	C - Conversion		3,938,387	4,179,854	1,631.02
2021-06-30	2021-06-29	4	RACA	Therapeutics Acquisition Corp. Common Stock	A - Award		209,100	1,098,318	23.52	10.00	2,091,000	10,983,180
2021-06-29		3	AVTE	Aerovate Therapeutics, Inc. Common Stock				241,467
2021-06-24	2021-06-24	4	RACA	Therapeutics Acquisition Corp. Common Stock	A - Award		889,218	889,218		10.00	8,892,180	8,892,180
2021-06-21	2021-06-17	4	FMTX	Forma Therapeutics Holdings, Inc. Stock Option (Right to Buy)	A - Award		8,375	8,375
2021-06-21	2021-06-17	4	FMTX	Forma Therapeutics Holdings, Inc. Common Stock	A - Award		2,750	2,750
2021-06-16	2021-06-16	4	HOWL	Werewolf Therapeutics, Inc. Common Stock	P - Purchase		9,285	4,291,881	0.22	13.37	124,140	57,382,449
2021-06-16	2021-06-15	4	HOWL	Werewolf Therapeutics, Inc. Common Stock	P - Purchase		7,958	4,282,596	0.19	12.95	103,056	55,459,618
2021-06-16	2021-06-14	4	HOWL	Werewolf Therapeutics, Inc. Common Stock	P - Purchase		306,055	4,274,638	7.71	12.75	3,902,201	54,501,634
2021-06-16	2021-06-15	4	JANX	Janux Therapeutics, Inc. Series A Convertible Preferred Stock	C - Conversion		-434,056	0	-100.00
2021-06-16	2021-06-15	4	JANX	Janux Therapeutics, Inc. Series A Convertible Preferred Stock	C - Conversion		-2,459,649	0	-100.00
2021-06-16	2021-06-15	4	JANX	Janux Therapeutics, Inc. Series A Convertible Preferred Stock	C - Conversion		-236,842	0	-100.00
2021-06-16	2021-06-15	4	JANX	Janux Therapeutics, Inc. Series A Convertible Preferred Stock	C - Conversion		-1,342,106	0	-100.00
2021-06-16	2021-06-15	4	JANX	Janux Therapeutics, Inc. Common Stock	P - Purchase		188,986	1,048,406	21.99	17.00	3,212,762	17,822,902
2021-06-16	2021-06-15	4	JANX	Janux Therapeutics, Inc. Common Stock	C - Conversion		556,026	859,420	183.27
2021-06-16	2021-06-15	4	JANX	Janux Therapeutics, Inc. Common Stock	C - Conversion		303,394	303,394
2021-06-16	2021-06-15	4	JANX	Janux Therapeutics, Inc. Common Stock	P - Purchase		2,752,190	7,622,238	56.51	17.00	46,787,230	129,578,046
2021-06-16	2021-06-15	4	JANX	Janux Therapeutics, Inc. Common Stock	C - Conversion		3,150,810	4,870,048	183.27
2021-06-16	2021-06-15	4	JANX	Janux Therapeutics, Inc. Common Stock	C - Conversion		1,719,238	1,719,238
2021-06-04	2021-06-02	4	ETNB	89bio, Inc. Common Stock	P - Purchase		22,138	4,965,769	0.45	18.77	415,530	93,207,484
2021-05-28	2021-05-28	4	ETNB	89bio, Inc. Common Stock	P - Purchase		123,505	4,943,631	2.56	18.77	2,318,189	92,791,954
2021-05-28	2021-05-27	4	ETNB	89bio, Inc. Common Stock	P - Purchase		35,535	4,820,126	0.74	18.76	666,637	90,425,564
2021-05-28	2021-05-26	4	ETNB	89bio, Inc. Common Stock	P - Purchase		48,377	4,784,591	1.02	18.03	872,237	86,266,176
2021-05-06	2021-05-04	4	HOWL	Werewolf Therapeutics, Inc. Series B Preferred Stock	C - Conversion		-2,930,482	0	-100.00
2021-05-06	2021-05-04	4	HOWL	Werewolf Therapeutics, Inc. Series B Preferred Stock	C - Conversion		-16,606,068	0	-100.00
2021-05-06	2021-05-04	4	HOWL	Werewolf Therapeutics, Inc. Common Stock	P - Purchase		105,788	443,825	31.29	16.00	1,692,608	7,101,200
2021-05-06	2021-05-04	4	HOWL	Werewolf Therapeutics, Inc. Common Stock	C - Conversion		338,037	338,037
2021-05-06	2021-05-04	4	HOWL	Werewolf Therapeutics, Inc. Common Stock	P - Purchase		1,609,212	3,524,758	84.01	16.00	25,747,392	56,396,128
2021-05-06	2021-05-04	4	HOWL	Werewolf Therapeutics, Inc. Common Stock	C - Conversion		1,915,546	1,915,546
2021-04-05	2021-04-01	4	KALA	Kala Pharmaceuticals, Inc. Common Stock	J - Other		1,407,863	10,594,767	15.32	6.74	9,488,997	71,408,730
2021-04-05	2021-04-01	4	KALA	Kala Pharmaceuticals, Inc. Common Stock	J - Other		279,846	279,846		6.74	1,886,162	1,886,162
2021-04-05	2021-04-01	4	ETNB	89bio, Inc. Common Stock	J - Other		341,152	4,113,725	9.04	23.68	8,078,479	97,413,008
2021-04-05	2021-04-01	4	ETNB	89bio, Inc. Common Stock	J - Other		287,125	287,125		23.68	6,799,120	6,799,120
2021-04-05	2021-04-01	4	FMTX	Forma Therapeutics Holdings, Inc. Common Stock	J - Other		542,018	7,500,226	7.79	28.02	15,187,344	210,156,333
2021-04-05	2021-04-01	4	ITOS	iTeos Therapeutics, Inc. Common Stock	J - Other		131,364	3,155,667	4.34	34.18	4,490,022	107,860,698
2021-04-05	2021-04-01	4	ITOS	iTeos Therapeutics, Inc. Common Stock	J - Other		289,843	289,843		34.18	9,906,834	9,906,834
2021-04-05	2021-04-01	4	NKTX	Nkarta, Inc. Common Stock	J - Other		307,214	4,589,999	7.17	32.90	10,107,341	151,010,967
2021-04-05	2021-04-01	4	NKTX	Nkarta, Inc. Common Stock	J - Other		260,819	260,819		32.90	8,580,945	8,580,945
2021-04-05	2021-04-01	4	WVE	Wave Life Sciences Ltd. Ordinary Shares	J - Other		768,431	7,573,613	11.29	5.61	4,310,898	42,487,969
2021-04-05	2021-04-01	4	WVE	Wave Life Sciences Ltd. Ordinary Shares	J - Other		201,594	201,594		5.61	1,130,942	1,130,942
2021-04-05	2021-04-01	4	SLDB	Solid Biosciences Inc. Common Stock	J - Other		663,720	11,580,287	6.08	5.53	3,670,372	64,038,987
2021-04-05	2021-04-01	4	SLDB	Solid Biosciences Inc. Common Stock	J - Other		787,586	787,586		5.53	4,355,351	4,355,351
2021-04-05	2021-04-01	4	VOR	Vor Biopharma Inc. Common Stock	J - Other		242,656	8,539,921	2.92	43.10	10,458,474	368,070,595
2021-04-05	2021-04-01	4	VOR	Vor Biopharma Inc. Common Stock	J - Other		755,726	755,726		43.10	32,571,791	32,571,791
2021-04-05	2021-04-01	4	STSA	Satsuma Pharmaceuticals, Inc. Common Stock	J - Other		192,387	5,348,241	3.73	5.91	1,137,007	31,608,104
2021-04-05	2021-04-01	4	STSA	Satsuma Pharmaceuticals, Inc. Common Stock	J - Other		566,011	566,011		5.91	3,345,125	3,345,125
2021-03-23	2021-03-19	4	SLDB	Solid Biosciences Inc. Common Stock	P - Purchase		2,206,685	10,916,567	25.34	5.75	12,688,439	62,770,260
2021-03-16	2021-03-15	4	SCPH	scPharmaceuticals Inc. Common Stock	S - Sale		-110,588	2,727,446	-3.90	7.03	-777,788	19,182,673
2021-03-16	2021-03-12	4	SCPH	scPharmaceuticals Inc. Common Stock	S - Sale		-39,469	2,838,034	-1.37	7.22	-284,816	20,479,821
2021-03-15	2021-03-11	4	PHAT	Phathom Pharmaceuticals, Inc. Common Stock	S - Sale		-710,000	3,115,008	-18.56	43.75	-31,062,500	136,281,600
2021-03-02	2021-02-26	4	STSA	Satsuma Pharmaceuticals, Inc. Common Stock	P - Purchase		1,232,394	5,155,854	31.41	5.68	6,999,998	29,285,251
2021-02-11	2021-02-09	4	ORTX	Orchard Therapeutics plc Non-Voting Ordinary Shares	P - Purchase		3,215,434	3,215,434		6.22	19,999,999	19,999,999
2021-02-09	2021-02-09	4	VOR	Vor Biopharma Inc. Series B Preferred Stock	C - Conversion		-19,230,770	0	-100.00
2021-02-09	2021-02-09	4	VOR	Vor Biopharma Inc. Series B Preferred Stock	C - Conversion		-51,464,036	0	-100.00
2021-02-09	2021-02-09	4	VOR	Vor Biopharma Inc. Series A-2 Preferred Stock	C - Conversion		-3,812,500	0	-100.00
2021-02-09	2021-02-09	4	VOR	Vor Biopharma Inc. Series A-2 Preferred Stock	C - Conversion		-22,637,875	0	-100.00
2021-02-09	2021-02-09	4	VOR	Vor Biopharma Inc. Common Stock	P - Purchase		130,970	1,825,326	7.73	18.00	2,357,460	32,855,868
2021-02-09	2021-02-09	4	VOR	Vor Biopharma Inc. Common Stock	P - Purchase		2,848,596	8,297,265	52.28	18.00	51,274,728	149,350,770
2021-02-09	2021-02-09	4	VOR	Vor Biopharma Inc. Common Stock	C - Conversion		1,414,026	1,694,356	504.41
2021-02-09	2021-02-09	4	VOR	Vor Biopharma Inc. Common Stock	C - Conversion		3,784,120	5,448,669	227.34
2021-02-09	2021-02-09	4	VOR	Vor Biopharma Inc. Common Stock	C - Conversion		280,330	280,330
2021-02-09	2021-02-09	4	VOR	Vor Biopharma Inc. Common Stock	C - Conversion		1,664,549	1,664,549
2021-02-08	2021-02-04	4	ITRM	Iterum Therapeutics plc 6.500% Exchangeable Senior Subordinated Note due 2025	C - Conversion		-8,486,000	0	-100.00
2021-02-08	2021-02-04	4	ITRM	Iterum Therapeutics plc Ordinary Shares	C - Conversion		11,651,597	11,651,597
2020-12-17		3	MGEN	MIRAGEN THERAPEUTICS, INC. Common Stock				410,686
2020-12-15		3	SLDB	Solid Biosciences Inc. Common Stock				8,709,882
2020-12-07	2020-12-03	4	STSA	Satsuma Pharmaceuticals, Inc. Director Options to Purchase Common Stock (right to buy)	A - Award		20,000	20,000
2020-12-04	2020-12-03	4	RYTM	RHYTHM PHARMACEUTICALS, INC. Common Stock	S - Sale		-44,738	4,360,860	-1.02	28.75	-1,286,218	125,374,725
2020-12-04	2020-12-03	4	RYTM	RHYTHM PHARMACEUTICALS, INC. Common Stock	S - Sale		-139,308	4,405,598	-3.07	28.95	-4,032,967	127,542,062
2020-12-04	2020-12-03	4	RYTM	RHYTHM PHARMACEUTICALS, INC. Common Stock	S - Sale		-12,976	4,544,906	-0.28	29.11	-377,731	132,302,214
2020-12-04	2020-12-03	4	RYTM	RHYTHM PHARMACEUTICALS, INC. Common Stock	S - Sale		-10,582	4,557,882	-0.23	31.23	-330,476	142,342,655
2020-12-04	2020-12-02	4	RYTM	RHYTHM PHARMACEUTICALS, INC. Common Stock	S - Sale		-12,060	4,568,464	-0.26	32.23	-388,694	147,241,595
2020-12-04	2020-12-02	4	RYTM	RHYTHM PHARMACEUTICALS, INC. Common Stock	S - Sale		-18,879	4,580,524	-0.41	32.50	-613,568	148,867,030
2020-11-06		3	ORTX	Orchard Therapeutics plc Ordinary shares				9,111,848
2020-11-06	2020-09-24	4	ORTX	Orchard Therapeutics plc Ordinary shares	P - Purchase		473,327	9,880,865	5.03	4.61	2,182,037	45,550,788
2020-11-06	2020-08-21	4	ORTX	Orchard Therapeutics plc Ordinary shares	P - Purchase		10,226	9,407,538	0.11	4.51	46,119	42,427,996
2020-11-06	2020-08-21	4	ORTX	Orchard Therapeutics plc Ordinary shares	P - Purchase		54,416	9,397,312	0.58	4.64	252,490	43,603,528
2020-11-06	2020-08-20	4	ORTX	Orchard Therapeutics plc Ordinary shares	P - Purchase		4,525	9,342,896	0.05	4.61	20,860	43,070,751
2020-11-06	2020-08-20	4	ORTX	Orchard Therapeutics plc Ordinary shares	P - Purchase		58,106	9,338,371	0.63	4.61	267,869	43,049,890
2020-11-06	2020-08-19	4	ORTX	Orchard Therapeutics plc Ordinary shares	P - Purchase		9,050	9,280,265	0.10	4.65	42,082	43,153,232
2020-11-06	2020-08-19	4	ORTX	Orchard Therapeutics plc Ordinary shares	P - Purchase		55,204	9,271,215	0.60	4.69	258,907	43,481,998
2020-11-06	2020-08-18	4	ORTX	Orchard Therapeutics plc Ordinary shares	P - Purchase		45,249	9,216,011	0.49	4.72	213,575	43,499,572
2020-11-06	2020-08-17	4	ORTX	Orchard Therapeutics plc Ordinary shares	P - Purchase		8,235	9,170,762	0.09	4.74	39,034	43,469,412
2020-11-06	2020-08-14	4	ORTX	Orchard Therapeutics plc Ordinary shares	P - Purchase		13,031	9,162,527	0.14	4.74	61,767	43,430,378
2020-11-06	2020-08-12	4	ORTX	Orchard Therapeutics plc Ordinary shares	P - Purchase		16,291	9,149,496	0.18	4.74	77,219	43,368,611
2020-11-06	2020-08-10	4	ORTX	Orchard Therapeutics plc Ordinary shares	P - Purchase		6,787	9,133,205	0.07	4.71	31,967	43,017,396
2020-11-06	2020-08-10	4	ORTX	Orchard Therapeutics plc Ordinary shares	P - Purchase		14,570	9,126,418	0.16	4.75	69,208	43,350,486
2020-10-09	2020-10-08	4	PCVX	Vaxcyte, Inc. Common Stock	S - Sale		-167,661	5,001,593	-3.24	50.69	-8,498,065	253,510,743
2020-10-09	2020-10-07	4	PCVX	Vaxcyte, Inc. Common Stock	S - Sale		-98,597	5,169,254	-1.87	50.95	-5,023,527	263,374,008
2020-10-02		3	CRDF	Cardiff Oncology, Inc. Common Stock				3,290,000
2020-10-01	2020-10-01	4	PCVX	Vaxcyte, Inc. Common Stock	S - Sale		-15,967			48.64	-776,705
2020-10-01	2020-09-30	4	PCVX	Vaxcyte, Inc. Common Stock	S - Sale		-124,656	5,283,818	-2.30	50.27	-6,265,871	265,592,697
2020-10-01	2020-09-29	4	PCVX	Vaxcyte, Inc. Common Stock	S - Sale		-80,707	5,408,474	-1.47	52.08	-4,202,987	281,657,641
2020-09-29	2020-09-29	4	PMVP	PMV Pharmaceuticals, Inc. Series D Preferred Stock	C - Conversion		-760,265	0	-100.00
2020-09-29	2020-09-29	4	PMVP	PMV Pharmaceuticals, Inc. Common Stock	P - Purchase		950,000	1,710,265	124.96	18.00	17,100,000	30,784,770
2020-09-29	2020-09-29	4	PMVP	PMV Pharmaceuticals, Inc. Common Stock	C - Conversion		760,265	760,265
2020-09-23	2020-09-21	4	DYN	Dyne Therapeutics, Inc. Series B Preferred Stock	C - Conversion		-7,114,905	0	-100.00
2020-09-23	2020-09-21	4	DYN	Dyne Therapeutics, Inc. Common Stock	P - Purchase		660,000	2,805,045	30.77	19.00	12,540,000	53,295,855
2020-09-23	2020-09-21	4	DYN	Dyne Therapeutics, Inc. Common Stock	C - Conversion		2,145,045	2,145,045
2020-09-21	2020-09-17	4	ETNB	89bio, Inc. Common Stock	P - Purchase		1,300,000	4,736,214	37.83	28.00	36,400,000	132,613,992
2020-09-11	2020-09-09	4	TGTX	TG THERAPEUTICS, INC. Common Stock	S - Sale		-158,589	12,629,868	-1.24	25.81	-4,092,738	325,941,529
2020-08-24	2020-08-21	4	INBX	Inhibrx, Inc. Series Mezzanine 2 Preferred Stock	C - Conversion		-3,700,634	0	-100.00
2020-08-24	2020-08-21	4	INBX	Inhibrx, Inc. Common Stock	C - Conversion		2,129,003	2,129,003
2020-08-20	2020-08-18	4	WVE	Wave Life Sciences Ltd. Share Option (right to buy)	A - Award		10,500	10,500
2020-07-29	2020-07-28	4	ITOS	iTeos Therapeutics, Inc. Series B-2 Convertible Preferred Stock	C - Conversion		-9,751,773	0	-100.00
2020-07-29	2020-07-28	4	ITOS	iTeos Therapeutics, Inc. Common Stock	P - Purchase		1,425,000	4,417,259	47.62	19.00	27,075,000	83,927,921
2020-07-29	2020-07-28	4	ITOS	iTeos Therapeutics, Inc. Common Stock	C - Conversion		2,992,259	2,992,259
2020-07-28	2020-07-28	4	INZY	Inozyme Pharma, Inc. Series A-2 Convertible Preferred Stock	C - Conversion		-10,489,510	0	-100.00
2020-07-28	2020-07-28	4	INZY	Inozyme Pharma, Inc. Common Stock	P - Purchase		600,000	2,003,653	42.75	16.00	9,600,000	32,058,448
2020-07-28	2020-07-28	4	INZY	Inozyme Pharma, Inc. Common Stock	C - Conversion		1,403,653	1,403,653
2020-07-22	2020-07-21	4	PAND	Pandion Therapeutics, Inc. Series B Preferred Stock	C - Conversion		-7,184,596	0	-100.00
2020-07-22	2020-07-21	4	PAND	Pandion Therapeutics, Inc. Common Stock	P - Purchase		361,111	1,770,023	25.63	18.00	6,499,998	31,860,414
2020-07-22	2020-07-21	4	PAND	Pandion Therapeutics, Inc. Common Stock	C - Conversion		1,408,912	1,408,912
2020-07-16	2020-07-14	4	NKTX	Nkarta, Inc. Series B Preferred Stock	C - Conversion		-8,405,656	0	-100.00
2020-07-16	2020-07-14	4	NKTX	Nkarta, Inc. Common Stock	P - Purchase		3,333,333	5,605,129	146.73	18.00	59,999,994	100,892,322
2020-07-16	2020-07-14	4	NKTX	Nkarta, Inc. Common Stock	C - Conversion		2,271,796	2,271,796
2020-07-10	2020-07-08	4	ETNB	89bio, Inc. Common Stock	P - Purchase		275,000	3,436,214	8.70	27.50	7,562,500	94,495,885
2020-07-02	2020-06-30	4	AKUS	Akouos, Inc. Series B Preferred Stock	C - Conversion		-12,643,557	0	-100.00
2020-07-02	2020-06-30	4	AKUS	Akouos, Inc. Series A Preferred Stock	C - Conversion		-18,044,028	0	-100.00
2020-07-02	2020-06-30	4	AKUS	Akouos, Inc. Common Stock	P - Purchase		825,000	2,281,249	56.65	17.00	14,025,000	38,781,233
2020-07-02	2020-06-30	4	AKUS	Akouos, Inc. Common Stock	C - Conversion		599,987	1,456,249	70.07
2020-07-02	2020-06-30	4	AKUS	Akouos, Inc. Common Stock	C - Conversion		856,262	856,262
2020-07-02	2020-07-02	4	RYTM	RHYTHM PHARMACEUTICALS, INC. Common Stock	S - Sale		-44,153	5,140,408	-0.85	22.04	-972,969	113,275,573
2020-07-02	2020-07-01	4	RYTM	RHYTHM PHARMACEUTICALS, INC. Common Stock	S - Sale		-25,527	5,184,561	-0.49	21.87	-558,311	113,393,607
2020-07-02	2020-06-30	4	RYTM	RHYTHM PHARMACEUTICALS, INC. Common Stock	S - Sale		-61,901	5,210,088	-1.17	22.15	-1,371,237	115,414,390
2020-06-29	2020-06-29	4	RYTM	RHYTHM PHARMACEUTICALS, INC. Common Stock	S - Sale		-52,049	5,271,989	-0.98	22.19	-1,154,999	116,988,599
2020-06-29	2020-06-26	4	RYTM	RHYTHM PHARMACEUTICALS, INC. Common Stock	S - Sale		-86,706	5,324,038	-1.60	23.31	-2,020,848	124,086,821
2020-06-29	2020-06-25	4	RYTM	RHYTHM PHARMACEUTICALS, INC. Common Stock	S - Sale		-11,568	5,410,744	-0.21	25.05	-289,768	135,534,268
2020-06-29	2020-06-25	4	VSTM	Verastem, Inc. Common Stock	S - Sale		-1,161,300	16,142,051	-6.71	1.91	-2,219,941	30,857,145
2020-06-24	2020-06-23	4	FMTX	Forma Therapeutics Holdings, Inc., Series D Redeemable Convertible Preferred Stock	C - Conversion		-21,437,376	0	-100.00
2020-06-24	2020-06-23	4	FMTX	Forma Therapeutics Holdings, Inc., Common Stock	P - Purchase		4,000,000	9,011,651	79.81	20.00	80,000,000	180,233,020
2020-06-24	2020-06-23	4	FMTX	Forma Therapeutics Holdings, Inc., Common Stock	C - Conversion		5,011,651	5,011,651
2020-06-22	2020-06-18	4	FMTX	Forma Therapeutics Holdings, Inc., Stock Option (Right to Buy)	A - Award		17,533	0	-100.00
2020-06-18		3	PCVX	Vaxcyte, Inc. Common Stock				10,978,362
2020-06-18		3	PCVX	Vaxcyte, Inc. Common Stock				10,978,362
2020-06-18		3	PCVX	Vaxcyte, Inc. Common Stock				10,978,362
2020-06-18		3	PCVX	Vaxcyte, Inc. Common Stock				10,978,362
2020-06-18		3	PCVX	Vaxcyte, Inc. Common Stock				10,978,362
2020-06-18		3	PCVX	Vaxcyte, Inc. Common Stock				10,978,362
2020-05-07		3	TGTX	TG THERAPEUTICS, INC. Common Stock				25,576,914
2020-05-07		3	TGTX	TG THERAPEUTICS, INC. Common Stock				25,576,914
2020-05-07		3	TGTX	TG THERAPEUTICS, INC. Common Stock				25,576,914
2020-05-07		3	TGTX	TG THERAPEUTICS, INC. Common Stock				25,576,914
2020-05-07		3	TGTX	TG THERAPEUTICS, INC. Common Stock				25,576,914
2020-05-07		3	TGTX	TG THERAPEUTICS, INC. Common Stock				25,576,914
2020-04-29	2020-04-27	4	VSTM	Verastem, Inc. Common Stock	S - Sale		-1,301,300	17,303,351	-6.99	2.31	-3,002,099	39,918,831
2020-04-03	2020-04-02	4	RARX	Ra Pharmaceuticals, Inc. Common Stock	D - Sale to Issuer		-4,858,260	0	-100.00	48.00	-233,196,480
2020-04-03	2020-04-01	4	PHAT	Phathom Pharmaceuticals, Inc. Common Stock	P - Purchase		117,600	3,825,008	3.17	24.86	2,923,642	95,093,141
2020-03-31	2020-03-31	4	PHAT	Phathom Pharmaceuticals, Inc. Common Stock	P - Purchase		30,600	3,707,408	0.83	24.55	751,264	91,020,945
2020-03-31	2020-03-27	4	PHAT	Phathom Pharmaceuticals, Inc. Common Stock	P - Purchase		30,000	3,676,808	0.82	24.60	738,000	90,449,477
2020-03-17	2020-03-16	4	IMRA	IMARA Inc. Series B Preferred Stock	C - Conversion		-1,741,358	0	-100.00
2020-03-17	2020-03-16	4	IMRA	IMARA Inc. Common Stock	P - Purchase		625,000	1,454,348	75.36	16.00	10,000,000	23,269,568
2020-03-17	2020-03-16	4	IMRA	IMARA Inc. Common Stock	C - Conversion		829,348	829,348
2020-03-13	2020-03-13	4	KALA	Kala Pharmaceuticals, Inc. Common Stock	P - Purchase		6,337,135	10,874,613	139.66	7.89	49,999,995	85,800,697
2020-03-05		3	VSTM	Verastem, Inc. Common Stock				37,209,302
2020-03-05		3	VSTM	Verastem, Inc. Common Stock				37,209,302
2020-03-05		3	VSTM	Verastem, Inc. Common Stock				37,209,302
2020-03-05		3	VSTM	Verastem, Inc. Common Stock				37,209,302
2020-03-05		3	VSTM	Verastem, Inc. Common Stock				37,209,302
2020-03-05		3	VSTM	Verastem, Inc. Common Stock				37,209,302
2020-02-21	2020-02-14	4/A	SCPH	scPharmaceuticals Inc. Common Stock	P - Purchase		271,993	3,518,998	8.38	8.20	2,230,343	28,855,784
2020-02-19	2020-02-14	4	SCPH	scPharmaceuticals Inc. Common Stock	P - Purchase		271,993	3,247,005	9.14	8.20	2,230,343	26,625,441
2020-02-06		3/A	PHAT	Phathom Pharmaceuticals, Inc. Common Stock				3,646,808
2020-01-24	2020-01-23	4	THOR	Synthorx, Inc. Stock Option (right to buy)	D - Sale to Issuer		-15,335	0	-100.00	55.60	-852,626
2020-01-24	2020-01-23	4	THOR	Synthorx, Inc. Stock Option (right to buy)	D - Sale to Issuer		-30,000	0	-100.00	57.00	-1,710,000
2020-01-24	2020-01-23	4	THOR	Synthorx, Inc. Common Stock	U - Other		-9,724,598	0	-100.00	68.00	-661,272,664
2019-12-02	2019-12-02	4	DRNA	Dicerna Pharmaceuticals Inc Common Stock	S - Sale		-137,176	0	-100.00	24.98	-3,427,137
2019-12-02	2019-11-29	4	DRNA	Dicerna Pharmaceuticals Inc Common Stock	S - Sale		-138,000	137,176	-50.15	24.22	-3,341,725	3,321,772
2019-12-02	2019-11-27	4	DRNA	Dicerna Pharmaceuticals Inc Common Stock	S - Sale		-368,700	275,176	-57.26	24.04	-8,864,765	6,616,139
2019-11-26	2019-11-26	4	DRNA	Dicerna Pharmaceuticals Inc Common Stock	S - Sale		-239,700	643,876	-27.13	23.59	-5,653,444	15,186,137
2019-11-26	2019-11-25	4	DRNA	Dicerna Pharmaceuticals Inc Common Stock	S - Sale		-361,200	883,576	-29.02	24.06	-8,689,677	21,256,895
2019-11-26	2019-11-22	4	DRNA	Dicerna Pharmaceuticals Inc Common Stock	S - Sale		-197,700	1,244,776	-13.71	22.52	-4,451,492	28,027,874
2019-11-21	2019-11-21	4	DRNA	Dicerna Pharmaceuticals Inc Common Stock	S - Sale		-351,505	1,442,476	-19.59	22.98	-8,076,952	33,145,502
2019-11-21	2019-11-20	4	DRNA	Dicerna Pharmaceuticals Inc Common Stock	S - Sale		-265,505	1,793,981	-12.89	22.93	-6,088,879	41,141,725
2019-11-21	2019-11-19	4	DRNA	Dicerna Pharmaceuticals Inc Common Stock	S - Sale		-397,183	2,059,486	-16.17	23.92	-9,501,293	49,266,406
2019-11-13	2019-11-13	4	ETNB	89bio, Inc. Series A Preferred Stock	C - Conversion		-10,327,777	0	-100.00
2019-11-13	2019-11-13	4	ETNB	89bio, Inc. Common Stock	C - Conversion		1,661,214	3,161,214	110.75
2019-11-13	2019-11-11	4	ETNB	89bio, Inc. Common Stock	P - Purchase		1,500,000	1,500,000		16.00	24,000,000	24,000,000
2019-11-04		3	PHAT	Phathom Pharmaceuticals, Inc. Common Stock				7,293,292
2019-11-04		3	PHAT	Phathom Pharmaceuticals, Inc. Common Stock				7,293,292
2019-11-04		3	PHAT	Phathom Pharmaceuticals, Inc. Common Stock				7,293,292
2019-11-04		3	PHAT	Phathom Pharmaceuticals, Inc. Common Stock				7,293,292
2019-11-04		3	PHAT	Phathom Pharmaceuticals, Inc. Common Stock				7,293,292
2019-11-04		3	PHAT	Phathom Pharmaceuticals, Inc. Common Stock				7,293,292
2019-10-18		3	RYTM	RHYTHM PHARMACEUTICALS, INC. Common Stock				10,844,624
2019-10-18		3	RYTM	RHYTHM PHARMACEUTICALS, INC. Common Stock				10,844,624
2019-10-18		3	RYTM	RHYTHM PHARMACEUTICALS, INC. Common Stock				10,844,624
2019-10-18		3	RYTM	RHYTHM PHARMACEUTICALS, INC. Common Stock				10,844,624
2019-10-18		3	RYTM	RHYTHM PHARMACEUTICALS, INC. Common Stock				10,844,624
2019-09-17	2019-09-17	4	STSA	Satsuma Pharmaceuticals, Inc. Series B Preferred Stock	C - Conversion		-1,340,116	0	-100.00
2019-09-17	2019-09-17	4	STSA	Satsuma Pharmaceuticals, Inc. Series A Preferred Stock	C - Conversion		-2,008,409	0	-100.00
2019-09-17	2019-09-17	4	STSA	Satsuma Pharmaceuticals, Inc. Common Stock	P - Purchase		1,333,333	4,681,858	39.82	15.00	19,999,995	70,227,870
2019-09-17	2019-09-17	4	STSA	Satsuma Pharmaceuticals, Inc. Common Stock	C - Conversion		1,340,116	3,348,525	66.73
2019-09-17	2019-09-17	4	STSA	Satsuma Pharmaceuticals, Inc. Common Stock	C - Conversion		2,008,409	2,008,409
2019-08-16	2019-08-15	4	WVE	Wave Life Sciences Ltd. Share Option (right to buy)	A - Award		10,500	10,500
2019-06-21	2019-06-20	4	DRNA	Dicerna Pharmaceuticals Inc Director Stock Option (right to buy)	A - Award		25,000	25,000
2019-06-13	2019-06-11	4	RARX	Ra Pharmaceuticals, Inc. Director Options to Purchase Common Stock (right to buy)	A - Award		15,000	15,000
2019-06-11	2019-06-07	4	THOR	Synthorx, Inc. Stock Option (right to buy)	A - Award		15,335	15,335
2019-01-28	2019-01-24	4	WVE	Wave Life Sciences Ltd. Ordinary Shares	P - Purchase		263,158	7,775,207	3.50	38.00	10,000,004	295,457,866
2018-12-14	2018-12-12	4	RARX	Ra Pharmaceuticals, Inc. Common Stock	P - Purchase		1,006,452	4,858,260	26.13	15.50	15,600,006	75,303,030
2018-12-13	2018-12-11	4	THOR	Synthorx, Inc. Series C Preferred Stock	C - Conversion		-5,854,439	0	-100.00
2018-12-13	2018-12-11	4	THOR	Synthorx, Inc. Series B Preferred Stock	C - Conversion		-2,443,794	0	-100.00
2018-12-13	2018-12-11	4	THOR	Synthorx, Inc. Common Stock	P - Purchase		4,545,455	9,724,598	87.76	11.00	50,000,005	106,970,578
2018-12-13	2018-12-11	4	THOR	Synthorx, Inc. Common Stock	C - Conversion		3,653,908	5,179,143	239.56
2018-12-13	2018-12-11	4	THOR	Synthorx, Inc. Common Stock	C - Conversion		1,525,235	1,525,235
2018-12-07	2018-12-06	4	THOR	Synthorx, Inc. Stock Option (right to buy)	A - Award		30,000	30,000
2018-11-09	2018-11-08	4	DRNA	Dicerna Pharmaceuticals Inc Common Stock	D - Sale to Issuer		-107,920	2,456,669	-4.21	14.86	-1,603,680	36,505,856
2018-11-09	2018-11-07	4	DRNA	Dicerna Pharmaceuticals Inc Common Stock	D - Sale to Issuer		-250,000	2,564,589	-8.88	14.74	-3,685,050	37,802,555
2018-11-06	2018-11-06	4	DRNA	Dicerna Pharmaceuticals Inc Common Stock	D - Sale to Issuer		-263,300	2,814,589	-8.55	13.84	-3,644,967	38,963,481
2018-11-06	2018-11-05	4	DRNA	Dicerna Pharmaceuticals Inc Common Stock	D - Sale to Issuer		-71,400	3,077,889	-2.27	12.89	-920,203	39,667,833
2018-11-06	2018-11-02	4	DRNA	Dicerna Pharmaceuticals Inc Common Stock	D - Sale to Issuer		-175,700	3,149,289	-5.28	13.49	-2,370,650	42,492,097
2018-11-01	2018-11-01	4	DRNA	Dicerna Pharmaceuticals Inc Common Stock	D - Sale to Issuer		-180,100	3,324,989	-5.14	13.38	-2,408,964	44,474,055
2018-11-01	2018-10-31	4	DRNA	Dicerna Pharmaceuticals Inc Common Stock	D - Sale to Issuer		-178,400	3,505,089	-4.84	13.46	-2,401,603	47,185,158
2018-11-01	2018-10-30	4	DRNA	Dicerna Pharmaceuticals Inc Common Stock	D - Sale to Issuer		-250,000	3,683,489	-6.36	13.86	-3,465,075	51,054,263
2018-11-01	2018-06-28	4	RARX	Ra Pharmaceuticals, Inc. Director Options to Purchase Common Stock (right to buy)	A - Award		15,000	15,000
2018-10-25		3	EIGR	Eiger BioPharmaceuticals, Inc. Common Stock				4,830,916
2018-10-25		3	EIGR	Eiger BioPharmaceuticals, Inc. Common Stock				4,830,916
2018-10-25		3	EIGR	Eiger BioPharmaceuticals, Inc. Common Stock				4,830,916
2018-10-25		3	EIGR	Eiger BioPharmaceuticals, Inc. Common Stock				4,830,916
2018-10-25		3	EIGR	Eiger BioPharmaceuticals, Inc. Common Stock				4,830,916
2018-10-05	2018-10-03	4	KALA	Kala Pharmaceuticals, Inc. Common Stock	P - Purchase		2,424,242	4,537,478	114.72	8.25	19,999,996	37,434,194
2018-10-03	2018-10-01	4	ARVN	ARVINAS INC. Series C Preferred Stock	C - Conversion		-947,085	0	-100.00
2018-10-03	2018-10-01	4	ARVN	ARVINAS INC. Series B Preferred Stock	C - Conversion		-6,002,761	0	-100.00
2018-10-03	2018-10-01	4	ARVN	ARVINAS INC. Common Stock	P - Purchase		1,000,000	3,138,412	46.76	16.00	16,000,000	50,214,592
2018-10-03	2018-10-01	4	ARVN	ARVINAS INC. Common Stock	C - Conversion		291,410	2,138,412	15.78
2018-10-03	2018-10-01	4	ARVN	ARVINAS INC. Common Stock	C - Conversion		1,847,002	1,847,002
2018-08-15	2018-08-13	4	WVE	Wave Life Sciences Ltd. Share Option (right to buy)	A - Award		9,000	9,000
2018-07-02	2018-06-28	4	RARX	Ra Pharmaceuticals, Inc. Director Options to Purchase Common Stock (right to buy)	A - Award		15,000	15,000
2018-06-25	2018-06-21	4	DRNA	Dicerna Pharmaceuticals Inc Director Stock Option (right to buy)	A - Award		25,000	25,000
2018-06-22	2018-06-22	4	EIDX	Eidos Therapeutics, Inc. Series B Convertible Preferred Stock	C - Conversion		-922,950	0	-100.00
2018-06-22	2018-06-22	4	EIDX	Eidos Therapeutics, Inc. Common Stock	P - Purchase		1,058,824	2,162,671	95.92	17.00	18,000,008	36,765,407
2018-06-22	2018-06-22	4	EIDX	Eidos Therapeutics, Inc. Common Stock	C - Conversion		1,103,847	1,103,847
2018-03-27	2018-03-23	4	DRNA	Dicerna Pharmaceuticals Inc Common Stock	D - Sale to Issuer		-55,300	3,933,489	-1.39	11.05	-611,126	43,469,380
2018-03-21	2018-03-21	4	DRNA	Dicerna Pharmaceuticals Inc Common Stock	D - Sale to Issuer		-36,224	3,988,789	-0.90	11.17	-404,720	44,565,543
2018-03-21	2018-03-21	4	DRNA	Dicerna Pharmaceuticals Inc Common Stock	D - Sale to Issuer		-49,000	4,025,013	-1.20	11.14	-545,860	44,838,645
2018-03-21	2018-03-21	4	DRNA	Dicerna Pharmaceuticals Inc Common Stock	D - Sale to Issuer		-31,145	4,074,013	-0.76	11.07	-344,831	45,106,657
2018-03-21	2018-03-21	4	DRNA	Dicerna Pharmaceuticals Inc Common Stock	D - Sale to Issuer		-64,600	4,105,158	-1.55	11.24	-726,098	46,141,565
2018-03-21	2018-03-20	4	DRNA	Dicerna Pharmaceuticals Inc Common Stock	D - Sale to Issuer		-67,985	4,169,758	-1.60	11.16	-759,039	46,554,514
2018-03-21	2018-03-20	4	DRNA	Dicerna Pharmaceuticals Inc Common Stock	D - Sale to Issuer		-55,200	4,237,743	-1.29	11.16	-615,784	47,274,142
2018-03-21	2018-03-20	4	DRNA	Dicerna Pharmaceuticals Inc Common Stock	D - Sale to Issuer		-50,000	4,292,943	-1.15	11.00	-550,000	47,222,373
2018-03-21	2018-03-19	4	DRNA	Dicerna Pharmaceuticals Inc Common Stock	D - Sale to Issuer		-34,700	4,342,943	-0.79	12.46	-432,188	54,091,355
2018-03-21	2018-03-19	4	DRNA	Dicerna Pharmaceuticals Inc Common Stock	D - Sale to Issuer		-84,670	4,377,643	-1.90	12.63	-1,069,450	55,293,133
2018-02-16	2018-02-14	4	RARX	Ra Pharmaceuticals, Inc. Common Stock	P - Purchase		2,500,000	3,851,808	184.94	6.00	15,000,000	23,110,848
2018-01-19	2018-01-18	4	DRNA	Dicerna Pharmaceuticals Inc Common Stock	D - Sale to Issuer		-59,700	4,462,313	-1.32	9.23	-550,858	41,174,208
2018-01-19	2018-01-17	4	DRNA	Dicerna Pharmaceuticals Inc Common Stock	D - Sale to Issuer		-220,900	4,522,013	-4.66	9.33	-2,059,981	42,169,580
2018-01-08	2018-01-05	4	DRNA	Dicerna Pharmaceuticals Inc Common Stock	D - Sale to Issuer		-18,100	4,742,913	-0.38	9.15	-165,544	43,379,157
2018-01-08	2018-01-04	4	DRNA	Dicerna Pharmaceuticals Inc Common Stock	D - Sale to Issuer		-77,400	4,761,013	-1.60	9.20	-711,910	43,790,845
2018-01-03	2018-01-03	4	DRNA	Dicerna Pharmaceuticals Inc Common Stock	D - Sale to Issuer		-59,100	4,838,413	-1.21	9.25	-546,870	44,771,287
2018-01-03	2018-01-02	4	DRNA	Dicerna Pharmaceuticals Inc Common Stock	D - Sale to Issuer		-68,000	4,897,513	-1.37	9.47	-643,654	46,357,409
2018-01-03	2017-12-29	4	DRNA	Dicerna Pharmaceuticals Inc Common Stock	D - Sale to Issuer		-23,100	4,965,513	-0.46	9.13	-210,875	45,329,175
2018-01-03	2017-12-29	4	DRNA	Dicerna Pharmaceuticals Inc Common Stock	D - Sale to Issuer		-85,400	4,988,613	-1.68	9.10	-777,362	45,409,349
2017-12-20	2017-12-18	4	DRNA	Dicerna Pharmaceuticals Inc Redeemable Convertible Preferred Stock	M - Exercise		-76,500	0	-100.00	3.19	-244,035
2017-12-20	2017-12-18	4	DRNA	Dicerna Pharmaceuticals Inc Common Stock	M - Exercise		2,645,442	5,074,013	108.93
2017-11-21		3	SCPH	scPharmaceuticals Inc. Common Stock				5,714,286
2017-11-21		3	SCPH	scPharmaceuticals Inc. Common Stock				5,714,286
2017-11-21		3	SCPH	scPharmaceuticals Inc. Common Stock				5,714,286
2017-11-15	2017-11-14	4	WVE	Wave Life Sciences Ltd. Ordinary Shares	P - Purchase		23,398	7,512,049	0.31	24.00	561,550	180,288,425
2017-11-15	2017-11-13	4	WVE	Wave Life Sciences Ltd. Ordinary Shares	P - Purchase		400,000	7,488,651	5.64	23.30	9,320,000	174,485,568
2017-10-16	2017-10-12	4	KALV	KalVista Pharmaceuticals, Inc. Common Stock	P - Purchase		850,000	1,441,070	143.81	8.50	7,225,000	12,249,095
2017-09-29	2017-09-27	4	KALV	KalVista Pharmaceuticals, Inc. Director Stock Option (right to buy)	A - Award		6,000	6,000
2017-08-17	2017-08-10	4	WVE	Wave Life Sciences Ltd. Share Option (right to buy)	A - Award		9,000	9,000
2017-07-26	2017-07-25	4	KALA	Kala Pharmaceuticals, Inc. Series C Preferred Stock	C - Conversion		-4,409,170	0	-100.00
2017-07-26	2017-07-25	4	KALA	Kala Pharmaceuticals, Inc. Series B Preferred Stock	C - Conversion		-3,819,444	0	-100.00
2017-07-26	2017-07-25	4	KALA	Kala Pharmaceuticals, Inc. Common Stock	P - Purchase		533,333	2,113,236	33.76	15.00	7,999,995	31,698,540
2017-07-26	2017-07-25	4	KALA	Kala Pharmaceuticals, Inc. Common Stock	C - Conversion		1,579,903	1,579,903
2017-07-20	2017-07-18	4	DRNA	Dicerna Pharmaceuticals Inc Director Stock Option (right to buy)	A - Award		25,000	25,000
2017-06-22	2017-06-20	4	RARX	Ra Pharmaceuticals, Inc. Director Options to Purchase Common Stock (right to buy)	A - Award		15,000	15,000
2017-05-24	2017-05-22	4	GTHX	G1 Therapeutics, Inc. Series C Preferred Stock	C - Conversion		-1,682,822	0	-100.00	2.97	-5,000,001
2017-05-24	2017-05-22	4	GTHX	G1 Therapeutics, Inc. Series B Preferred Stock	C - Conversion		-5,169,916	0	-100.00	1.45	-7,499,997
2017-05-24	2017-05-22	4	GTHX	G1 Therapeutics, Inc. Common Stock	P - Purchase		400,000	2,684,244	17.51	15.00	6,000,000	40,263,660
2017-05-24	2017-05-22	4	GTHX	G1 Therapeutics, Inc. Common Stock	C - Conversion		560,940	2,284,244	32.55
2017-05-24	2017-05-22	4	GTHX	G1 Therapeutics, Inc. Common Stock	C - Conversion		1,723,304	1,723,304
2017-04-13	2017-04-11	4	DRNA	Dicerna Pharmaceuticals Inc Redeemable Convertible Preferred Stock	J - Other		76,500	76,500		100.00	7,650,000	7,650,000
2017-03-27	2017-03-23	4	KALV	KalVista Pharmaceuticals, Inc. Director Stock Option (right to buy)	A - Award		12,000	12,000
2016-11-23	2016-11-21	4	KALV	KalVista Pharmaceuticals, Inc. Common Stock	A - Award		591,070	591,070
2016-11-14	2016-11-10	4	WVE	Wave Life Sciences Ltd. Share Option (right to buy)	A - Award		9,000	9,000
2016-10-31	2016-10-31	4	RARX	Ra Pharmaceuticals, Inc. Series B-2 Preferred Stock	C - Conversion		-4,015,378	0	-100.00
2016-10-31	2016-10-31	4	RARX	Ra Pharmaceuticals, Inc. Series B-1 Preferred Stock	C - Conversion		-4,316,531	0	-100.00
2016-10-31	2016-10-31	4	RARX	Ra Pharmaceuticals, Inc. Common Stock	P - Purchase		161,538	1,351,808	13.57	13.00	2,099,994	17,573,504
2016-10-31	2016-10-31	4	RARX	Ra Pharmaceuticals, Inc. Common Stock	C - Conversion		573,624	1,190,270	93.02
2016-10-31	2016-10-31	4	RARX	Ra Pharmaceuticals, Inc. Common Stock	C - Conversion		616,646	616,646
2016-09-19	2016-09-16	4	ACRS	Aclaris Therapeutics, Inc. Common Stock	S - Sale		-23,600	2,102,169	-1.11	24.54	-579,212	51,593,324
2016-09-19	2016-09-16	4	ACRS	Aclaris Therapeutics, Inc. Common Stock	S - Sale		-150,000	2,125,769	-6.59	24.50	-3,675,000	52,081,340
2016-09-19	2016-09-15	4	ACRS	Aclaris Therapeutics, Inc. Common Stock	S - Sale		-58,950	2,275,769	-2.52	24.20	-1,426,590	55,073,610
2016-09-19	2016-09-15	4	ACRS	Aclaris Therapeutics, Inc. Common Stock	S - Sale		-273,000	2,334,719	-10.47	24.00	-6,552,000	56,033,256
2016-09-19	2016-09-15	4	ACRS	Aclaris Therapeutics, Inc. Common Stock	S - Sale		-20,000	2,607,719	-0.76	24.04	-480,700	62,676,526
2016-06-15	2016-06-14	4	DRNA	Dicerna Pharmaceuticals Inc Director Stock Option (right to buy)	A - Award		15,000	15,000
2016-02-24	2016-02-23	4	ACRS	Aclaris Therapeutics, Inc. Common Stock	P - Purchase		28,408	2,627,719	1.09	17.62	500,512	46,296,993
2016-02-24	2016-02-22	4	ACRS	Aclaris Therapeutics, Inc. Common Stock	P - Purchase		11,318	2,599,311	0.44	15.99	180,958	41,559,084
2016-01-20	2016-01-20	4	ACRS	Aclaris Therapeutics, Inc. Common Stock	P - Purchase		1,803	2,587,993	0.07	19.88	35,849	51,457,065
2016-01-20	2016-01-19	4	ACRS	Aclaris Therapeutics, Inc. Common Stock	P - Purchase		4,200	2,586,190	0.16	19.88	83,480	51,403,888
2016-01-20	2016-01-15	4	ACRS	Aclaris Therapeutics, Inc. Common Stock	P - Purchase		1,800	2,581,990	0.07	19.86	35,743	51,271,092
2016-01-13	2016-01-13	4	ACRS	Aclaris Therapeutics, Inc. Common Stock	P - Purchase		5,543	2,580,190	0.22	19.97	110,674	51,517,364
2016-01-13	2016-01-12	4	ACRS	Aclaris Therapeutics, Inc. Common Stock	P - Purchase		5,941	2,574,647	0.23	19.12	113,585	49,224,161
2016-01-13	2016-01-11	4	ACRS	Aclaris Therapeutics, Inc. Common Stock	P - Purchase		4,153	2,568,706	0.16	17.93	74,479	46,066,403
2015-11-18	2015-11-16	4	WVE	Wave Life Sciences Ltd. Series B Preferred Shares	C - Conversion		-1,172,060	0	-100.00
2015-11-18	2015-11-16	4	WVE	Wave Life Sciences Ltd. Ordinary Shares	P - Purchase		1,875,000	7,088,651	35.96	16.00	30,000,000	113,418,416
2015-11-18	2015-11-16	4	WVE	Wave Life Sciences Ltd. Ordinary Shares	C - Conversion		1,172,060	5,213,651	29.00
2015-11-18	2015-08-14	4	WVE	Wave Life Sciences Ltd. Series B Preferred Shares	P - Purchase		1,172,060	1,172,060		12.37	14,498,382	14,498,382
2015-11-12		3	WVE	Wave Life Sciences Ltd. Ordinary Shares				8,083,182
2015-11-12		3	WVE	Wave Life Sciences Ltd. Ordinary Shares				8,083,182
2015-11-12		3	WVE	Wave Life Sciences Ltd. Ordinary Shares				8,083,182
2015-11-12		3	WVE	Wave Life Sciences Ltd. Ordinary Shares				8,083,182
2015-10-30	2015-10-29	4	ACRS	Aclaris Therapeutics, Inc. Common Stock	P - Purchase		95,000	2,564,552	3.85	14.00	1,330,000	35,903,728
2015-10-30	2015-10-28	4	ACRS	Aclaris Therapeutics, Inc. Common Stock	P - Purchase		149,200	2,469,552	6.43	14.00	2,088,800	34,573,728
2015-10-26	2015-10-22	4	ACRS	Aclaris Therapeutics, Inc. Common Stock	P - Purchase		5,410	2,320,352	0.23	14.03	75,883	32,546,185
2015-10-21	2015-10-21	4	ACRS	Aclaris Therapeutics, Inc. Common Stock	P - Purchase		3,100	2,314,942	0.13	14.83	45,976	34,333,136
2015-10-21	2015-10-20	4	ACRS	Aclaris Therapeutics, Inc. Common Stock	P - Purchase		7,965	2,311,842	0.35	14.95	119,070	34,559,957
2015-10-21	2015-10-19	4	ACRS	Aclaris Therapeutics, Inc. Common Stock	P - Purchase		23,934	2,303,877	1.05	14.88	356,049	34,273,165
2015-10-16	2015-10-14	4	ACRS	Aclaris Therapeutics, Inc. Common Stock	P - Purchase		42,813	2,279,943	1.91	14.06	601,792	32,047,563
2015-10-13	2015-10-08	4	ACRS	Aclaris Therapeutics, Inc. Common Stock	P - Purchase		21,691	2,237,130	0.98	11.00	238,555	24,603,732
2015-10-13	2015-10-07	4	ACRS	Aclaris Therapeutics, Inc. Common Stock	P - Purchase		27,398	2,215,439	1.25	11.00	301,378	24,369,829
2015-10-13	2015-10-07	4	ACRS	Aclaris Therapeutics, Inc. Common Stock	P - Purchase		1,250,000	2,188,041	133.26	11.00	13,750,000	24,068,451
2015-10-13	2015-10-07	4	ACRS	Aclaris Therapeutics, Inc. Common Stock	P - Purchase		938,041	938,041		10.66	9,999,986	9,999,986
2015-10-13		3	ACRS	Aclaris Therapeutics, Inc. Common Stock, $0.00001 par value				4,474,260
2015-10-13		3	ACRS	Aclaris Therapeutics, Inc. Common Stock, $0.00001 par value				4,474,260
2015-10-13		3	ACRS	Aclaris Therapeutics, Inc. Common Stock, $0.00001 par value				4,474,260
2015-06-29	2015-06-25	4	DRNA	Dicerna Pharmaceuticals Inc Director Stock Option (right to buy)	A - Award		15,000	15,000
2015-02-18	2013-07-25	4	SGMO	SANGAMO BIOSCIENCES INC Common Stock	S - Sale		-76,800	3,118,218	-2.40	10.00	-768,000	31,182,180
2015-02-18	2013-07-25	4	SGMO	SANGAMO BIOSCIENCES INC Common Stock	S - Sale		-76,800	3,195,018	-2.35	9.91	-761,088	31,662,628
2015-02-18	2013-07-25	4	SGMO	SANGAMO BIOSCIENCES INC Common Stock	S - Sale		-19,200	3,271,818	-0.58	10.00	-192,000	32,718,180
2015-02-18	2013-07-25	4	SGMO	SANGAMO BIOSCIENCES INC Common Stock	S - Sale		-191,999	3,291,018	-5.51	9.50	-1,823,031	31,248,216
2015-02-18	2013-07-25	4	SGMO	SANGAMO BIOSCIENCES INC Common Stock	S - Sale		-4,071	3,483,017	-0.12	9.51	-38,729	33,135,682
2015-02-18	2013-07-23	4	SGMO	SANGAMO BIOSCIENCES INC Common Stock	S - Sale		-5,012	3,487,088	-0.14	9.37	-46,938	32,657,277
2015-02-18	2013-07-22	4	SGMO	SANGAMO BIOSCIENCES INC Common Stock	S - Sale		-23,042	3,492,100	-0.66	9.60	-221,203	33,524,160
2015-02-18	2013-07-22	4	SGMO	SANGAMO BIOSCIENCES INC Common Stock	S - Sale		-11,520	3,515,142	-0.33	9.56	-110,189	33,622,333
2015-02-18	2013-07-22	4	SGMO	SANGAMO BIOSCIENCES INC Common Stock	S - Sale		-76,801	3,526,662	-2.13	9.56	-734,218	33,714,889
2015-02-18	2013-07-19	4	SGMO	SANGAMO BIOSCIENCES INC Common Stock	S - Sale		-105,522	3,603,463	-2.85	9.85	-1,039,392	35,494,111
2015-02-18	2013-07-19	4	SGMO	SANGAMO BIOSCIENCES INC Common Stock	S - Sale		-4,532	3,603,463	-0.13	9.85	-44,640	35,494,111
2015-02-18	2013-07-19	4	SGMO	SANGAMO BIOSCIENCES INC Common Stock	S - Sale		-76,800	3,603,463	-2.09	9.85	-756,480	35,494,111
2015-02-18	2013-07-19	4	SGMO	SANGAMO BIOSCIENCES INC Common Stock	S - Sale		-23,040	3,603,463	-0.64	9.77	-225,202	35,221,689
2015-02-18	2013-07-18	4	SGMO	SANGAMO BIOSCIENCES INC Common Stock	S - Sale		-74,035	3,626,503	-2.00	10.02	-741,498	36,321,241
2015-02-18	2013-07-17	4	SGMO	SANGAMO BIOSCIENCES INC Common Stock	S - Sale		-29,070	3,626,503	-0.80	10.21	-296,889	37,037,112
2015-02-18	2013-07-17	4	SGMO	SANGAMO BIOSCIENCES INC Common Stock	S - Sale		-19,200	3,626,503	-0.53	10.24	-196,512	37,117,258
2015-02-18	2013-07-17	4	SGMO	SANGAMO BIOSCIENCES INC Common Stock	P - Purchase		19,200	3,645,703	0.53	9.79	187,895	35,677,579
2015-02-18	2014-01-09	4	SGMO	SANGAMO BIOSCIENCES INC Common Stock	S - Sale		-44,957	3,970,562	-1.12	18.28	-821,814	72,581,873
2015-02-18	2014-01-09	4	SGMO	SANGAMO BIOSCIENCES INC Common Stock	S - Sale		-27,483	4,015,519	-0.68	18.47	-507,551	74,157,802
2015-02-18	2013-12-13	4	SGMO	SANGAMO BIOSCIENCES INC Common Stock	P - Purchase		5,040	4,043,002	0.12	12.09	60,921	48,869,787
2015-02-18	2013-12-12	4	SGMO	SANGAMO BIOSCIENCES INC Common Stock	P - Purchase		9,600	4,037,962	0.24	12.09	116,071	48,821,787
2015-02-18	2014-03-06	4	SGMO	SANGAMO BIOSCIENCES INC Common Stock	S - Sale		-20,415	3,683,000	-0.55	24.00	-489,989	88,397,156
2015-02-18	2014-03-06	4	SGMO	SANGAMO BIOSCIENCES INC Common Stock	S - Sale		-241,471	3,683,000	-6.15	23.24	-5,610,579	85,574,505
2015-02-18	2014-03-06	4	SGMO	SANGAMO BIOSCIENCES INC Common Stock	S - Sale		-31,531	3,683,000	-0.85	23.18	-730,844	85,366,784
2015-02-18	2014-03-06	4	SGMO	SANGAMO BIOSCIENCES INC Common Stock	P - Purchase		42,000	3,683,000	1.15	22.56	947,533	83,089,585
2015-02-18	2014-03-06	4	SGMO	SANGAMO BIOSCIENCES INC Common Stock	P - Purchase		42,001	3,683,000	1.15	22.44	942,712	82,664,935
2015-02-18	2014-03-03	4	SGMO	SANGAMO BIOSCIENCES INC Common Stock	S - Sale		-16,800	3,683,000	-0.45	18.23	-306,190	67,124,885
2015-02-18	2014-03-03	4	SGMO	SANGAMO BIOSCIENCES INC Common Stock	S - Sale		-67,200	3,699,800	-1.78	18.21	-1,223,712	67,373,358
2015-02-18	2014-02-28	4	SGMO	SANGAMO BIOSCIENCES INC Common Stock	P - Purchase		42,000	3,767,000	1.13	18.10	760,145	68,177,803
2015-02-18	2014-02-27	4	SGMO	SANGAMO BIOSCIENCES INC Common Stock	S - Sale		-17,243	3,725,000	-0.46	19.46	-335,504	72,478,815
2015-02-18	2014-02-27	4	SGMO	SANGAMO BIOSCIENCES INC Common Stock	S - Sale		-14,953	3,742,243	-0.40	19.26	-287,995	72,075,600
2015-02-18	2014-02-26	4	SGMO	SANGAMO BIOSCIENCES INC Common Stock	P - Purchase		42,000	3,757,196	1.13	19.90	835,724	74,761,437
2015-02-18	2014-02-26	4	SGMO	SANGAMO BIOSCIENCES INC Common Stock	P - Purchase		32,194	3,715,196	0.87	19.15	616,518	71,146,375
2015-02-18	2014-02-20	4	SGMO	SANGAMO BIOSCIENCES INC Common Stock	S - Sale		-35,280	3,683,002	-0.95	18.40	-649,152	67,767,237
2015-02-18	2014-02-20	4	SGMO	SANGAMO BIOSCIENCES INC Common Stock	S - Sale		-39	3,718,282	0.00	18.39	-717	68,379,206
2015-02-18	2014-02-19	4	SGMO	SANGAMO BIOSCIENCES INC Common Stock	S - Sale		-6,720	3,718,321	-0.18	18.51	-124,420	68,844,341
2015-02-18	2014-02-18	4	SGMO	SANGAMO BIOSCIENCES INC Common Stock	S - Sale		-11,172	3,725,041	-0.30	18.11	-202,278	67,444,847
2015-02-18	2014-02-14	4	SGMO	SANGAMO BIOSCIENCES INC Common Stock	S - Sale		-15,380	3,736,213	-0.41	18.61	-286,166	69,517,474
2015-02-18	2014-02-13	4	SGMO	SANGAMO BIOSCIENCES INC Common Stock	S - Sale		-15,409	3,751,593	-0.41	18.46	-284,438	69,251,406
2015-02-18	2014-02-12	4	SGMO	SANGAMO BIOSCIENCES INC Common Stock	P - Purchase		42,000	3,767,002	1.13	18.04	757,621	67,951,442
2015-02-18	2014-02-11	4	SGMO	SANGAMO BIOSCIENCES INC Common Stock	P - Purchase		42,000	3,725,002	1.14	19.65	825,275	73,194,054
2015-02-18	2014-02-07	4	SGMO	SANGAMO BIOSCIENCES INC Common Stock	S - Sale		-34,688	3,683,002	-0.93	18.52	-642,432	68,210,302
2015-02-18	2014-02-06	4	SGMO	SANGAMO BIOSCIENCES INC Common Stock	S - Sale		-7,312	3,717,690	-0.20	18.42	-134,683	68,477,619
2015-02-18	2014-02-05	4	SGMO	SANGAMO BIOSCIENCES INC Common Stock	P - Purchase		10,666	3,725,002	0.29	18.36	195,852	68,399,604
2015-02-18	2014-02-05	4	SGMO	SANGAMO BIOSCIENCES INC Common Stock	P - Purchase		17,640	3,714,336	0.48	18.21	321,224	67,638,059
2015-02-18	2014-02-05	4	SGMO	SANGAMO BIOSCIENCES INC Common Stock	P - Purchase		13,694	3,696,696	0.37	18.16	248,752	67,150,483
2015-02-18	2014-01-29	4	SGMO	SANGAMO BIOSCIENCES INC Call Option (obligation to sell)	S - Sale		-8,275	8,275	-50.00	2.60	-21,515	21,515
2015-02-18	2014-01-29	4	SGMO	SANGAMO BIOSCIENCES INC Call Option (right to buy)	P - Purchase		-8,275	8,275	-50.00	5.00	-41,375	41,375
2015-02-18	2014-01-29	4	SGMO	SANGAMO BIOSCIENCES INC Call Option (obligation to sell)	S - Sale		-8,275	8,275	-50.00	3.90	-32,272	32,272
2015-02-18	2014-01-29	4	SGMO	SANGAMO BIOSCIENCES INC Call Option (right to buy)	P - Purchase		-8,275	8,275	-50.00	7.00	-57,925	57,925
2015-02-18	2014-04-01	4	SGMO	SANGAMO BIOSCIENCES INC Common Stock	S - Sale		-75,100	4,067,200	-1.81	18.14	-1,361,938	73,758,672
2015-02-18	2014-04-01	4	SGMO	SANGAMO BIOSCIENCES INC Common Stock	S - Sale		-51,500	4,142,300	-1.23	18.08	-930,914	74,876,215
2015-02-18	2014-04-01	4	SGMO	SANGAMO BIOSCIENCES INC Common Stock	S - Sale		-50,000	4,193,800	-1.18	17.94	-897,250	75,257,741
2015-02-18	2014-04-01	4	SGMO	SANGAMO BIOSCIENCES INC Common Stock	S - Sale		-24,900	4,243,800	-0.58	17.88	-445,336	75,900,363
2015-02-18	2014-04-01	4	SGMO	SANGAMO BIOSCIENCES INC Common Stock	S - Sale		-48,500	4,268,700	-1.12	17.88	-866,942	76,303,439
2015-02-18	2014-03-28	4	SGMO	SANGAMO BIOSCIENCES INC Common Stock	P - Purchase		62,160	4,317,200	1.46	17.10	1,063,247	73,845,706
2015-02-18	2014-03-28	4	SGMO	SANGAMO BIOSCIENCES INC Common Stock	P - Purchase		21,840	4,255,040	0.52	17.07	372,809	72,633,533
2015-02-18	2014-03-27	4	SGMO	SANGAMO BIOSCIENCES INC Common Stock	P - Purchase		251,987	4,233,200	6.33	17.66	4,449,486	74,748,152
2015-02-18	2014-03-27	4	SGMO	SANGAMO BIOSCIENCES INC Common Stock	P - Purchase		4,200	3,981,213	0.11	17.35	72,870	69,074,046
2015-02-18	2014-03-26	4	SGMO	SANGAMO BIOSCIENCES INC Common Stock	P - Purchase		190,693	3,977,013	5.04	18.16	3,463,366	72,230,510
2015-02-18	2014-03-26	4	SGMO	SANGAMO BIOSCIENCES INC Common Stock	P - Purchase		19,320	3,786,320	0.51	17.88	345,345	67,680,470
2015-02-18	2014-03-25	4	SGMO	SANGAMO BIOSCIENCES INC Common Stock	P - Purchase		21,000	3,767,000	0.56	19.46	408,555	73,286,985
2015-02-18	2014-03-25	4	SGMO	SANGAMO BIOSCIENCES INC Common Stock	P - Purchase		42,000	3,746,000	1.13	19.44	816,556	72,828,983
2015-02-18	2014-03-25	4	SGMO	SANGAMO BIOSCIENCES INC Common Stock	P - Purchase		21,000	3,704,000	0.57	19.33	405,930	71,598,320
2015-02-18	2014-03-21	4	SGMO	SANGAMO BIOSCIENCES INC Common Stock	P - Purchase		101,808	3,683,000	2.84	21.22	2,159,989	78,139,633
2015-02-18	2014-03-19	4	SGMO	SANGAMO BIOSCIENCES INC Common Stock	S - Sale		-17,808	3,683,000	-0.48	24.28	-432,432	89,434,289
2015-02-18	2014-03-18	4	SGMO	SANGAMO BIOSCIENCES INC Common Stock	S - Sale		-49,560	3,683,000	-1.33	23.74	-1,176,802	87,452,835
2015-02-18	2014-03-18	4	SGMO	SANGAMO BIOSCIENCES INC Common Stock	S - Sale		-34,440	3,683,000	-0.93	23.74	-817,771	87,452,098
2015-02-18	2014-03-17	4	SGMO	SANGAMO BIOSCIENCES INC Common Stock	P - Purchase		52,161	3,683,000	1.44	23.02	1,200,835	84,788,921
2015-02-18	2014-03-13	4	SGMO	SANGAMO BIOSCIENCES INC Common Stock	P - Purchase		71,319	3,683,000	1.97	22.76	1,623,356	83,832,078
2015-02-18	2014-03-12	4	SGMO	SANGAMO BIOSCIENCES INC Common Stock	S - Sale		-123,480	3,683,000	-3.24	23.40	-2,889,432	86,182,200
2015-02-18	2014-03-10	4	SGMO	SANGAMO BIOSCIENCES INC Common Stock	P - Purchase		12,522	3,683,000	0.34	22.30	279,180	82,113,222
2015-02-18	2014-03-07	4	SGMO	SANGAMO BIOSCIENCES INC Common Stock	P - Purchase		258,377	3,683,000	7.54	22.25	5,748,552	81,941,962
2015-02-18	2014-03-06	4	SGMO	SANGAMO BIOSCIENCES INC Common Stock	S - Sale		-21,001	3,683,000	-0.57	24.10	-506,124	88,760,300
2015-02-18	2014-03-06	4	SGMO	SANGAMO BIOSCIENCES INC Common Stock	S - Sale		-40,482	3,683,000	-1.09	24.10	-975,414	88,741,885
2015-02-18	2014-05-07	4	SGMO	SANGAMO BIOSCIENCES INC Common Stock	P - Purchase		40,566	4,822,236	0.85	11.74	476,042	56,588,939
2015-02-18	2014-05-07	4	SGMO	SANGAMO BIOSCIENCES INC Common Stock	P - Purchase		6,998	4,781,670	0.15	11.71	81,947	55,993,356
2015-02-18	2014-04-30	4	SGMO	SANGAMO BIOSCIENCES INC Common Stock	P - Purchase		73,289	4,774,672	1.56	13.57	994,341	64,779,885
2015-02-18	2014-04-30	4	SGMO	SANGAMO BIOSCIENCES INC Common Stock	P - Purchase		51,211	4,701,383	1.10	13.28	680,338	62,457,873
2015-02-18	2014-04-28	4	SGMO	SANGAMO BIOSCIENCES INC Common Stock	P - Purchase		74,844	4,650,172	1.64	13.29	995,014	61,821,712
2015-02-18	2014-04-25	4	SGMO	SANGAMO BIOSCIENCES INC Common Stock	P - Purchase		166,000	4,575,328	3.76	13.63	2,262,779	62,367,211
2015-02-18	2014-04-22	4	SGMO	SANGAMO BIOSCIENCES INC Common Stock	S - Sale		-41,500	4,409,328	-0.93	15.02	-623,160	66,210,028
2015-02-18	2014-04-22	4	SGMO	SANGAMO BIOSCIENCES INC Common Stock	S - Sale		-62,250	4,450,828	-1.38	14.88	-925,969	66,206,066
2015-02-18	2014-04-22	4	SGMO	SANGAMO BIOSCIENCES INC Common Stock	S - Sale		-166,000	4,513,078	-3.55	14.86	-2,467,142	67,074,719
2015-02-18	2014-04-22	4	SGMO	SANGAMO BIOSCIENCES INC Common Stock	S - Sale		-43,409	4,679,078	-0.92	14.86	-645,158	69,541,861
2015-02-18	2014-04-22	4	SGMO	SANGAMO BIOSCIENCES INC Common Stock	S - Sale		-39,591	4,722,487	-0.83	14.70	-582,110	69,435,199
2015-02-18	2014-04-17	4	SGMO	SANGAMO BIOSCIENCES INC Common Stock	P - Purchase		41,500	4,762,078	0.88	14.02	581,959	66,779,096
2015-02-18	2014-04-16	4	SGMO	SANGAMO BIOSCIENCES INC Common Stock	S - Sale		-21,829	4,720,578	-0.46	14.09	-307,658	66,531,826
2015-02-18	2014-04-15	4	SGMO	SANGAMO BIOSCIENCES INC Common Stock	P - Purchase		20,750	4,742,407	0.44	13.16	273,070	62,410,076
2015-02-18	2014-04-15	4	SGMO	SANGAMO BIOSCIENCES INC Common Stock	P - Purchase		1,079	4,721,657	0.02	13.10	14,136	61,857,484
2015-02-18	2014-04-14	4	SGMO	SANGAMO BIOSCIENCES INC Common Stock	S - Sale		-3,055	4,720,578	-0.06	14.78	-45,165	69,789,497
2015-02-18	2014-04-11	4	SGMO	SANGAMO BIOSCIENCES INC Common Stock	P - Purchase		33,992	4,723,633	0.72	14.49	492,459	68,433,633
2015-02-18	2014-04-11	4	SGMO	SANGAMO BIOSCIENCES INC Common Stock	P - Purchase		83,000	4,689,641	1.80	14.48	1,201,840	67,906,002
2015-02-18	2014-04-10	4	SGMO	SANGAMO BIOSCIENCES INC Common Stock	S - Sale		-3,403	4,606,641	-0.07	15.67	-53,326	72,186,986
2015-02-18	2014-04-10	4	SGMO	SANGAMO BIOSCIENCES INC Common Stock	P - Purchase		83,000	4,610,044	1.83	14.91	1,237,339	68,725,153
2015-02-18	2014-04-09	4	SGMO	SANGAMO BIOSCIENCES INC Common Stock	S - Sale		-69,856	4,527,044	-1.52	16.27	-1,136,424	73,646,404
2015-02-18	2014-04-08	4	SGMO	SANGAMO BIOSCIENCES INC Common Stock	P - Purchase		121,876	4,596,900	2.72	15.49	1,888,274	71,221,610
2015-02-18	2014-04-07	4	SGMO	SANGAMO BIOSCIENCES INC Common Stock	P - Purchase		33,667	4,475,024	0.76	15.42	519,310	69,026,798
2015-02-18	2014-04-04	4	SGMO	SANGAMO BIOSCIENCES INC Common Stock	P - Purchase		179,031	4,441,357	4.20	15.38	2,753,712	68,313,400
2015-02-18	2014-04-03	4	SGMO	SANGAMO BIOSCIENCES INC Common Stock	P - Purchase		195,126	4,262,326	4.80	16.61	3,241,999	70,818,120
2015-02-18	2014-06-05	4	SGMO	SANGAMO BIOSCIENCES INC Common Stock	S - Sale		-32,899	2,829,441	-1.15	14.13	-464,863	39,980,001
2015-02-18	2014-06-05	4	SGMO	SANGAMO BIOSCIENCES INC Common Stock	S - Sale		-18,377	2,862,340	-0.64	13.98	-256,857	40,007,212
2015-02-18	2014-06-05	4	SGMO	SANGAMO BIOSCIENCES INC Common Stock	S - Sale		-586	2,880,717	-0.02	13.11	-7,681	37,757,846
2015-02-18	2014-06-05	4	SGMO	SANGAMO BIOSCIENCES INC Common Stock	S - Sale		-918,499	2,881,303	-24.17	13.00	-11,940,487	37,456,939
2015-02-18	2014-06-04	4	SGMO	SANGAMO BIOSCIENCES INC Common Stock	S - Sale		-29,155	3,799,802	-0.76	13.10	-382,076	49,796,405
2015-02-18	2014-06-04	4	SGMO	SANGAMO BIOSCIENCES INC Common Stock	S - Sale		-20,826	3,828,957	-0.54	13.10	-272,925	50,178,481
2015-02-18	2014-06-04	4	SGMO	SANGAMO BIOSCIENCES INC Common Stock	S - Sale		-20,659	3,849,783	-0.53	13.08	-270,226	50,356,317
2015-02-18	2014-06-03	4	SGMO	SANGAMO BIOSCIENCES INC Common Stock	S - Sale		-76,833	3,870,442	-1.95	12.86	-988,072	49,773,884
2015-02-18	2014-05-30	4	SGMO	SANGAMO BIOSCIENCES INC Common Stock	S - Sale		-24,233	3,947,275	-0.61	13.45	-325,856	53,078,217
2015-02-18	2014-05-30	4	SGMO	SANGAMO BIOSCIENCES INC Common Stock	S - Sale		-41,651	3,971,508	-1.04	13.38	-557,290	53,138,777
2015-02-18	2014-05-29	4	SGMO	SANGAMO BIOSCIENCES INC Common Stock	S - Sale		-146,285	4,013,159	-3.52	13.53	-1,979,675	54,310,081
2015-02-18	2014-05-29	4	SGMO	SANGAMO BIOSCIENCES INC Common Stock	S - Sale		-9,390	4,159,444	-0.23	13.51	-126,884	56,205,319
2015-02-18	2014-05-28	4	SGMO	SANGAMO BIOSCIENCES INC Common Stock	S - Sale		-24,302	4,168,834	-0.58	13.47	-327,455	56,172,537
2015-02-18	2014-05-28	4	SGMO	SANGAMO BIOSCIENCES INC Common Stock	S - Sale		-124,387	4,193,136	-2.88	13.42	-1,669,497	56,279,433
2015-02-18	2014-05-27	4	SGMO	SANGAMO BIOSCIENCES INC Common Stock	S - Sale		-108,863	4,317,523	-2.46	13.56	-1,475,965	58,536,977
2015-02-18	2014-05-27	4	SGMO	SANGAMO BIOSCIENCES INC Common Stock	S - Sale		-154,574	4,426,386	-3.37	13.55	-2,094,509	59,978,416
2015-02-18	2014-05-23	4	SGMO	SANGAMO BIOSCIENCES INC Common Stock	S - Sale		-51,597	4,580,960	-1.11	13.27	-684,713	60,791,172
2015-02-18	2014-05-22	4	SGMO	SANGAMO BIOSCIENCES INC Common Stock	S - Sale		-40,818	4,632,557	-0.87	13.58	-554,104	62,886,961
2015-02-18	2014-05-22	4	SGMO	SANGAMO BIOSCIENCES INC Common Stock	S - Sale		-15,578	4,673,375	-0.33	13.51	-210,432	63,129,352
2015-02-18	2014-05-13	4	SGMO	SANGAMO BIOSCIENCES INC Common Stock	S - Sale		-56,060	4,688,953	-1.18	13.12	-735,305	61,502,183
2015-02-18	2014-05-12	4	SGMO	SANGAMO BIOSCIENCES INC Common Stock	S - Sale		-10,270	4,745,013	-0.22	13.06	-134,098	61,957,058
2015-02-18	2014-05-12	4	SGMO	SANGAMO BIOSCIENCES INC Common Stock	S - Sale		-19,389	4,755,283	-0.41	13.01	-252,232	61,861,477
2015-02-18	2014-05-08	4	SGMO	SANGAMO BIOSCIENCES INC Common Stock	S - Sale		-62,475	4,774,672	-1.29	12.40	-774,565	59,196,383
2015-02-18	2014-05-08	4	SGMO	SANGAMO BIOSCIENCES INC Common Stock	S - Sale		-20,825	4,837,147	-0.43	12.39	-258,022	59,932,251
2015-02-18	2014-05-07	4	SGMO	SANGAMO BIOSCIENCES INC Common Stock	P - Purchase		35,736	4,857,972	0.74	12.08	431,870	58,708,592
2015-02-18	2014-08-01	4	SGMO	SANGAMO BIOSCIENCES INC Common Stock	S - Sale		-27,770	1,829,426	-1.50	12.82	-356,100	23,459,095
2015-02-18	2014-07-30	4	SGMO	SANGAMO BIOSCIENCES INC Common Stock	S - Sale		-31,108	1,857,196	-1.65	12.59	-391,774	23,389,526
2015-02-18	2014-07-30	4	SGMO	SANGAMO BIOSCIENCES INC Common Stock	S - Sale		-57,890	1,888,304	-2.97	12.36	-715,520	23,339,437
2015-02-18	2014-07-30	4	SGMO	SANGAMO BIOSCIENCES INC Common Stock	S - Sale		-20,592	1,946,194	-1.05	12.35	-254,311	24,035,496
2015-02-18	2014-07-29	4	SGMO	SANGAMO BIOSCIENCES INC Common Stock	S - Sale		-1,407	1,966,786	-0.07	12.41	-17,464	24,412,141
2015-02-18	2014-07-28	4	SGMO	SANGAMO BIOSCIENCES INC Common Stock	S - Sale		-35,271	1,968,193	-1.76	12.11	-427,273	23,842,690
2015-02-18	2014-07-28	4	SGMO	SANGAMO BIOSCIENCES INC Common Stock	S - Sale		-24,810	2,003,464	-1.22	12.10	-300,201	24,241,914
2015-02-18	2014-07-25	4	SGMO	SANGAMO BIOSCIENCES INC Common Stock	S - Sale		-47,429	2,028,274	-2.28	12.31	-583,951	24,972,312
2015-02-18	2014-07-24	4	SGMO	SANGAMO BIOSCIENCES INC Common Stock	S - Sale		-124,050	2,075,703	-5.64	12.28	-1,523,235	25,487,972
2015-02-18	2014-07-17	4	SGMO	SANGAMO BIOSCIENCES INC Common Stock	P - Purchase		37,215	2,199,753	1.72	12.26	456,211	26,966,332
2015-02-18	2014-07-01	4	SGMO	SANGAMO BIOSCIENCES INC Common Stock	S - Sale		-49,620	2,162,538	-2.24	16.05	-796,207	34,700,301
2015-02-18	2014-07-01	4	SGMO	SANGAMO BIOSCIENCES INC Common Stock	S - Sale		-33,080	2,212,158	-1.47	15.96	-527,791	35,294,981
2015-02-18	2014-06-16	4	SGMO	SANGAMO BIOSCIENCES INC Common Stock	S - Sale		-107,796	2,245,238	-4.58	16.60	-1,788,875	37,259,725
2015-02-18	2014-06-16	4	SGMO	SANGAMO BIOSCIENCES INC Common Stock	S - Sale		-137,171	2,353,034	-5.51	16.52	-2,266,545	38,880,357
2015-02-18	2014-06-16	4	SGMO	SANGAMO BIOSCIENCES INC Common Stock	S - Sale		-3,695	2,490,205	-0.15	16.52	-61,053	41,145,906
2015-02-18	2014-06-16	4	SGMO	SANGAMO BIOSCIENCES INC Common Stock	S - Sale		-1,838	2,493,900	-0.07	16.35	-30,059	40,785,490
2015-02-18	2014-06-09	4	SGMO	SANGAMO BIOSCIENCES INC Common Stock	S - Sale		-22,545	2,495,738	-0.90	15.50	-349,448	38,683,939
2015-02-18	2014-06-09	4	SGMO	SANGAMO BIOSCIENCES INC Common Stock	S - Sale		-60,955	2,518,283	-2.36	15.50	-944,711	39,029,609
2015-02-18	2014-06-06	4	SGMO	SANGAMO BIOSCIENCES INC Common Stock	S - Sale		-83,500	2,579,238	-3.14	14.40	-1,202,400	37,141,027
2015-02-18	2014-06-06	4	SGMO	SANGAMO BIOSCIENCES INC Common Stock	S - Sale		-41,749	2,662,738	-1.54	14.13	-589,913	37,624,488
2015-02-18	2014-06-06	4	SGMO	SANGAMO BIOSCIENCES INC Common Stock	S - Sale		-9,852	2,704,487	-0.36	14.07	-138,635	38,057,000
2015-02-18	2014-06-05	4	SGMO	SANGAMO BIOSCIENCES INC Common Stock	S - Sale		-48,849	2,714,339	-1.77	14.14	-690,481	38,367,182
2015-02-18	2014-06-05	4	SGMO	SANGAMO BIOSCIENCES INC Common Stock	S - Sale		-66,253	2,763,188	-2.34	14.13	-936,188	39,045,228
2015-02-18		3	SGMO	SANGAMO BIOSCIENCES INC Common Stock				7,253,006
2015-02-18		3	SGMO	SANGAMO BIOSCIENCES INC Common Stock				7,253,006
2015-02-18		3	SGMO	SANGAMO BIOSCIENCES INC Common Stock				7,253,006
2015-02-18		3	SGMO	SANGAMO BIOSCIENCES INC Common Stock				7,253,006
2015-02-18		3	SGMO	SANGAMO BIOSCIENCES INC Common Stock				8,056,724
2015-02-18		3	SGMO	SANGAMO BIOSCIENCES INC Common Stock				8,056,724
2015-02-18		3	SGMO	SANGAMO BIOSCIENCES INC Common Stock				8,056,724
2015-02-18		3	SGMO	SANGAMO BIOSCIENCES INC Common Stock				8,056,724
2015-02-18		3	SGMO	SANGAMO BIOSCIENCES INC Common Stock				7,366,004
2015-02-18		3	SGMO	SANGAMO BIOSCIENCES INC Common Stock				7,366,004
2015-02-18		3	SGMO	SANGAMO BIOSCIENCES INC Common Stock				7,366,004
2015-02-18		3	SGMO	SANGAMO BIOSCIENCES INC Common Stock				7,366,004
2015-01-20	2013-09-26	4	ACHN	ACHILLION PHARMACEUTICALS INC Call Option (obligation to sell)	S - Sale		-7,760	7,760	-50.00	0.05	-366	366
2015-01-20	2013-09-26	4	ACHN	ACHILLION PHARMACEUTICALS INC Call Option (right to buy)	P - Purchase		7,760	7,760		1.36	10,592	10,592
2015-01-20	2013-09-12	4	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock, $0.001 par value	S - Sale		-18,857	4,848,760	-0.39	7.26	-136,996	35,226,241
2015-01-20	2013-09-12	4	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock, $0.001 par value	P - Purchase		7,761	4,856,521	0.16	7.20	55,918	34,991,234
2015-01-20	2013-09-12	4	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock, $0.001 par value	P - Purchase		4,190	4,860,711	0.09	7.20	30,189	35,021,423
2015-01-20	2013-09-12	4	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock, $0.001 par value	P - Purchase		6,906	4,867,617	0.14	7.20	49,689	35,022,504
2015-01-20	2013-09-11	4	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock, $0.001 par value	S - Sale		-38,800	4,828,817	-0.80	7.30	-283,240	35,250,364
2015-01-20	2013-09-11	4	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock, $0.001 par value	P - Purchase		19,400	4,848,217	0.40	7.20	139,777	34,931,403
2015-01-20	2013-09-11	4	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock, $0.001 par value	P - Purchase		19,400	4,867,617	0.40	7.18	139,292	34,949,490
2015-01-20	2013-08-28	4	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock, $0.001 par value	P - Purchase		38,500	4,906,117	0.79	6.38	245,822	31,325,557
2015-01-20	2013-08-27	4	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock, $0.001 par value	P - Purchase		77,000	4,983,117	1.57	6.48	499,345	32,315,514
2015-01-20	2013-08-26	4	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock, $0.001 par value	P - Purchase		38,500	5,021,617	0.77	6.58	253,330	33,042,240
2015-01-20	2013-08-26	4	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock, $0.001 par value	P - Purchase		115,500	5,137,117	2.30	6.58	759,412	33,776,544
2015-01-20	2013-08-22	4	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock, $0.001 par value	P - Purchase		52,652	5,189,769	1.02	6.76	356,164	35,106,192
2015-01-20	2013-08-21	4	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock, $0.001 par value	S - Sale		-4,312	5,185,457	-0.08	6.87	-29,641	35,645,350
2015-01-20	2013-08-21	4	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock, $0.001 par value	P - Purchase		23,100	5,208,557	0.45	6.69	154,590	34,856,705
2015-01-20	2013-08-20	4	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock, $0.001 par value	S - Sale		-9,951	5,198,606	-0.19	6.86	-68,307	35,684,791
2015-01-20	2013-08-20	4	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock, $0.001 par value	P - Purchase		38,500	5,237,106	0.74	6.75	259,844	35,346,276
2015-01-20	2013-08-09	4	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock, $0.001 par value	P - Purchase		77,000	5,314,106	1.47	6.30	485,100	33,478,868
2015-01-20	2013-08-05	4	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock, $0.001 par value	S - Sale		-23,100	5,291,006	-0.43	7.11	-164,336	37,640,746
2015-01-20	2013-08-02	4	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock, $0.001 par value	P - Purchase		23,100	5,314,106	0.44	6.98	161,319	37,111,059
2015-01-20	2013-07-29	4	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock, $0.001 par value	S - Sale		-3,377	5,310,729	-0.06	6.95	-23,479	36,922,843
2015-01-20	2013-07-29	4	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock, $0.001 par value	P - Purchase		6,453	5,317,182	0.12	6.90	44,558	36,715,142
2015-01-20	2013-07-29	4	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock, $0.001 par value	P - Purchase		11,441	5,328,623	0.22	6.90	78,943	36,767,499
2015-01-20	2013-07-25	4	ACHN	ACHILLION PHARMACEUTICALS INC Call Option (obligation to sell)	S - Sale		-3,072	3,072	-50.00	0.40	-1,229	1,229
2015-01-20	2013-07-25	4	ACHN	ACHILLION PHARMACEUTICALS INC Call Option (right to buy)	P - Purchase		3,072	3,072		2.75	8,448	8,448
2015-01-20	2013-07-25	4	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock, $0.001 par value	S - Sale		-40,829	5,287,794	-0.77	7.19	-293,756	38,044,620
2015-01-20	2013-07-25	4	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock, $0.001 par value	S - Sale		-14,592	5,273,202	-0.28	7.15	-104,333	37,703,394
2015-01-20	2013-07-25	4	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock, $0.001 par value	P - Purchase		37,250	5,310,452	0.71	7.19	268,003	38,207,109
2015-01-20	2013-07-24	4	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock, $0.001 par value	S - Sale		-7,862	5,302,590	-0.15	7.26	-57,040	38,471,351
2015-01-20	2013-07-22	4	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock, $0.001 par value	P - Purchase		38,400	5,340,990	0.72	7.23	277,674	38,621,233
2015-01-20	2013-07-22	4	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock, $0.001 par value	P - Purchase		24,883	5,365,873	0.47	7.16	178,162	38,419,651
2015-01-20	2013-07-19	4	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock, $0.001 par value	S - Sale		-38,400	5,327,473	-0.72	7.21	-276,960	38,424,399
2015-01-20	2013-07-17	4	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock, $0.001 par value	P - Purchase		38,400	5,365,873	0.72	7.09	272,387	38,062,284
2015-01-20	2013-07-15	4	ACHN	ACHILLION PHARMACEUTICALS INC Call Option (obligation to sell)	S - Sale		-768	768	-50.00	0.39	-303	303
2015-01-20	2013-07-15	4	ACHN	ACHILLION PHARMACEUTICALS INC Call Option (right to buy)	P - Purchase		768	768		2.64	2,031	2,031
2015-01-20	2013-09-30	4	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock, $0.001 par value	P - Purchase		1,552,000	4,816,562	47.54	3.50	5,432,000	16,857,967
2015-01-20	2013-09-27	4	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock, $0.001 par value	P - Purchase		400,000	5,216,562	8.30	4.00	1,600,000	20,866,248
2015-01-20	2013-09-27	4	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock, $0.001 par value	P - Purchase		200,000	5,416,562	3.83	4.00	800,000	21,666,248
2015-01-20	2013-09-25	4	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock, $0.001 par value	S - Sale		-135,800	5,280,762	-2.51	7.26	-985,908	38,338,332
2015-01-20	2013-09-24	4	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock, $0.001 par value	S - Sale		-50,051	5,230,711	-0.95	7.38	-369,376	38,602,647
2015-01-20	2013-09-24	4	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock, $0.001 par value	S - Sale		-49,354	5,181,357	-0.94	7.34	-362,505	38,057,067
2015-01-20	2013-09-24	4	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock, $0.001 par value	S - Sale		-4,424	5,176,933	-0.09	7.33	-32,428	37,946,919
2015-01-20	2013-09-24	4	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock, $0.001 par value	S - Sale		-77,600	5,099,333	-1.50	7.30	-566,480	37,225,131
2015-01-20	2013-09-23	4	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock, $0.001 par value	S - Sale		-27,783	5,071,550	-0.54	7.42	-206,128	37,626,844
2015-01-20	2013-09-23	4	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock, $0.001 par value	S - Sale		-5,665	5,065,885	-0.11	7.42	-42,006	37,563,537
2015-01-20	2013-09-20	4	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock, $0.001 par value	S - Sale		-26,539	5,039,346	-0.52	7.40	-196,481	37,308,798
2015-01-20	2013-09-18	4	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock, $0.001 par value	S - Sale		-2,328	5,037,018	-0.05	7.48	-17,413	37,676,895
2015-01-20	2013-09-17	4	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock, $0.001 par value	S - Sale		-77,600	4,959,418	-1.54	7.42	-575,994	36,811,776
2015-01-20	2013-09-16	4	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock, $0.001 par value	S - Sale		-91,801	4,867,617	-1.85	7.53	-690,913	36,634,659
2015-01-20		3/A	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock, $0.001 par value				6,842,944
2014-10-01	2014-09-30	4	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock, $0.001 par value	S - Sale		-700,000	6,700,000	-9.46	10.02	-7,010,500	67,100,500
2014-10-01	2014-09-30	4	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock, $0.001 par value	S - Sale		-411,000	7,400,000	-5.26	10.11	-4,153,319	74,779,960
2014-10-01	2014-09-29	4	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock, $0.001 par value	S - Sale		-221,014	7,811,000	-2.75	10.96	-2,423,264	85,642,147
2014-09-26	2014-09-26	4	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock, $0.001 par value	S - Sale		-250,000	8,032,014	-3.02	11.10	-2,775,000	89,155,355
2014-09-26	2014-09-26	4	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock, $0.001 par value	S - Sale		-120,000	8,282,014	-1.43	10.96	-1,314,600	90,729,463
2014-09-26	2014-09-26	4	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock, $0.001 par value	S - Sale		-300,000	8,402,014	-3.45	11.12	-3,335,190	93,407,710
2014-09-26	2014-09-25	4	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock, $0.001 par value	S - Sale		-250,000	8,702,014	-2.79	11.06	-2,765,000	96,244,275
2014-09-26	2014-09-25	4	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock, $0.001 par value	S - Sale		-131,800	8,952,014	-1.45	11.06	-1,457,049	98,964,515
2014-09-26	2014-09-25	4	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock, $0.001 par value	S - Sale		-116,186	9,083,814	-1.26	11.01	-1,279,696	100,050,944
2014-09-26	2014-09-24	4	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock, $0.001 par value	S - Sale		-500,000	9,200,000	-5.15	11.28	-5,640,000	103,776,000
2014-09-26	2014-09-24	4	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock, $0.001 par value	S - Sale		-210,109	9,700,000	-2.12	11.29	-2,372,215	109,516,880
2014-09-26	2014-09-24	4	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock, $0.001 par value	S - Sale		-319,100	9,910,109	-3.12	11.24	-3,588,280	111,439,176
2014-09-26	2014-09-24	4	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock, $0.001 par value	S - Sale		-175,720	10,229,209	-1.69	11.24	-1,974,460	114,939,484
2014-09-23	2014-09-23	4	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock, $0.001 par value	S - Sale		-317,500	10,404,929	-2.96	11.02	-3,498,628	114,655,034
2014-09-23	2014-09-23	4	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock, $0.001 par value	S - Sale		-655,239	10,722,429	-5.76	11.11	-7,279,574	119,124,042
2014-09-23	2014-09-23	4	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock, $0.001 par value	S - Sale		-11,783	11,377,668	-0.10	11.10	-130,808	126,308,044
2014-09-23	2014-09-22	4	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock, $0.001 par value	S - Sale		-60,549	11,389,451	-0.53	11.09	-671,537	126,318,123
2014-09-23	2014-09-22	4	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock, $0.001 par value	S - Sale		-50,000	11,450,000	-0.43	11.09	-554,420	126,962,180
2014-09-23	2014-09-22	4	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock, $0.001 par value	S - Sale		-335,140	11,500,000	-2.83	11.08	-3,714,457	127,457,950
2014-09-23	2014-09-19	4	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock, $0.001 par value	S - Sale		-814,860	11,835,140	-6.44	11.50	-9,370,890	136,104,110
2014-09-23	2014-09-19	4	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock, $0.001 par value	S - Sale		-5,900	12,650,000	-0.05	11.84	-69,848	149,759,555
2014-09-23	2014-09-19	4	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock, $0.001 par value	S - Sale		-16,387	12,655,900	-0.13	11.67	-191,248	147,703,212
2014-09-23	2014-09-19	4	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock, $0.001 par value	S - Sale		-327,713	12,672,287	-2.52	11.65	-3,818,971	147,675,229
2014-09-12	2014-09-11	4	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock, $0.001 par value	S - Sale		-250,000	13,000,000	-1.89	12.35	-3,087,500	160,550,000
2014-09-12	2014-09-11	4	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock, $0.001 par value	S - Sale		-17,357	13,250,000	-0.13	12.32	-213,922	163,303,600
2014-09-12	2014-09-11	4	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock, $0.001 par value	S - Sale		-115,000	13,267,357	-0.86	12.33	-1,418,502	163,650,195
2014-09-12	2014-09-11	4	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock, $0.001 par value	S - Sale		-531,352	13,382,357	-3.82	12.31	-6,538,446	164,673,918
2014-09-12	2014-09-11	4	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock, $0.001 par value	S - Sale		-83,560	13,913,709	-0.60	12.62	-1,054,845	175,643,880
2014-09-12	2014-09-11	4	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock, $0.001 par value	S - Sale		-184,643	13,997,269	-1.30	12.41	-2,292,010	173,750,900
2014-09-12	2014-09-10	4	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock, $0.001 par value	S - Sale		-121,943	14,181,912	-0.85	12.61	-1,537,677	178,831,074
2014-09-12	2014-09-10	4	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock, $0.001 par value	S - Sale		-69,833	14,303,855	-0.49	12.63	-881,907	180,640,524
2014-09-12	2014-09-10	4	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock, $0.001 par value	S - Sale		-273,017	14,373,688	-1.86	127,013.00	-34,676,708,221	1,825,645,233,944
2014-09-12	2014-09-10	4	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock, $0.001 par value	S - Sale		-49,057	14,646,705	-0.33	12.69	-622,573	185,878,404
2014-09-12	2014-09-10	4	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock, $0.001 par value	S - Sale		-8,600	14,695,762	-0.06	12.73	-109,443	187,016,798
2014-09-12	2014-09-11	4/A	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock, $0.001 par value	S - Sale		-250,000	13,000,000	-1.89	12.35	-3,087,500	160,550,000
2014-09-12	2014-09-11	4/A	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock, $0.001 par value	S - Sale		-17,357	13,250,000	-0.13	12.32	-213,922	163,303,600
2014-09-12	2014-09-11	4/A	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock, $0.001 par value	S - Sale		-115,000	13,267,357	-0.86	12.33	-1,418,502	163,650,195
2014-09-12	2014-09-11	4/A	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock, $0.001 par value	S - Sale		-531,352	13,382,357	-3.82	12.31	-6,538,446	164,673,918
2014-09-12	2014-09-11	4/A	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock, $0.001 par value	S - Sale		-83,560	13,913,709	-0.60	12.62	-1,054,845	175,643,880
2014-09-12	2014-09-11	4/A	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock, $0.001 par value	S - Sale		-184,643	13,997,269	-1.30	12.41	-2,292,010	173,750,900
2014-09-12	2014-09-10	4/A	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock, $0.001 par value	S - Sale		-121,943	14,181,912	-0.85	12.61	-1,537,677	178,831,074
2014-09-12	2014-09-10	4/A	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock, $0.001 par value	S - Sale		-69,833	14,303,855	-0.49	12.63	-881,907	180,640,524
2014-09-12	2014-09-10	4/A	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock, $0.001 par value	S - Sale		-273,017	14,373,688	-1.86	12.70	-3,467,671	182,564,523
2014-09-12	2014-09-10	4/A	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock, $0.001 par value	S - Sale		-49,057	14,646,705	-0.33	12.69	-622,573	185,878,404
2014-09-12	2014-09-10	4/A	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock, $0.001 par value	S - Sale		-8,600	14,695,762	-0.06	12.73	-109,443	187,016,798
2014-09-02	2014-09-02	4	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock, $0.001 par value	S - Sale		-158,655	14,704,362	-1.07	12.04	-1,909,921	177,014,051
2014-09-02	2014-09-02	4	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock, $0.001 par value	S - Sale		-103,052	14,863,017	-0.69	12.01	-1,237,284	178,451,327
2014-09-02	2014-09-02	4	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock, $0.001 par value	S - Sale		-1,100	14,966,069	-0.01	11.93	-13,125	178,572,142
2014-09-02	2014-08-29	4	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock, $0.001 par value	S - Sale		-64,000	14,967,169	-0.43	11.41	-730,458	170,826,287
2014-09-02	2014-08-29	4	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock, $0.001 par value	S - Sale		-217,000	15,031,169	-1.42	11.40	-2,473,800	171,355,327
2014-09-02	2014-08-29	4	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock, $0.001 par value	S - Sale		-46,600	15,248,169	-0.30	11.44	-533,337	174,515,294
2014-09-02	2014-08-29	4	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock, $0.001 par value	S - Sale		-30,500	15,294,769	-0.20	11.44	-348,798	174,910,978
2014-09-02	2014-08-29	4	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock, $0.001 par value	S - Sale		-33,960	15,325,269	-0.22	11.41	-387,450	174,845,994
2014-09-02	2014-08-29	4	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock, $0.001 par value	S - Sale		-2,635	15,359,229	-0.02	11.42	-30,095	175,419,290
2014-09-02	2014-08-29	4	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock, $0.001 par value	S - Sale		-4,150	15,361,864	-0.03	11.53	-47,831	177,053,164
2014-09-02	2014-08-28	4	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock, $0.001 par value	S - Sale		-173,641	15,366,014	-1.12	11.51	-1,999,372	176,930,432
2014-08-27	2014-08-27	4	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock, $0.001 par value	S - Sale		-150,100	15,539,655	-0.96	11.48	-1,722,518	178,329,973
2014-08-27	2014-08-27	4	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock, $0.001 par value	S - Sale		-116,989	15,689,755	-0.74	11.75	-1,374,258	184,305,983
2014-08-27	2014-08-26	4	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock, $0.001 par value	S - Sale		-312,867	15,806,744	-1.94	11.77	-3,681,881	186,016,925
2014-08-27	2014-08-26	4	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock, $0.001 par value	S - Sale		-150,000	16,119,611	-0.92	11.78	-1,767,000	189,889,018
2014-08-27	2014-08-26	4	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock, $0.001 par value	S - Sale		-250,000	16,269,611	-1.51	11.80	-2,948,825	191,904,943
2014-08-27	2014-08-26	4	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock, $0.001 par value	S - Sale		-52,361	16,519,611	-0.32	11.16	-584,218	184,317,560
2014-08-27	2014-08-26	4	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock, $0.001 par value	S - Sale		-1,347,639	16,571,972	-7.52	11.13	-14,999,626	184,451,020
2014-08-27	2014-08-25	4	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock, $0.001 par value	S - Sale		-105,196	17,919,611	-0.58	11.01	-1,158,355	197,320,005
2014-08-27	2014-08-25	4	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock, $0.001 par value	S - Sale		-226,200	18,024,807	-1.24	10.94	-2,473,927	197,135,512
2014-08-22	2013-10-01	4	ACHN	ACHILLION PHARMACEUTICALS INC Call Option (obligation to sell)	S - Sale		-30,000	5,000	-85.71	0.20	-6,000	1,000
2014-08-22	2013-10-01	4	ACHN	ACHILLION PHARMACEUTICALS INC Call Option (right to buy)	P - Purchase		30,000	30,000		0.60	18,000	18,000
2014-08-22	2013-10-01	4	ACHN	ACHILLION PHARMACEUTICALS INC Call Option (right to buy)	P - Purchase		10,000	0	-100.00	0.03	300
2014-08-22	2013-10-01	4	ACHN	ACHILLION PHARMACEUTICALS INC Call Option (right to buy)	S - Sale		-10,000	0	-100.00	0.05	-500
2014-08-22	2013-10-01	4	ACHN	ACHILLION PHARMACEUTICALS INC Call Option (right to buy)	P - Purchase		20,000	0	-100.00	0.02	400
2014-08-22	2013-10-01	4	ACHN	ACHILLION PHARMACEUTICALS INC Call Option (right to buy)	S - Sale		-20,000	0	-100.00	0.05	-1,000
2014-08-22		3/A	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock, $0.001 par value				11,657,061
2014-08-19	2014-08-18	4	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock, $0.001 par value	S - Sale		-235,000	18,251,007	-1.27	9.51	-2,234,850	173,567,077
2014-08-19	2014-08-18	4	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock, $0.001 par value	S - Sale		-50,000	18,486,007	-0.27	9.74	-487,250	180,146,138
2014-08-19	2014-08-18	4	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock, $0.001 par value	S - Sale		-415,000	18,536,007	-2.19	9.68	-4,016,619	179,402,597
2014-08-19	2014-08-18	4	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock, $0.001 par value	S - Sale		-400,000	18,951,007	-2.07	9.70	-3,881,280	183,885,411
2014-08-19	2014-08-18	4	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock, $0.001 par value	S - Sale		-635,000	19,351,007	-3.18	9.73	-6,179,884	188,325,935
2014-08-19	2014-08-18	4	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock, $0.001 par value	S - Sale		-258,978	19,986,007	-1.28	9.57	-2,479,663	191,362,020
2014-08-19	2014-08-15	4	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock, $0.001 par value	S - Sale		-660,300	20,244,985	-3.16	9.40	-6,203,651	190,205,683
2014-08-19	2014-08-15	4	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock, $0.001 par value	S - Sale		-900,000	20,905,285	-4.13	9.34	-8,406,810	195,274,177
2014-08-19	2014-08-15	4	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock, $0.001 par value	S - Sale		-680,722	21,805,285	-3.03	9.49	-6,458,963	206,897,266
2014-06-23	2014-06-18	4	DRNA	Dicerna Pharmaceuticals Inc Director Stock Option (right to buy)	A - Award		15,000	15,000
2014-05-08	2014-04-16	4/A	DRNA	Dicerna Pharmaceuticals Inc Director Stock Option (right to buy)	A - Award		25,000	25,000
2014-04-21	2014-04-16	4	DRNA	Dicerna Pharmaceuticals Inc Director Stock Option (right to buy)	A - Award		25,000	25,000
2014-02-05	2014-02-04	4	DRNA	Dicerna Pharmaceuticals Inc Series C Preferred Stock, par value $0.0001	C - Conversion		-1,428,571	0	-100.00
2014-02-05	2014-02-04	4	DRNA	Dicerna Pharmaceuticals Inc Common Stock, par value $0.0001 per share	P - Purchase		1,000,000	2,428,571	70.00	15.00	15,000,000	36,428,565
2014-02-05	2014-02-04	4	DRNA	Dicerna Pharmaceuticals Inc Common Stock, par value $0.0001 per share	C - Conversion		1,428,571	1,428,571
2014-01-13	2014-01-10	4	DSCI	DERMA SCIENCES, INC. COMMON STOCK, PAR VALUE $0.01	S - Sale		-190,000	1,694,876	-10.08	11.85	-2,251,500	20,084,281
2014-01-13	2014-01-10	4	DSCI	DERMA SCIENCES, INC. COMMON STOCK, PAR VALUE $0.01	S - Sale		-110,000	1,884,876	-5.51	11.80	-1,298,000	22,241,537
2013-11-22	2013-11-20	4	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock, $0.001 par value	P - Purchase		860,000	23,366,007	3.82	2.53	2,175,800	59,115,998
2013-11-22	2013-11-20	4	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock, $0.001 par value	P - Purchase		250,000	22,506,007	1.12	2.60	650,475	58,558,380
2013-11-01	2013-10-31	4	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock, $0.001 par value	P - Purchase		50,000	20,461,007	0.24	2.30	115,000	47,060,316
2013-11-01	2013-10-31	4	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock, $0.001 par value	P - Purchase		830,200	20,411,007	4.24	2.46	2,039,386	50,139,639
2013-11-01	2013-10-31	4	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock, $0.001 par value	P - Purchase		30,000	19,580,807	0.15	2.30	69,150	45,133,760
2013-11-01	2013-10-31	4	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock, $0.001 par value	P - Purchase		275,807	19,550,807	1.43	2.46	679,175	48,143,862
2013-10-16	2013-10-14	4	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock, $0.001 par value	P - Purchase		43,130	19,275,000	0.22	2.85	123,093	55,010,850
2013-10-16	2013-10-14	4	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock, $0.001 par value	P - Purchase		369,900	19,231,870	1.96	2.84	1,048,740	54,526,198
2013-10-16	2013-10-14	4	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock, $0.001 par value	P - Purchase		206,000	18,861,970	1.10	2.80	576,800	52,813,516
2013-10-16	2013-10-14	4	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock, $0.001 par value	P - Purchase		950,000	18,655,970	5.37	2.79	2,650,025	52,040,828
2013-10-16	2013-10-14	4	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock, $0.001 par value	P - Purchase		230,100	17,705,970	1.32	2.78	638,528	49,134,067
2013-10-16	2013-10-14	4	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock, $0.001 par value	P - Purchase		475,699	17,475,870	2.80	2.77	1,318,542	48,439,616
2013-10-16	2013-10-14	4	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock, $0.001 par value	P - Purchase		13,200	17,000,171	0.08	2.76	36,498	47,005,473
2013-10-16	2013-10-14	4	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock, $0.001 par value	P - Purchase		81,200	16,986,971	0.48	2.76	223,706	46,799,105
2013-10-15	2013-10-11	4	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock, $0.001 par value	P - Purchase		1,109,308	16,905,771	7.02	2.62	2,902,615	44,235,640
2013-10-15	2013-10-11	4	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock, $0.001 par value	P - Purchase		92,002	15,769,463	0.59	2.56	235,332	40,336,709
2013-10-15	2013-10-11	4	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock, $0.001 par value	P - Purchase		147,500	15,704,461	0.95	2.55	376,612	40,098,200
2013-10-15	2013-10-11	4	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock, $0.001 par value	P - Purchase		250,000	15,556,961	1.63	2.55	637,500	39,670,251
2013-10-15	2013-10-11	4	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock, $0.001 par value	P - Purchase		99,900	15,306,961	0.66	2.52	251,958	38,605,686
2013-10-15	2013-10-11	4	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock, $0.001 par value	P - Purchase		750,000	15,207,061	5.19	2.50	1,875,000	38,017,652
2013-10-04	2013-09-30	4	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock, $0.001 par value	P - Purchase		1,000,000	14,457,061	7.43	3.01	3,006,500	43,465,154
2013-10-04	2013-09-30	4	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock, $0.001 par value	P - Purchase		300,000	13,457,061	2.28	3.00	900,000	40,371,183
2013-10-04	2013-09-30	4	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock, $0.001 par value	P - Purchase		365,603	13,157,061	2.86	2.99	1,091,362	39,275,143
2013-10-04	2013-09-30	4	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock, $0.001 par value	P - Purchase		1,134,397	12,791,458	9.73	2.96	3,356,227	37,844,808
2013-10-04		3	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock, $0.001 par value				11,657,061
2013-05-01		3	DSCI	DERMA SCIENCES, INC. COMMON STOCK, PAR VALUE $0.01				1,990,931
2013-05-01	2013-04-29	4	DSCI	DERMA SCIENCES, INC. COMMON STOCK, PAR VALUE $0.01	P - Purchase		3,945	1,994,876	0.20	11.40	44,973	22,741,586

गैर-डेरिवेटिव या डेरिवेटिव प्रतिभूति की खुला बाज़ार या निजी खरीद

गैर-डेरिवेटिव या डेरिवेटिव प्रतिभूति का खुला बाज़ार या निजी बिक्री

कंपनी से प्रतिभूतियों का अनुदान, पुरस्कार या अन्य अधिग्रहण (जैसे एक ऑप्शन)

डेरिवेटिव का रूपांतरण

कंपनी को प्रतिभूतियों की बिक्री या हस्तांतरण

कंपनी से प्राप्त प्रतिभूतियों के हिस्से का उपयोग करके एक्सरसाइज मूल्य या कर दायित्व का भुगतान

इनसाइडर द्वारा या उसे प्रतिभूतियों का उपहार

इक्विटी स्वैप और समान हेजिंग लेनदेन

कंपनी से प्राप्त डेरिवेटिव प्रतिभूति के एक्सरसाइज या रूपांतरण (जैसे कि एक ऑप्शन)

किसी लेन-देन को स्वेच्छा से फॉर्म 4 पर रिपोर्ट किया गया

अन्य (लेन-देन का वर्णन करने वाले फ़ुटनोट के साथ)